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The incidence of CHD is about 0.8%, meaning 12.5 cases per 1000 life births [1]. Errors in the mor-
phogenesis of a normal four-chambered heart result in congenital heart disease (CHD), the most 
common form of birth defects. Heart formation is a complex morphogenetic process that requires 
correct function of 1) various embryological developmental regions (including the heart fields and 
the neural crest); 2) complex looping patterns resulting from selective growth and cell death, and 
3) numerous regulatory and structural genes [2]. Disruption of these processes cumulates in vari-
ous forms of CHD. In the minority of cases of CHD, there is a chromosomal or monogenetic defect. 
The majority of cases of CHD, however, are of multifactorial origin, meaning a complex interplay 
of genetic and environmental factors (i.e. a polygenic model). 
Up until now, several candidate genes have been identified in patients with defects of 
cardiac septation, conotruncal anomalies and/or underdevelopment of one of the ventricles [3]. 
In patients with a so called functionally univentricular heart, all these defects can be combined 
in one heart. Data on the embryological development of univentricular lesions are scarce, as are 
candidate genes [4]. Inheritance seems to be comparable to other types of congenital heart defect 
[5, 6], with 2-5% of siblings affected. Hypoplastic left heart syndrome is an exception with an 
overrepresentation of familial congenital heart disease, with 19-33% of siblings affected [7-9]. 
About ten percent of children with CHD have functionally univentricular hearts. The 
exact assessment of the incidence of functionally univentricular hearts is hampered by the com-
plexity of the lesions combined in this group. In epidemiologic studies, lesions like atrioventricular 
valve defects, aortic stenosis, pulmonary atresia, double outlet right ventricle and Ebstein’s anom-
aly may all include patients with an anatomy that does not allow biventricular repair. It is common 
to classify hypoplastic left heart syndrome, hypoplastic right heart syndrome and tricuspid atresia 
among the ‘single ventricle’ lesions. Combined, the estimate of these lesions is ± 650 per million 
[1]. In the Netherlands, this comes to about 120 new patients per year. 
In the normal heart, the right ventricle supports the pulmonary circulation and the left 
ventricle supports the systemic circulation. This results in two closed circuits, thereby preventing 
de-oxygenated blood to enter the systemic circulation without passing through the lungs for oxy-
genation (figure 1, right panel). In patients with a functionally univentricular heart, there is only 
one ventricle capable of sustaining both circulations (figure 1, left panel). Therefore, both the sys-
temic venous return and pulmonary venous return enter this single ventricle. Mixing of systemic 
venous blood with pulmonary venous blood causes arterial desaturation. Furthermore, the single 
ventricle, receiving both venous returns, suffers a volume overload and has to support both the 
pulmonary and systemic circulation. 
Various forms of CHD are clustered in the group of patients with functionally univen-
tricular hearts. Some patients have an underdeveloped right ventricle (e.g. patients with tricuspid 
atresia, pulmonary atresia/intact ventricular septum) and others have an underdeveloped left ven-
tricle (e.g. hypoplastic left heart syndrome). In many cases, underdevelopment of the ventricles 
is accompanied by septation defects (double inlet left ventricle, atrioventricular septal defect) or 
conotruncal anomalies (double outlet right ventricle, transposition of the great arteries). All these 
forms of CHD have in common that biventricular repair is not possible (hence the name “func-
tionally univentricular”). Palliation is the best available surgical option. In 1971, Francis Fontan 
described a surgical concept for patients with tricuspid atresia [10]. Although his original solution 
for connecting the systemic venous return directly to the pulmonary arterial circulation has been 
abandoned nowadays, his concept is the base of the surgical palliation that is currently being 
performed.
Figure 1. Right panel represents schematically the normal circulation, with two functional ventricles. The left 
panel represents the circulation in patients with a functionally univentricular heart. 
The Fontan operation
If left untreated the prognosis of patients with functionally univentricular hearts is poor, but vari-
able, depending on the anatomical and functional details of individual heart malformations [11, 
12]. Without surgical intervention only 10% of patients with tricuspid atresia survived beyond the 
first year of life [12]. Moodie et al. reported a survival of 50% of patients with left ventricular mor-
Chapter 1 General introduction and outline of the thesis
12 13
phology of the single ventricle at the age of fourteen years. In other types of morphology, survival 
may be as poor as 50% at the age of four years. Other factors affecting the natural history include 
the position of the great arteries and the extent of outflow tract obstruction [11].  
Before Fontan’s publication “Surgical repair of tricuspid atresia” [10], there were few sur-
gical options for patients with functionally univentricular hearts. The main options were ensuring 
adequate pulmonary blood flow (by creating a shunt from the systemic circulation to the pulmo-
nary circulation) or preventing excessive pulmonary blood flow (by pulmonary artery banding). 
Regulation of pulmonary blood flow lead to a substantial improvement of survival ranging from 
70% at five-year follow-up to 50% at the age of fifteen years [12, 13].  Separation of the systemic 
venous return and pulmonary venous return was not achieved and therefore these patients suf-
fered from the consequences of long-term desaturation and volume loading of the single ventricle. 
The concept of the Fontan operation is separation of the pulmonary and systemic cir-
culation by directly connecting the systemic venous return to the pulmonary arterial circulation, 
thus without interposition of a subpulmonary ventricle. This results in normalization of arterial 
saturation and in volume unloading of the single ventricle. Blood flow to the pulmonary arterial 
circulation, however, now depends on post-capillary energy that has to provide the impelling force 
for the systemic venous return [14]. 
Throughout the years, the means by which to connect the systemic venous return to 
the pulmonary arterial circulation have changed substantially. In his original paper, Fontan de-
scribed the use of a valved conduit from the right atrium to the pulmonary artery [10]. Valved 
conduits were soon abandoned, since their use was complicated by calcification of the valves. It 
was thought that inclusion of the right atrium in the circuit (i.e. an atriopulmonary connection, 
figure 2A), with maintenance of some contractility, would be beneficial for adequate pulmonary 
blood flow. However, the increased systemic venous pressure in this circulation eventually caused 
right atrial dilatation, with loss of flow efficiency, increased risk of thrombo-embolism and atrial 
arrhythmias. Therefore postoperative mortality of the initial Fontan operations was high and 
long-term survival was poor [15].
In 1988, de Leval and coworkers described the total cavopulmonary connection (TCPC, 
figure 2B) as a logical alternative to the atriopulmonary connection for patients with functionally 
univentricular hearts [16]. In the TCPC the superior caval vein is directed to the pulmonary artery 
with an end-to-side connection (a so called bidirectional Glenn anastomosis). The inferior caval 
vein is tunneled through the right atrium to the pulmonary artery (intra-atrial lateral tunnel ILT). 
This tunnel consists of right atrial free wall and prosthetic material that is sutured into the right 
atrium. Because this tunnel has a smaller diameter than the right atrium, energy loss is limited 
compared to the atriopulmonary connection [16]. In 1990, Marceletti et al. described the extracar-
diac conduit (ECC, figure 2C) as a new form of total cavopulmonary connection [17]. In this modi-
fication, the inferior caval vein is directed to the pulmonary artery by means of an extracardiac, 
completely prosthetic, conduit. 
Since the 1990’s the Fontan operation has increasingly been done in two stages [18]. 
In the first stage the superior caval vein is connected to the pulmonary artery  (i.e. a partial ca-
vopulmonary connection or PCPC). In the second stage the inferior caval vein is directed to the 
pulmonary artery (resulting in a TCPC), hereby restoring the pulmonary and systemic circulation 
functioning as two closed circuits. 
Figure 2. Panel A, atriopulmonary connection, with a direct connection between the right atrium (RA) and the 
pulmonary artery (PA). Panel B, total cavopulmonary connection, intra-atrial lateral tunnel, SVC = superior 
caval vein, IVC = inferior caval vein. Panel C, total cavopulmonary connection, extra cardiac conduit.
In 1977, Choussat et al. described their “ten commandments” a patient should met to 
be considered a suitable Fontan candidate [19]. In the current era criteria to opt for Fontan opera-
tion have been revised and include an unobstructed flow from the single ventricle to the aorta, 
balanced pulmonary and systemic flow and unobstructed venous return to the ventricle [14]. This 
may require additional procedures, for example to ensure or limit pulmonary blood flow by creat-
ing a systemic to pulmonary artery shunt or by pulmonary artery banding, or to ensure an unob-
structed single ventricular outflow tract (by performing a Damus-Kaye-Stansel procedure (usually 
as part of the Norwood operation for hypoplastic left heart syndrome) or a hemi-arterial switch 
operation).
 
Long-term outcome after Fontan operation
The Fontan procedure has dramatically increased life expectancy of patients with functionally 
univentricular hearts, and is accepted as the best palliative option for these patients. In a recent 
cohort study from Belgium, ± 90% of all patients with hypoplastic left heart syndrome or univen-
tricular physiology underwent PCPC or TCPC in a five-year follow-up after birth [20]. The period 
before the PCPC is characterized by volume overload and altered afterload of the single ventricle 
[14, 21], combined with a varying degree of hypoxaemia. This may result in abnormalities in ven-
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tricular systolic and diastolic function, incoordinate wall motion, increased ventricular wall stress, 
accompanied by increased myocardial oxygen consumption and increased coronary blood flow, 
and ventricular hypertrophy [14, 22-24]. The combination of hypoxaemia and abnormal loading 
conditions may have important long-term consequences for ventricular function, that extent be-
yond the period these abnormalities exist.
Contemporary techniques have improved long-term outcome, but medical complica-
tions still frequently occur. Survival has improved with the switch from atriopulmonary to TCPC: 
d’Udekem et al. reported a fifteen year survival in patients with atriopulmonary connection of 
81% compared to 94% in patients after TCPC [25].   The most common factors related to death 
are: heart failure, thrombo-embolism and sudden death [25-27].  
After the Fontan operation severe functional decline, including decline of aerobic fitness 
and heart failure, is common [27-31]. In a recent survey in patients aged 6-18 years of contempo-
rary outcomes of the Fontan operation (85% of 546 patients after TCPC), stroke and/or throm-
bosis occurred in 8% of patients, and 33% had non-sinus rhythm. Twenty-five percent of patients 
had a ventricular ejection fraction <50%, and 72% had abnormal diastolic function. Predicted 
maximum oxygen uptake was 65 ± 16% of normal and 58% used ACE inhibitors [32]. Important 
deficits in health status, a measure of health related quality of life, were noted, particularly in 
physical functioning. Poor health status was explained by non-cardiac conditions and by current 
medical problems, including arrhythmias occurring during follow-up, and the number of current 
medications [33]. 
Advances in pediatric cardiac care have resulted in an increasing number of adults with 
complex congenital heart disease being followed up in tertiary care centers. Marelli et al., studying 
the prevalence and age distribution of congenital heart disease from 1985 to 2000, reported the 
number of adults with complex congenital heart disease to increase with time: in the year 2000 
the number of adults already equalled the number of children with severe congenital heart disease 
[34].  Further increases in the adult population are to be expected since the largest reduction in 
mortality rates in children have been achieved over the past years [35].  As the population of adults 
with complex congenital heart disease and Fontan physiology increases, so does the occurrence of 
highly morbid and mortal outcomes, including heart failure and thrombo-embolism [36].
Poor outcome in patients has been related to pre-operative factors, including the balance 
between systemic and pulmonary flow, ventricular volume before cavopulmonary connections, 
timing and staging of the operation, heart rate and rhythm and to factors inherent to the Fontan 
circulation. These include: a.) limited venous capacitance b.) energy loss from non-laminar flow 
in the Fontan pathway, c.) abnormal growth and compliance of the pulmonary artery resulting 
from the abnormal, non-pulsatile flow pattern after the PCPC, d.) impaired diastolic ventricular 
function, all of which factors (a-d) may contribute to impaired ventricular filling, e.) the ventricular 
dominancy of the single ventricle, and f.) abnormal regional and global ventricular function [14, 
37-42]. 
The abnormal performance of the functionally univentricular heart results in activation 
of circulatory and myocardial adaptive mechanisms to stress [43]. Few data exist on the role of 
neuro-hormonal activation in children and young adults after Fontan operation treated accord-
ing to current treatment strategies. The long-term effects of the abnormal, non-pulsatile flow 
pattern on pulmonary artery growth and function are a matter of concern. Several groups have 
studied the effects of a bidirectional Glenn or Fontan pathway on pulmonary artery growth and 
diameters but have shown equivocal results [44-46]. It has become increasingly clear that the 
transport function of the intra-atrial lateral tunnel or the extracardiac conduit as well as that of 
the pulmonary circulation is important for ventricular performance, exercise function, and the 
long-term outlook of patients after the Fontan operation [14, 47-49]. Consequently, studies of 
ventricular function, atrial level transport and of the pulmonary arteries in the Fontan circulation 
might benefit from studies during stress.
Outcome studies in patients with congenital heart disease are often limited by an insuf-
ficient number of patients included to provide adequate statistical power and by absence of a 
primary outcome that can be observed in a reasonable period [50]. However, with an increasing 
patient population it becomes important to identify patients at risk for adverse outcome. Second-
ary outcome variables, reliably predicting primary outcome – such as mortality – and occurring 
more frequently are needed in the follow-up of patients with complex congenital heart disease. 
Therefore, there is an increasing need of easily accessible and accurate assessment of hemody-
namics in the search for parameters that give prognostic information in this patient population. 
Cardiovascular magnetic resonance imaging
From 1984, cardiac magnetic resonance (CMR) imaging is used to study the cardiovascular sys-
tem [51]. It has proven to be a valuable, additional imaging modality in the study of the anatomy 
and function of the heart and great vessels [52]. CMR imaging is not hampered by the anatomic 
orientation in the thorax that is one of the limitations of echocardiography. It is therefore capable 
of providing adequate analysis of right and left ventricular function, even in complex congenital 
heart disease.  
CMR imaging is considered the gold-standard for assessment of global ventricular func-
tion [52]. In patients with Fontan physiology it is an important tool to evaluate cardiac and pulmo-
nary artery function. CMR imaging has been used for the assessment of ventricular performance 
in congenital heart disease for at least fifteen years now. Clinical indications for CMR assessment 
of global ventricular and vascular function become relevant in children aged eight years and older. 
Although CMR imaging is increasingly being implemented in the follow-up of pediatric patients 
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with congenital and acquired heart disease, normative data on ventricular volumes, function, and 
mass for this population are lacking. Normal values from small studies, employing gradient-echo 
MRI sequences are used [53, 54]. In recent years, however, steady-state free precession (SSFP) 
gradient echo sequences have become the standard method for assessment of ventricular func-
tion and volumetric parameters with CMR imaging [52]. Compared to the previously used spoiled 
gradient-echo sequences, SSFP provides better blood-myocardial contrast, higher image quality 
and faster acquisition times [55]. Better blood-myocardial contrast in SSFP imaging results in sta-
tistically significantly higher end-diastolic volumes, and end-systolic volumes, lower mass and 
lower ejection fraction [56, 57]. Therefore, SSFP derived data cannot be compared to data obtained 
with spoiled gradient echo sequences. 
In addition, SSFP has a lower interobserver variability and better reproducibility com-
pared to gradient-echo [56-58]. Therefore, it has been suggested that this technique allows con-
siderable reduction in subject numbers to prove a hypothesis in research studies and study groups 
can be up to 90% smaller than with echocardiography for establishing significant differences [59, 
60]. The reproducibility of CMR imaging in patients with congenital heart disease has only been 
tested in a limited number of studies, generally including few patients. 
Stress imaging
Studies of cardiac anatomy and function in patients with congenital heart disease are generally 
performed at rest.  Exercise results in the combined activation of cardiac, pulmonary, vascular, 
neurohormonal, muscular and metabolic systems. Combined, this will result in important changes 
in contractility and loading conditions that may directly affect cardiac function. Therefore, it has 
been questioned if the function of the heart at rest is an adequate predictor for cardiac function 
with exercise, particularly in patients who have undergone complex repair of congenital heart dis-
ease. Assessment of the contractile reserve, i.e. the change of cardiac function with exercise, has 
been shown to have prognostic value in several types of acquired heart disease [61-65].  
CMR imaging combined with pharmacological stress was introduced in 1992 [66], and 
has proven to be a valuable tool to detect ischemia in patients with known or suspected coronary 
arterial disease [67, 68]. Dobutamine stress CMR imaging can assess wall motion abnormalities, 
contractile reserve, abnormalities of diastolic function, and vascular function. There is extensive 
experience with stress CMR imaging in adults using pharmacological stress.  Experience with CMR 
imaging combined with stress in patients with congenital heart disease is limited. A few groups 
have reported on the use of this modality to evaluate the reaction of the cardiovascular system in 
congenital heart disease patients under pharmacological stress conditions [69-76]. These studies 
have shown abnormal systolic function, abnormal diastolic function, and abnormal vascular re-
sponses to stress in these patients that help understand the pathophysiological processes. An im-
portant advantage of dobutamine stress CMR imaging is that all these parameters can be obtained 
in one single study. A few studies have been performed using physical stress [48, 77-80] in older 
children and young adults, but practical limitations have prevented the widespread use of this 
technique. In congenital heart disease, dobutamine is the most commonly used pharmacological 
stressor. Dobutamine increases the myocardial demand for oxygen similar to physical exercise, 
and is used to study contractile reserve and abnormalities of ventricular wall motion. Dobutamine 
also enhances diastolic function, and decreases preload and afterload. Studies in patients with 
congenital heart disease have used low dose dobutamine, with doses ranging from 5.0 to 20 μg/
kg/min [69, 81]. Few studies have been done in children. As with CMR studies at rest, safety and 
variability of stress CMR imaging have not been tested in patients with congenital heart disease. 
Outline of the thesis
The aim of this thesis was to study outcome in patients with functionally univentricular hearts 
after Fontan operation at young age. Main objectives of the studies in this thesis were:
- To compare morbidity and mortality in patients after two contemporary modifications 
of the Fontan operation, i.e. the intra-atrial lateral tunnel and the extracardiac conduit
- To study clinical and hemodynamic parameters in a subgroup of patients after Fontan 
operation at young age, with a special emphasis on the use of CMR imaging
- To compare the CMR results of Fontan patients with matched healthy controls by assess-
ing normal values of biventricular function, volumes, and mass
- To study the safety and reproducibility of CMR imaging at rest and during low-dose do-
butamine stress in patients with complex CHD
- To explore the role of some candidate genes for development of univentricular hearts in 
an unselected clinical population after the Fontan operation
In chapter 2 we describe a multicenter comparative study on morbidity and mortality after two 
currently used modifications of the Fontan operation: the intra-atrial lateral tunnel and the extra-
cardiac conduit.
In chapter 3 to 5 we report our results on clinical outcome and hemodynamic assessment of 
ventricular and pulmonary arterial function in up to 40 patients after staged Fontan operation, 
completed at young age. In chapter 3 a detailed assessment of the clinical state at mid-term to 
long-term follow-up after TCPC – predominantly intra-atrial lateral tunnel technique – performed 
in at least two stages is described. Chapter 4 shows our results of global ventricular function at 
rest and during low-dose dobutamine stress. In chapter 5 we explore pulmonary artery size and 
function at rest and during low-dose dobutamine stress in selected Fontan patients.
Chapter 1 General introduction and outline of the thesis
18 19
In chapter 6 we describe the results of CMR assessment of biventricular function, volumes, and 
mass in 60 healthy children aged 8-17 years. Adequate normal values as assessed with currently 
used CMR imaging settings were missing in the literature and hampered comparison of our results 
acquired in Fontan patients. 
Chapter 7 and 8 describe the safety, feasibility and intra-observer and interobserver variability 
of CMR assessment of biventricular function, volumes, and mass in patients with complex CHD. 
In chapter 7 we report our results during CMR studies at rest. Chapter 8 describes the results of 
these parameters during low-dose dobutamine stress. Chapter 9 provides an overview of stress 
imaging studies that have been performed in children with cardiac disease and adults with con-
genital heart disease, focusing on studies using echocardiography or cardiac magnetic resonance 
imaging.  
Chapter 10 studies genetic factors that may play a role in the development of functionally univen-
tricular hearts. The results of the aforementioned studies are discussed in chapter 11. 
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Abstract
Objective: to compare the outcome of two contemporary techniques for total cavopulmonary 
connection (TCPC): the intra-atrial lateral tunnel (ILT) and extracardiac conduit (ECC).
Methods: we included 209 patients after staged TCPC (102 ILT, 107 ECC), operated on between 
1988 and 2008. Medical records, and surgical records were reviewed for (1) patient demographics 
and cardiac anatomy; (2) pre-Fontan procedures; (3) pre-Fontan hemodynamics and cardiac func-
tional status (4) operative details; (5) post-operative hospital course; (6) follow-up information on 
arrhythmias, and thrombo-embolic events; (7) post-Fontan interventions; (8) clinical status at last 
follow-up until June 2008. 
Results: median follow-up duration was 4.3 years (interquartile range 1.5-7.4). At 6 year follow-
up freedom from Fontan failure (i.e. mortality or re-operations for Fontan failure) was 83% for 
the ILT, and 79% for the ECC (p = 0.6), freedom from late re-operations (other than re-operations 
for Fontan failure) was 79% for the ILT and ECC and freedom from arrhythmias was 83% for the 
ILT, and 92% for the ECC (p = 0.022). Multivariable Cox regression analysis identified intensive 
care unit stay and cardiopulmonary bypass time as risk factors for Fontan failure, but they were 
not strong predictors. Right ventricular morphology was identified as risk factor for arrhythmias. 
The occurrence of thrombo-embolic events was low with no difference between the ILT and ECC 
group, and irrespective of the post-operative use of anticoagulant or anti-platelet aggregation 
therapy. At most recent follow-up sinus rhythm was present in 70% of patients; in 23% of patients 
ventricular function was moderately or severely impaired at echocardiography.
Conclusions: outcome after staged ILT and ECC-type Fontan operations is good, with comparable 
freedom from late re-operations and freedom from Fontan failure at 6 year follow-up. The inci-
dence of arrhythmias was significantly lower in the ECC-group. Right ventricular morphology was 
identified as risk factor for arrhythmias. 
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Introduction
The Fontan operation is a palliative procedure for patients in whom biventricular repair of their 
complex congenital heart defect – resulting in a functionally univentricular heart – cannot be per-
formed. In 1988, De Leval and coworkers described the total cavopulmonary connection (TCPC) 
as a modified approach to Fontan reconstruction [1], a modification with superior hydrodynamic 
characteristics compared to the previously used atriopulmonary connection. In this reconstruc-
tion, systemic venous return is directed to the pulmonary arterial circulation by means of a bidi-
rectional Glenn anastomosis (BDG), connecting the superior caval vein to the pulmonary artery, 
and a connection from the inferior caval vein to the pulmonary artery. The latter can be done 
by either an intra-atrial lateral tunnel (ILT), according to the report by De Leval [1], or by an ex-
tracardiac conduit (ECC) [2]. TCPC results in separation of the systemic and pulmonary venous 
return and in volume unloading of the systemic ventricle. Nowadays, this is performed as a staged 
procedure since volume unloading with a BDG prior to TCPC improves outcome and ventricular 
energetics after TCPC [3-5]. The BDG is usually performed in the first year of life and completion 
with an ILT or ECC usually takes place in the third or fourth year of life [6,7]. 
Since the introduction and implementation of the TCPC in the late 1980s, morbidity and 
mortality have decreased significantly as compared to outcome after atriopulmonary connection 
[7,8]. Recent survival cohorts of Fontan patients have shown improved survival, but most of these 
studies also included patients with older Fontan types (right atrium to right ventricle conduit, 
atriopulmonary connection) [5,8,9]. It is of importance to study the outcome of Fontan patients 
operated on according to current treatment strategies, and to compare the outcome of patients 
with an ILT and ECC. The current survival reports that include patients with a TCPC have limited 
patient numbers (especially for comparison of ILT and ECC), or include patients with and without 
staging, or have a limited follow-up duration [9-12]. The objective of our study was to compare the 
outcome of staged ILT and staged ECC.
Materials and Methods
Patients 
We searched for patients after TCPC, operated on between January 1988 and January 2008, in 
the surgical databases of three tertiary referral centers for pediatric cardiac surgery and cardiol-
ogy. The following patients were excluded: (1) patients who had undergone conversion of a right 
atrium to right ventricle conduit or atriopulmonary connection into a TCPC; (2) patients who did 
not have a preceding BDG anastomosis; (3) patients who had undergone a Kawashima operation 
for functionally univentricular hearts with azygos continuation of the inferior caval vein. 
Data inclusion 
Medical records, and surgical records of all patients were reviewed for the following data: (1) pa-
tient demographics and cardiac anatomy; (2) pre-Fontan procedures; (3) pre-Fontan hemodynam-
ics and cardiac functional status from cardiac catheterization, echocardiography, and electrocardi-
ography reports; (4) operative details; (5) post-operative hospital course; (6) follow-up information 
on occurrence and treatment of arrhythmias, and thrombo-embolic events; (7) post-Fontan inter-
ventions; (8) clinical status at last follow-up from medical history, physical examination, echocar-
diography, and electrocardiography reports. These data were included until June 2008.
Definitions 
Early sequelae were defined as complications within 30 days after Fontan completion. All other 
complications were considered late. The primary endpoint was Fontan failure, defined as death, or 
re-operation for revision of the Fontan circulation. Fontan takedown or heart transplantation has 
not been performed in this cohort. Secondary endpoints were arrhythmias, and late re-operations 
other than re-operations for Fontan failure. Arrhythmias were defined as documented bradyar-
rhythmias or tachyarrhythmias that required intervention.
Statistical analysis 
Continuous data were tested for normality using the Kolmogorov-Smirnov test. Data with a nor-
mal distribution are expressed as mean value ± one standard deviation (SD), whereas the median 
(interquartile range, 25th and 75th percentile) is shown for data with a non-normal distribution. 
Dichotomous data are presented as counts and percentages, and differences between groups of 
patients were evaluated by chi-square tests or Fischer’s exact tests, as appropriate. A p-value < 
0.05 (two-sided test) was considered to indicate statistical significance.
The incidence of the primary and secondary endpoints over time was evaluated accord-
ing to the Kaplan-Meier method. Follow-up time was defined as the time from Fontan surgery to 
the endpoint event or last follow-up visit. Differences in the incidence of the endpoints between 
the two Fontan types were evaluated by the log-rank test.
Predictors of Fontan failure or arrhythmias were explored in univariable Cox regression 
models. Variables with a p-value < 0.15 were entered in a stepwise multivariable Cox regression 
model, that was corrected for the participating centers, and for the year of operation. Variables 
with skewed distributions (intensive care stay, cardiopulmonary bypass time) were entered in the 
model as a single term and as a quadratic term to test for possible non-linear contributions. The 
quadratic terms for these two variables were not significant in a multivariable model, implying a 
linear relationship between the risk factor and outcome. A p-value < 0.05 was required for a vari-
able to be retained in the equation.
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Results
Demographics and anatomy 
From 1988 to 2008, 277 patients had undergone a TCPC in the three institutions. The following 
patients were excluded: 1) fifteen patients for a previous atriopulmonary connection (n = 13) or 
right atrium to right ventricle conduit; 2) 41 patients did not have a preceding BDG anastomosis; 
3) twelve patients for a Kawashima type operation. In this study, 209 patients (118 men) were 
included. Characteristics of the study population are listed in table 1. 
Table 1. Characteristics of the study population
Variable ILT ECC
Number (males) 102 (62) 107 (56)
Ventricular morphology  
   Right ventricle (n) 48 44
      Hypoplastic left heart syndrome (n) 15 29 †
   Left ventricle (n)  52 62
      Tricuspid atresia (n) 16 38 †
   Indeterminate (n) 2 1
Abbreviations: ECC = extracardiac conduit; ILT = intra-atrial lateral tunnel. † Statistically significantly 
different from ILT.
 
Six patients were lost to follow-up. Three patients returned to their home country immediately 
after hospital discharge. Another three patients moved after 1.7 to 2.7 years of follow-up and 
were censored at that time. These six patients and 26 patients who died after Fontan completion 
were excluded from the assessment of current clinical status. Median follow-up duration of the 
remaining patients was 4.3 years (1.5-7.4). Median age at most recent follow-up visit and follow-
up duration were significantly longer in patients with an ILT (table 2). 
Surgical procedures 
Before Fontan completion, 502 procedures were performed in 209 patients. Subtypes of pre-Fon-
tan procedures are displayed in table 3. Of note, five patients received a pacemaker before the 
TCPC. Two of these patients had a congenital complete atrioventricular block. The other three 
patients developed complete atrioventricular block or symptomatic bradycardia during the pre-
Fontan period. Median age at BDG anastomosis and the median interval between BDG and TCPC 
were comparable in patients with an ILT or ECC. The BDG was bilateral for persisting left superior 
vena cava in nineteen patients. There was no difference in pre-Fontan hemodynamics and vari-
ables of cardiac function for the two subgroups (table 3, cardiac catheterization reports available 
in 97%, echocardiography reports available in 93% of patients). Between 10 and 15% of patients 
had moderately or severely impaired ventricular function or moderate to severe atrioventricular 
valve insufficiency on pre-Fontan echocardiography. 
The first staged TCPC (ILT) in this study was performed in 1990. Before this year, staged 
volume unloading with a BDG was not performed. The first staged ECC in this study was per-
formed in 1996. An ILT or an ECC was performed according to the surgeon’s preference. Age and 
weight at the time of Fontan completion were comparable in the two groups (table 4). In both 
groups, circulatory arrest was performed in only one patient. In the ECC-group, the majority of op-
erations (76%) were performed with continuous coronary perfusion. Seventeen patients received 
a 16 mm Vascutek conduit, one patient had a 16 mm Goretex conduit, 33 had an 18 mm Goretex 
conduit, and in 56 patients the Goretex conduit diameter was at least 20 mm. Fenestrations were 
performed on hemodynamic indications (table 4).
Table 2. Follow-up details
Variable ILT (n = 83) ECC (n = 94)
Age at most recent follow-up visit (years) 10.7 (7.0-14.3) 7.5 (5.0-9.5)† 
Follow-up time since Fontan completion (years) 7.4 (4.3-10.0) 3.8 (1.6-5.6) †
Medication: none (n) 1 13† 
 Angiotensin converting enzyme inhibitors (n) 14 22
 Anti-arrhythmics (n) 2 0
 Platelet inhibition (n) 11 64
 Anticoagulants (n) 70 13
Rhythm status: sinus rhythm (n) 61 59
 Atrial rhythm (n) 11 26
 Pacemaker implantation 8 4
Moderately/severely impaired ventricular function (n) 22 14
Moderate/severe atrioventricular valve insufficiency (n) 12 7
Moderate/severe (neo-) aortic insufficiency (n) 5 4
Post-Fontan procedures  
 Closure of right-to-left connections (n) 14 5
 Atrioventricular valve repair (n) 1 2
 Damus-Kaye-Stansel anastomosis (n) 1 1
 Mechanical aortic valve prosthesis (n) 2 0
 Graft replacement of aortic valve and ascending aorta (n) 1 0
 Recoarctation repair (n) 0 1
 Left pulmonary artery repair (n) 2 2
Abbreviations: ECC = extracardiac conduit; ILT = intra-atrial lateral tunnel. † Statistically significantly 
different from ILT.
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In 35 patients (19 ILT, 16 ECC) 54 late procedures were performed after Fontan completion other 
than re-operations for Fontan failure (table 2). The Kaplan-Meier estimates of freedom from re-
operation were (figure 1a): (1) ILT: 1 year 98% (SE 2%); 3 years 92% (SE 3%); 6 years 79% (SE 5%); 
(2) ECC: 1 year 94% (SE 3%); 3 years 82% (SE 4%); 6 years 79% (SE 5%) (log rank test p = 0.6).
Fontan failure
Thirty-day mortality was 4% (4 ILT, 5 ECC). Late mortality occurred in 10% (13 ILT, 5 ECC). Twelve 
patients required a re-operation of the Fontan circulation (2 ILT, 10 ECC). These included seven 
early interventions, one of who died shortly after re-operation: creation or enlargement of a fen-
estration (n = 3), shortening of the ECC for distortion (n = 1), stenting of the superior caval vein for 
obstruction (n = 1), ECC replacement and fenestration for thrombosis of the conduit (n = 1), and 
extracorporeal membrane oxygenation for severe pulmonary hypertension (n = 1). Two
Table 3. Pre-Fontan variables
Variable ILT  ECC
Pre-Fontan procedures  
 Modified BT-shunt (n) 34  19 †
 Central shunt (n) 6  17 †
 Pulmonary artery banding (n) 26  24
 Atrioseptectomy 26  37
 Norwood (BT-shunt/RV-PA conduit) (n) 15  (10/4) 32  (25/7)† 
 Systemic atrioventricular valve repair (n) 2  3
 Branch pulmonary artery repair (n) 19  25
 Pacemaker implantation (n) 1  5
Age at BDG (years) 0.9  (0.6-1.8) 0.7  (0.5-1.3)
Interval between BDG and TCPC (years) 1.8  (1.3-2.4) 2.2  (1.7-3.0)
Pre-Fontan hemodynamics/cardiac function
 End-diastolic pressure (mm Hg) 9.0  (8.0-11.0) 9.4  (8.0-12.0)
 Mean pulmonary artery pressure (mm Hg) 11.2  (10.0-13.0) 11.0  (9.0-12.0)
 Mildly/moderately impaired ventricular function (n) 14  11
 Moderate/severe AV valve insufficiency (n)  12  13
 Sinus rhythm (n) 87  84
 Room-air oxygen saturation (%) 83  (79-87) 83  (79-85)
Abbreviations: AV = atrioventricular; BDG = bidirectional Glenn anastomosis; BT = Blalock-Taussig; 
ECC = extracardiac conduit; ILT = intra-atrial lateral tunnel; RV-PA = right ventricle to pulmonary artery; 
TCPC = total cavopulmonary connection. † Statistically significantly different from ILT.
Table 4. Characteristics of the Fontan completion
Variable ILT  ECC
Age at TCPC (years) 3.0  (2.5-3.9) 3.2 (2.5-4.1)
Weight at TCPC (kg) 14.0  (12.1-15.9) 14.0 (12.2-15.8)
Cardiopulmonary bypass time (minutes) 107 (90-138) 141 (97-204)  † 
Aortic cross-clamp time (minutes) 61 (49-74) 42 (19-62)  †; n = 26 
Minimal temperature (°C) 28 (26-29) 31 (28-32)  †
Chest tube drainage (days) 11 (7-18) 13 (8-22)
Intensive care unit stay (days) 6 (3-12) 4 (2-7)  †
Total hospital stay (days) 17 (12-27) 21 (14-32)
Concomitant procedures at TCPC  
 Branch pulmonary artery repair (n) 8  12
 Atrioventricular valve repair (n) 5  4
 Relief of subaortic obstruction (n) 4  1
 Fenestration (n) 19  15
Abbreviations: ECC = extracardiac conduit; ILT = intra-atrial lateral tunnel; TCPC = total cavopulmonary 
connection. † Statistically significantly different from ILT.
patients with thrombosis in the Fontan circulation and pulmonary hypertension were treated with 
sildenafil post-operatively. In five patients the ECC had to be revised or replaced during follow-up 
0.3 to 9.5 years after Fontan completion. Four of these were 16 mm conduits that are not being 
used nowadays. The Kaplan-Meier estimates for freedom from Fontan failure were (figure 1b): (1) 
ILT: 1 year 86% (SE 4%); 3 year 85% (SE 4%); 6 year 83% (SE 4%); (2) ECC: 1 year 88% (SE 3%); 3 
year 88% (SE 3%); 6 year 79% (SE 6%) (log rank test p = 0.93). Table 5 shows the variables iden-
tified as risk factors for Fontan failure by univariable Cox regression analysis. In a multivariable 
model intensive care unit stay and total cardiopulmonary bypass time were statistically significant 
predictors of Fontan failure, however both hazard ratios were only minimally over 1.0.
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Table 5. Predictors of Fontan failure
Risk factor Hazard Ratio 95% CI p-value
Univariable   
 Right ventricular morphology 2.5 1.2 – 5.4 0.014
 Pre-Fontan moderate/severe AVV insufficiency 2.4 1.0 – 5.7 0.05
 Total CPB time  1.009 1.005 – 1.012 <0.001
 Intensive care unit stay 1.04 1.02 – 1.06 <0.001
Multivariable   
 intensive care unit stay 1.04 1.02 – 1.06 <0.001
 Total CPB time 1.008 1.005 – 1.012 <0.001
Abbreviations: AVV = atrioventricular valve; CPB = cardiopulmonary bypass.
Table 6. Predictors of arrhythmias
Risk factor Hazard Ratio 95% CI p-value
Univariable   
 Right ventricular morphology 3.5 1.3 – 9.3 0.011
 ILT 5.1 0.97 – 27 0.054
 Pre-Fontan AVV repair 5.5 1.2 – 24.7 0.028
 Pre-Fontan moderate/severe AVV insufficiency 2.3 0.8 – 7.1  0.135
Multivariable   
 Right ventricular morphology 4.3 1.5 – 11.9 0.006
Abbreviations: AVV = atrioventricular valve; ILT = intra-atrial lateral tunnel.
Arrhythmias 
Early post-operative arrhythmias occurred in fifteen patients (twelve ILT, three ECC). Six patients 
received a (temporary) pacemaker for bradyarrhythmias, nine patients experienced tachyarrhyth-
mias. Late arrhythmias occurred in sixteen patients (thirteen ILT, three ECC). New atrial tachyar-
rhythmias were documented in six patients, two of who were on anti-arrhythmic medication at 
last follow-up. Two patients received a pacemaker. One patient had ventricular fibrillation and 
died. Bradyarrhythmias were diagnosed in nine patients, six of who received a pacemaker. The 
Kaplan Meier estimates of freedom from arrhythmias were (figure 1c): (1) ILT, 1 year 87% (SE 4%); 
3 years 87% (SE 4%); 6 years 83% (SE 4%); (2) ECC, 1 year 96% (SE 2%); 3 years 96% (SE 2%); 6 
years 92% (SE 4%) (log rank test p = 0.022). In a multivariable model right ventricular morphology 
was a predictor for arrhythmias (table 6).
  
Thrombo-embolic events 
Early thrombo-embolic complications occurred in thirteen patients (five ILT, nine ECC), five of who 
were on routine anticoagulation after TCPC. These included thrombosis of the ECC (n = 3), or ILT 
(n = 1), branch pulmonary arteries (n = 2), inferior caval vein/hepatic veins (n = 2); pulmonary 
embolisms (n = 2), and cerebrovascular accidents (n = 3). Late thrombo-embolic events occurred 
Figure 1. Kaplan-Meier estimates of freedom 
from late re-operation (A), freedom from Fon-
tan failure (B), and freedom from arrhythmias 
(C). The straight line represents the intra-atrial 
lateral tunnel; the dotted line represents the 
extracardiac conduit. The hatch marks on each 
curve represent the patients censored at end 
of follow-up. 
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in three patients (two ILT, one ECC), 0.2-10.1 years after Fontan completion: complete thrombosis 
of the 16 mm Vascutek ECC 4 months after Fontan operation; multiple pulmonary embolisms and 
veno-occlusive disease; and a transient ischemic attack. The first patient was on platelet aggrega-
tion inhibition; the latter two patients were on oral anticoagulation. Evaluation of hemostasis did 
not reveal any abnormalities. 
Clinical status at last follow-up 
Median room air oxygen saturation was 95% (92-97). Echocardiographic or angiographic evidence 
of persistent right-to-left connections was present in 29 patients: in 25 patients (21 ILT (8 after 
fenestrated Fontan), 4 ECC; p < 0.001) there was a connection through the intra-atrial baffle; in 
four patients (one ILT, three ECC) there were veno-venous collaterals. 
Rhythm status is displayed in table 2 and was available in 171 patients (97%). Sinus 
rhythm was present in 70%, thirteen (8%) patients had a pacemaker. Atrial rhythm was present 
in 22%, and only two patients had a junctional rhythm (1%). A summary of the medication used 
is displayed in table 2. The difference in anti-platelet and anti-coagulant therapy between the ILT 
and ECC group is explained by the fact that two institutions are performing ECC Fontan operations 
nowadays and prefer platelet aggregation inhibition at least during childhood. The third institution 
performs ILT Fontan operations and prefers oral anticoagulants as antithrombotic prophylaxis. 
One patient was on sildenafil therapy for pulmonary hypertension. 
Echocardiography at most recent follow-up was available in 158 patients (89%) (table 2). 
Global ventricular function was moderately or severely reduced in 23% of patients, the majority 
having had an ILT. Moderate or severe atrioventricular valve insufficiency was present in 12% of 
patients and moderate or severe (neo-)aortic insufficiency in 6% of patients.
Discussion
In this paper, we describe a cohort of Fontan patients who were all operated on according to cur-
rent techniques; i.e. TCPC preceded by BDG. Shortly after De Leval’s publication on the ILT [1], 
Marcelletti and coworkers reported on the use of the ECC for completion of the TCPC [2]. The lat-
ter technique was proposed for patients with complex anomalies of the atrioventricular valve, and 
the pulmonary or systemic venous return. Advantages of the ECC are the possibility to perform 
the Fontan completion without aortic cross-clamping, and possible reduction of the incidence 
of arrhythmias compared to the ILT. However, there are concerns on the incidence of thrombo-
embolic complications and late re-operations. In this study, we compared the outcome between 
102 patients with an ILT and 107 patients with an ECC. 
Fontan failure 
Thirty-day mortality was 4% in this cohort and late mortality was 10%. At six years of follow-up 
there was no significant difference in Fontan failure between the ILT and the ECC (figure 1b). We 
identified two risk factors for Fontan failure with multivariable Cox regression analysis; intensive 
care stay and total cardiopulmonary bypass time. The hazard ratios of intensive care stay and 
total cardiopulmonary bypass time were only marginally over 1.0. Both variables were not strong 
predictors of Fontan failure in this study. Others have identified right ventricular morphology as a 
risk factor for early mortality [13] and Anderson et al. recently demonstrated that right ventricular 
morphology is associated with poorer mid-term ventricular and valvular function [14]. However, 
we recently reported preserved contractile reserve with low-dose dobutamine stress-testing in 
patients with a dominant right ventricle at a median follow up time of 8.1 years after TCPC [15]. 
 Re-operations for Fontan failure were more frequent in the ECC-group. Most of the late 
re-operations included replacement of conduits with a diameter of 16 mm, which are not being 
used nowadays. Excluding these patients from the analysis, resulted in a non-significant compari-
son of re-operations between the ILT-group and ECC-group. Recently, Lee et al. [16] showed that 
even at only three years of follow-up, extracardiac conduit diameter decreased with about 14% 
irrespective of the original conduit diameter. The ideal conduit diameter still has to be assessed at 
long-term follow-up.
Arrhythmias 
Early and late arrhythmias occurred in 7% and 9% of patients respectively. Freedom from ar-
rhythmias was significantly higher in patients with an ECC, analyzed up to six years after Fontan 
completion. In our study, right ventricular morphology was identified as a risk factor for arrhyth-
mias in a multivariable model. 
 The incidence of late arrhythmias in our study is slightly lower than in a large cohort 
from the Pediatric Heart Network [17], but the North-American cohort also included some pa-
tients with an atriopulmonary connection. In comparison with the atriopulmonary connection, 
the incidence of atrial arrhythmias is lower in patients with an ILT [5,18], but can still run up to 20% 
during follow-up [7,19]. In patients with an ECC, the incidence of arrhythmias has been reported up 
to 15%, at a follow-up duration of fifteen years [20,21]. There are only a few studies comparing the 
incidence of arrhythmias in ILT and ECC-groups [10-12]. Fiore et al. did not find any difference in 
arrhythmias between their ILT and ECC group. In the study by Kumar et al. sinus node dysfunction 
occurred more frequently in patients with an ECC [12]. They concluded that staging with a BDG, 
as opposed to performing a hemi-Fontan, was a risk factor for developing sinus node dysfunction. 
Azakie et al. identified the ILT as a risk factor for mid-term arrhythmias (up to six years of follow-
up) and found a higher incidence of atrial rhythm in the ILT group [11]. In our cohort after staging 
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with a BDG, there was a clear difference in the incidence of arrhythmias, with a low incidence of 
3% in the ECC-group up to six years after TCPC. However, in a multivariable model corrected for 
year of Fontan operation, the ILT was not identified as a risk factor for arrhythmias. Possibly, in our 
study, evolution of operation techniques was an important factor in the incidence of arrhythmias 
throughout follow-up. 
At most recent follow-up, the majority of our patients was in sinus rhythm, with compa-
rable proportions in the ILT and ECC- groups, and a comparable percentage to other reports [14]. 
Surprisingly, more patients in the ECC-group had an atrial rhythm. This difference could not be 
explained by a differences in atrioseptectomies or staging procedures between the two groups. 
The above mentioned studies do not show a superiority of one Fontan modification over the other 
in the incidence of arrhythmias. However, different studies use different definitions of arrhythmias 
and all studies have been retrospective. This underlines the need for longer follow-up to study the 
incidence of arrhythmia and preservation of sinus rhythm using uniform definitions.
Thrombo-embolic events 
In theory, the ECC can be a risk factor for the development of thrombo-embolisms. In our study, 
as in other reports [20,21], there was no difference in the incidence of thrombo-embolic events 
between the ILT and ECC group. The incidence of early events was 6%, late incidence was only 
2%. This is considerably lower than earlier studies that reported incidences of up to 20% [22-24]. 
There is still much debate on the appropriate antithrombotic therapy after Fontan opera-
tion. In our study, two institutions preferred platelet aggregation inhibition at least during child-
hood, with oral anticoagulants in selected cases. The third institution preferred oral anticoagulant 
therapy as the standard. Up until now, neither of these two options has proven to be superior to 
the other in the prevention of late thrombo-embolic events [23,24]. Seipelt et al. recommended 
the use of anticoagulants in the early follow-up, since they saw a peak incidence of thrombo-
embolisms in the first post-operative year [23]. Although there were more early thrombo-embolic 
complications in our study than late complications, the preventive effect of anticoagulants was 
not evident. 
Cardiac functional status at last follow-up 
A considerable proportion of patients (23%) had moderately or severely reduced ventricular func-
tion as assessed with conventional echocardiography. The majority of these patients had an ILT 
and a longer follow-up time than the patients with an ECC. In a recent large cohort from the Pe-
diatric Heart Network [14], average ejection fraction was preserved even in patients over fifteen 
years of age and ten years after Fontan completion. However, from these data one can also cal-
culate that 25% of patients had an ejection fraction <50% and diastolic dysfunction was present 
in >70% of patients. Deterioration of systolic and diastolic ventricular function is an important 
complication that is inherent to both the underlying cardiac anatomy and to Fontan physiology. 
In addition, we recently reported reduced preload at rest and during stress [15], which is an im-
portant limiting factor in this process and should be the target of therapeutic interventions for 
preservation of adequate ventricular function on the long term.
Study limitations 
This study is limited by its retrospective nature. Operations took place from 1990 to 2008, leading 
to differences in peri- and post-operative care throughout time. We corrected for this time-related 
bias by including year of Fontan completion in the multivariable analyses. Exclusion of patients 
with a Kawashima-type operation for abnormal systemic venous return in patients with hetero-
taxy might have influenced our outcome, since others have identified heterotaxy as a risk factor 
[9,25]. Currently, MRI is the technique of choice for prospective evaluation of the single ventricular 
circulation. For logistic reasons this technique was not available to all patients in this study, as has 
been the case in other recent cohort studies [14].
Conclusions 
Outcome after staged ILT and ECC-type Fontan operations is good, with comparable freedom 
from late re-operations and freedom from Fontan failure at 6 year follow-up. The incidence of ar-
rhythmias was significantly lower in the ECC-group. Right ventricular morphology was identified 
as a risk factor for arrhythmias. 
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Abstract
Objective: to assess the clinical condition at mid-term follow-up after total cavopulmonary con-
nection for a functionally univentricular heart under five years of age.
Methods: 34 patients (median age 10.4 (range 6.8-20.7) years; 22 boys; median follow-up time 
7.8 (5.0-17.8) years) underwent electrocardiography, Holter monitoring, bicycle exercise-testing, 
cardiac magnetic resonance imaging, and NT-pro-BNP analysis. 
Results: 23 (68%) patients were in sinus rhythm. Holter monitoring demonstrated normal mean 
heart rate, low maximal heart rate, and no clinically significant arrhythmias, or sinus node dys-
function. With maximal bicycle ergometry (n = 19), maximum workload (60% of normal), maxi-
mum heart rate (90% of normal), and VO2max (69% of normal) were all significantly lower in 
Fontan patients compared to controls (p < 0.001). Variables of submaximal exercise indicated less 
efficient oxygen uptake during exercise in all Fontan patients. Ejection fraction was lower than in 
controls (59 (13)% vs 69 (5)%, p<0.001). Mean end-diastolic volumes, end-systolic volumes and 
ventricular mass were higher compared to controls (p<0.001). Mean values of NT-pro-BNP were 
increased compared to normal values, but only 8 patients had NT-pro-BNP levels above the upper 
limit of normal.
Conclusions: mid-term after Fontan operation under five years of age, patients are in acceptable 
clinical condition with preserved global ventricular function, moderately decreased exercise ca-
pacity, and NT-pro-BNP levels within the normal range. However, systemic ventricular mass is el-
evated after Fontan operation, pointing towards contractility-afterload mismatch. The long-term 
consequences of this phenomenon for ventricular function need further investigation.
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Introduction
The Fontan operation is a palliative procedure for patients in whom their congenital heart defect 
precludes biventricular repair. Nowadays, it is performed as a staged procedure resulting in re-
direction of the systemic venous return to the pulmonary circulation, without interposition of a 
subpulmonary ventricle. There have been important modifications of the original concept, aimed 
at improving systemic venous and pulmonary artery hemodynamics, and preventing late sequelae 
[1]. Currently, total cavopulmonary connection (TCPC), with either an intra-atrial lateral tunnel or 
an extracardiac conduit to connect the inferior caval vein to the pulmonary artery, is the proce-
dure of choice. 
Morbidity and mortality have improved significantly in recent years [2]. However, infor-
mation on mid-term and long-term outcome after Fontan operation according to current tech-
niques is sparse, since these patients are only just reaching adolescence and adulthood. Although 
there are several reports on clinical outcome in Fontan patients [2-4] most of these retrospective 
studies include relatively heterogeneous patient groups, with heterogeneous treatment strategies. 
Hence, the results that are observed in these reports might not be applicable to patients who have 
their Fontan completion in the present era. Today’s policy, for example, is to perform the TCPC at 
increasingly younger ages. 
The objective of this study was to assess clinical condition in a cohort of patients from 
five years after TCPC at young age, i.e. Fontan completion ≤ five years of age. For this purpose, we 
performed electrocardiography, bicycle exercise-testing, assessment of ventricular function with 
magnetic resonance imaging (MRI), and assessment of NT-pro-BNP. The latter is known to identify 
pediatric patients with cardiac disease, and closely correlates to ventricular function [5].
Materials and Methods
Patients
A cross-sectional study of patients after Fontan completion was performed. The following inclu-
sion criteria were used: 1) patients after initial Fontan completion (TCPC), operated on between 
1988 and 2001, who were seen for regular follow-up at three tertiary pediatric referral centers, 
2) age at Fontan completion ≤ five years, 3) duration of follow-up since Fontan completion ≥ five 
years. Exclusion criteria were: 1) contra-indications for MRI or bicycle exercise testing, 2) inad-
equate communication, either because of mental retardation or because of a language barrier. 
Medical records were reviewed for patient characteristics, anatomical, and operative details. The 
study was approved by the Dutch Central Committee on Research involving Human Subjects and 
institutional review boards. All subjects and/or their parents (if required) gave informed consent. 
Electrocardiography 
A standardized 12-lead electrocardiogram was obtained in all patients to obtain rhythm status, 
QRS duration (ms), and QT-interval corrected for heart rate (QTc (ms)). A 24-hour Holter monitor-
ing was performed in all patients on a day with usual activities.
Bicycle exercise-testing 
A Jaëger Oxycon Champion System (Viasys Healthcare, Hoechberg, Germany), allowing breath-by-
breath ergometry, was used for maximal exercise testing. Subjects were continuously monitored 
with a 12-lead electrocardiogram and blood pressure measurements. Workload increased stepwise 
with 10-20 Watts/minute. For bicycle exercise testing, a group of 32 gender- and height-matched 
controls was selected. Patients and controls were encouraged to perform until exhaustion, defined 
as a respiratory quotient (RQ) at peak exercise of ≥ 1.05. Twenty-eight controls and nineteen Fon-
tan patients managed to perform until RQ ≥ 1.05. Eight patients with a submaximal exercise test 
did have a RQ ≥ 1.00. The patients with a RQ < 1.05 were younger than the patients with a RQ ≥ 
1.05 (10.0 (2.5) years vs. 13.2 (3.7) years; p = 0.011). In the control group subjects with a RQ < 1.05 
were also younger than subjects with a RQ ≥ 1.05 (8.9 (0.8) years vs. 12.7 (3.4) years, p < 0.001).
In all patients and controls, two variables of submaximal exercise were assessed: 1) the 
slope of oxygen uptake versus exercise intensity according to the method of Reybrouck et al [6]; 
2) the oxygen-uptake efficiency slope (OUES) according to the method of Baba et al., i.e. the lin-
ear relation between log VE and VO2 [7]. These two variables are a measure of the efficiency of 
the system to extract oxygen during exercise and use in the periphery. A higher slope indicates a 
more efficient oxygen uptake. Since Giardini et al. recently reported non-linearity of the relation 
between log VE and VO2 throughout the exercise test for hypoxemic Fontan patients [8], we first 
validated the linearity of this relation in patients who performed a maximal exercise test. Maxi-
mum workload (Watts), maximum heart rate (beats per minute) and maximum oxygen consump-
tion (VO2max in ml/kg/min) were obtained in patients and controls with a RQ ≥ 1.05.
 
MRI 
Cardiac MRI was performed in all patients on a Signa 1.5 Tesla whole-body MRI system (General 
Electric, Milwaukee, WI, USA). Dedicated phased-array cardiac surface coils were placed over the 
thorax. Patients were monitored by vector cardiogram gating and blood pressure monitoring. 
A multi-phase, multi-slice volumetric data set was acquired using a fast 2-dimensional 
cine scan employing steady-state free precession. Ten to twelve contiguous slices were planned 
parallel to the atrioventricular valve plane of the systemic ventricle to cover the heart from base 
to apex. Imaging parameters: slice thickness 7 to 10 mm, inter-slice gap 0 mm, field of view 280-
370 mm, phase field of view 0.75, matrix 160 x 128 mm, repetition time 3.5 ms, echo time 1.5 
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ms, flip angle 45°, mean in-plane resolution 2 mm2. All images were acquired without breath-hold 
and built up during multiple heartbeats to eliminate the effects of respiration on caval vein and 
pulmonary artery flow dynamics, using three signal-averages. 
Analysis was performed on a commercially available Advanced Windows workstation 
(General Electric Medical Systems, Milwaukee, WI, USA). The ventricular volumetric data set was 
quantitatively analyzed using the AW 5.1 version of the MR Analytical Software System (Medis 
Medical Imaging Systems, Leiden, the Netherlands). Using manual detection of endocardial and 
epicardial borders in end-systole and end-diastole, the following parameters were calculated: end-
diastolic and end-systolic volume indexed for body surface area (EDVI and ESVI respectively), 
stroke volume index (SVI), ejection fraction (EF), and mass index of the systemic ventricle. Ven-
tricular volumes and mass were defined as the sum of the volumes and mass of the systemic 
ventricle and a hypoplastic chamber, if present. Data were compared with reference data from 60 
healthy children, aged 8-17 years [9].
NT-pro-BNP analysis 
Blood samples were taken from a peripheral vein after 30 minutes rest in supine position. Plasma and 
serum were separated immediately after sample collection and stored at -80°C. NT-pro-BNP was 
measured with the Elecsys electrochemiluminescence immunoassay (Roche Diagnostics, Mannheim, 
Germany). We preferred the determination of NT-pro-BNP for its stability in whole blood, its in-
dependency of exercise and position, and its longer half-life in serum than BNP [10]. Data were 
compared to reference data from a study using an identical analysis method [10, 11]. Expected mean 
values were calculated according to the equation: NT-pro-BNP = -0.3707*age + 12.346 [10]. The up-
per limit of normal was defined as the 97.5th percentile from the study of Albers et al [11].
Statistical analysis 
Continuous data were tested for normality using the Kolmogorov-Smirnov test. Values of NT-
pro-BNP were log10-transformed to obtain approximately normal distribution. Data with a nor-
mal distribution are expressed as mean value ± one standard deviation (SD), whereas the median 
(range) is shown for data with a non-normal distribution. Differences in continuous data between 
groups of patients were evaluated by Student’s T-test or non-parametric tests in case of small 
subgroups. Dichotomous data are presented as counts and percentages, and differences between 
groups of patients were evaluated by chi-square tests or Fischer’s exact tests, as appropriate.
Univariable regression analyses were performed to study the interrelation of NT-pro-
BNP with 1) demographic variables, 2) measures of systemic ventricular function, and volumes 
acquired with CMR imaging, and 3) physical exercise response, and to study the interrelation of 
ventricular mass and EF.
Analyses were performed using the SPSS-PC statistical software package version 14.0 
(SPSS, Chicago, Ill, USA). A p-value < 0.05 (two-sided test) was considered to indicate statistical 
significance.
 
Results
Patients 
We identified 100 patients who had undergone a TCPC in the period between 1988-2001 and 
were alive at the start of the study. The following patients were excluded: 1) 23 patients with 
Fontan completion at age > five years; 2) eight patients with a pacemaker; 3) five patients with 
hemi- or quadriplegia; 4) ten patients for inadequate communication. Of 54 eligible patients, 34 
patients (22 boys) participated in this study. There was no difference between participants and 
non-responders in patient, procedural, and follow-up characteristics. 
Median age was 10.4 (6.8-22.2) years. Mean age at Fontan completion was 3.0 (1.1) 
years, median weight 13.9 (8.9-22.0) kg. Median follow-up time after Fontan completion was 7.8 
(5.0-17.1) years. Twenty-seven patients had an intra-atrial lateral tunnel, seven patients had an 
extracardiac conduit. The majority of patients (n = 28; 82%) had had staged procedures, with a 
bidirectional Glenn anastomosis before completion of the Fontan circulation at a median age of 
1.0 (0.2-3.8) years. Median interval between bidirectional Glenn and Fontan completion was 1.7 
(0.5-3.3) years. Four patients had a fenestrated TCPC on hemodynamic indications. In one patient, 
the fenestration closed spontaneously, one other patient underwent catheter-based closure of the 
fenestration.
The dominant ventricle was of right ventricular (RV) morphology in sixteen patients, six 
of who had hypoplastic left heart syndrome. The dominant ventricle was of left ventricular (LV) 
morphology in seventeen patients, seven of who had tricuspid atresia. In one patient ventricular 
morphology could not be determined. There was one patient with right isomerism, and one pa-
tient with left isomerism, with normal systemic venous connections.
The majority of patients (n = 21) had a normal resting oxygen saturation ≥ 95%; ten 
patients were mildly hypoxemic (oxygen saturation between 90-94%). Three patients had oxygen 
saturations below 90%; two after a fenestrated intra-atrial lateral tunnel, the other patient had a 
baffle leak after unfenestrated Fontan. The New York University pediatric heart failure index [12] 
was between 4 and 9 in this patient group (score of 0 meaning no heart failure, score of 30 mean-
ing severe heart failure). Five patients were taking ACE inhibitors, and no patients were on diuretics 
or anti-arrhythmic medication.
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Electrocardiography 
Twenty-three patients were in sinus rhythm. Nine patients had a supraventricular rhythm, and in 
two patients the rhythm was of atrioventricular nodal origin. Mean QRS duration was 100 (13) ms. 
Mean QTc duration was 419 (26) ms. There was no difference in QRS duration and QTc duration 
between patients with a dominant RV and dominant LV. 
 None of the patients experienced any complaints during 24-hour Holter monitoring. 
Thirty patients showed sinus rhythm, with frequent episodes of supraventricular rhythm in two 
patients, and occasional episodes of supraventricular rhythm in twelve patients. Two patients had 
occasional episodes with a junctional rhythm. Mean heart rate was 79 (12) beats per minute. Mean 
maximum heart rate was 168 (SD 18; range 128-200) beats per minute; mean minimum heart rate 
was 46 (SD 9; range 33-67) beats per minute. There was no difference between patients with a 
lateral tunnel and patients with an extracardiac conduit (table 1). There were no cardiac pauses of 
more than 1.9 seconds. Only one patient (age 17 years; 16 years after Fontan completion for hy-
poplastic left heart syndrome) experienced frequent premature atrial contractions. Shortly after 
the investigations for this study, he presented with atrial flutter.
Table 1. Comparison of outcome variables in different Fontan types
Variable ILT   ECC   p-value
Age (years) 10.3 (6.8-20.7) 10.3 (8.0-14.1) NS
Age at Fontan completion (years) 2.9 (1.0-5.0) 2.8 (2.3-4.1) NS
Follow-up time (years) 7.7 (5.0-17.1) 7.9 (5.2-10.0) NS
Oxygen saturation at rest (%) 95 (87-100) 97 (95-98) NS
Systolic blood pressure at rest (mm Hg) 110 (7) 133 (9) 0.013
Diastolic blood pressure at rest (mm Hg) 77  (15) 73 (6) NS
NT-pro-BNP (pmol/l) 13 (3-57) 7 (4-37) 0.006
OUES 1.55 (0.52) 1.66 (0.37) NS
O
2
 uptake - exercise intensity slope 8.8 (1.3) 10.0 (1.2) NS
EDVI (ml/m2) 78 (15) 79 (16) NS 
ESVI (ml/m2) 36 (17) 24 (6) NS
Mass (gr/m2) 70 (16) 73 (7) NS
EF (%) 56 (14) 69 (4) 0.019
Mean heart rate (beats per minute) 77 (13) 79 (14) NS
Maximum heart rate (beats per minute) 161 (16)  175 (9) NS
Minimum heart rate (beats per minute) 46 (10) 47 (8) NS
Abbreviations: ECC = extra-cardiac conduit; EDVI = end-diastolic volume indexed for body surface area; 
EF = ejection fraction; ILT = intra-atrial lateral tunnel; OUES = oxygen-uptake efficiency slope.
Bicycle exercise-testing 
Bicycle exercise-testing was successfully performed in 32 patients and all controls. One patient 
(aged 6.8 years, height 117 cm) was too small for our ergometer. Breath-by-breath analysis failed 
because of a technical problem in the other patient.
When compared to the control group (n =28), Fontan patients (n = 19) reached a lower 
maximum workload (60% of controls; 146 (61) vs. 87 (30) Watts, or 3.2 (0.6) vs. 2.1 (0.5) Watts/
kg, p < 0.001), and lower maximum heart rate (90% of controls; 184 (12) vs. 166 (15) beats per 
minute, p = 0.001). VO2max was significantly lower in Fontan patients (69% of controls; 48 (7) vs. 
33 (8) ml/min/kg, p < 0.001). 
In patients who performed a maximal exercise test (n = 19), there was no difference 
between OUES for the entire exercise test, and OUES during the second half of the test (1.57 
(0.38) and 1.50 (0.57) respectively; p = 0.38). OUES during the first half of the test (1.46 (0.38)) 
was lower than OUES of the entire test (p = 0.046). In hypoxemic patients, this comparison of 
OUES yielded the same results. The relation between log VE and VO2 was not considered linear, 
but OUES of the second half of the test was considered to be representative of the OUES of the 
complete test. 
Both variables of submaximal exercise were higher in controls (n = 32) than in patients 
(n = 32): 1) the OUES was 2.00 (0.66) in controls, and 1.50 (0.44) in patients (p = 0.002); 2) the 
slope of oxygen uptake versus exercise intensity was 9.7 (0.9) in controls, and 8.9 (1.3) in Fontan 
patients (p = 0.004). 
There was no difference in variables of maximal exercise (eight RV, ten LV) and submaxi-
mal exercise (fourteen RV, seventeen LV) between patients with a dominant RV and patients with 
a dominant LV. There were also no differences between different Fontan types.
MRI 
Mean EDVI was 77 (16) ml/m2, mean ESVI was 33 (14) ml/m2, mean EF was 59 (12) %, and mean 
mass was 71 (19) g/m2. EF tended to be lower in patients with a dominant RV, when compared 
to patients with a dominant LV (RV EF 54 (14) %, LV EF 64 (9) %, p = 0.053). EF was significantly 
higher in the patients with an extracardiac conduit (table 1). There was no difference in volumes 
and mass between RV and LV morphology. RV ESVI tended to be higher than LV ESVI, but this dif-
ference was not statistically significant (p = 0.17). 
When compared to reference data for ventricular volumes, and mass [9], end-diastolic vol-
ume (96 (35) ml vs. 87 (31) ml, p = 0.017), end-systolic volume (41 (26) ml vs. 24 (11) ml, p < 0.001) and 
systemic ventricular mass (91 (48) g vs. 72 (33) g, p < 0.001) were higher in patients than in the refer-
ence population. EF was lower in patients than in controls (systemic ventricle EF 59 (12) % vs. LV EF 
69 (5) %, p < 0.001). In patients, the higher the mass was, the poorer was the EF (p = 0.027; β = -0.11).
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NT-pro-BNP 
Blood sample collection was successful in 28 patients. Median level of NT-pro-BNP was 11.5 (2.9-
57.0) pmol/l. Compared to reference studies for NT-pro-BNP using an identical analysis method 
[10, 11], mean NT-pro-BNP levels were higher than to be expected from these normative data 
(mean NT-pro-BNP in Fontan patients 18.0 (15.2) pmol/l, expected mean NT-pro-BNP 8.1 (1.4) 
pmol/l, p = 0.002). Eight Fontan patients (29%) had an NT-pro-BNP level above the upper limit 
of normal (seven lateral tunnel TCPC, one extracardiac conduit TCPC). Age and follow-up time 
of these eight patients did not differ from age and follow-up time of the patients with NT-pro-
BNP within the normal range. There was no difference in exercise response (maximum workload, 
maximum heart rate, VO2max, OUES, oxygen uptake versus exercise intensity slope), or systemic 
ventricular volumes, function, and mass between patients with NT-pro-BNP above the 97.5th 
percentile and the remaining group.
NT-pro-BNP levels did not differ between patients with a dominant RV and patients with 
a dominant LV. NT-pro-BNP was lower in patients with an extracardiac conduit (table 1). Uni-
variable regression analysis did not identify a significant relation between NT-pro-BNP and age, 
follow-up time, variables of exercise testing (heart rate increase, maximum workload, VO2max, 
OUES, or oxygen uptake versus exercise intensity slope), or MRI variables (EDVI, ESVI, EF, mass).
Discussion
The results of this study show acceptable clinical condition in a patient group five to eighteen 
years after Fontan completion under five years of age. In this patient cohort all patients had a 
TCPC, and therefore this study group is representative of the current treatment policy.
In our study, 68% of patients were in sinus rhythm and no patients were on anti-ar-
rhythmic medication. Only one patient experienced frequent premature atrial contractions (and 
presented with atrial flutter shortly after this investigation), and no patients showed signs of 
clinically relevant sinus node dysfunction. Although patients with a pacemaker were excluded in 
this study, they comprised only 7% of the complete cohort. The prevalence of arrhythmias after 
Fontan operation varies with the type of modification. Several groups identified the atriopulmo-
nary connection as a risk factor [2, 13] with a prevalence of atrial tachyarrhythmias at long-term 
follow-up of 29% in these patients [13]. Prevalence of atrial tachyarrhythmias in lateral tunnel 
type TCPC is about 15-20% at mid- to long-term follow-up [2, 4, 13]. Although, in theory, atrial 
tachyarrhythmias should be less frequent in extracardiac conduit TCPC, prevalence has been re-
ported to be up to 11% in a large cohort at mid-term follow-up [3]. Other risk factors for develop-
ing atrial tachyarrhythmias are older age at Fontan completion, longer duration of follow-up, and 
early post-operative atrial tachyarrhythmias [4, 13]. In this study, all patients underwent Fontan 
completion under five years of age, a possible explanation for the absence of arrhythmias in this 
study group. However, further follow-up is necessary to determine the prevalence of arrhythmias 
long-term after Fontan completion.  
Although global ventricular function was good in this study, maximal exercise capacity 
was only 60% of normal. This is comparable to outcome of maximal exercise capacity in 166 Fontan 
patients in a recent study from the Pediatric Heart Network [14]. Maximal oxygen consumption and 
peak heart rate in this study and our study were also comparable. The cause for impaired exercise 
capacity can be of cardiac, pulmonary, or muscular origin. Recently, we demonstrated an impaired 
preload reserve and an inadequate reaction of the pulmonary vasculature in Fontan patients with 
magnetic resonance imaging combined with low-dose dobutamine stress-testing [15, 16]. The re-
sultant inability to increase stroke volume with stress-testing could, in part, be responsible for the 
well known impaired exercise capacity. In contrast to others [17], we did not identify a difference in 
exercise capacity between patients with a dominant LV or RV, but subgroups were small.
The OUES and the oxygen uptake versus exercise intensity slope are two measures of 
submaximal exercise that integrate the contributions of the cardiovascular, pulmonary and mus-
cular systems to exercise capacity. Because of their linearity, they are good indicators of maximal 
exercise capacity, even when maximal exercise is not possible or wanted. The OUES and oxygen 
uptake versus exercise intensity slope both indicate how effectively oxygen is extracted and uti-
lized in the body [6, 7]. The steeper the slope, the better the cardiovascular, pulmonary, and mus-
cular systems work during exercise. The results in this study indicated a decreased efficiency of the 
system to extract oxygen, as has been demonstrated by others in a small group of Fontan patients 
[8]. As in the study by Giardini and coworkers [8], the relation between log VE and VO2 was not 
linear throughout the exercise test, but only for the second half of the exercise test. Therefore, the 
OUES is not a good indicator of maximal exercise capacity in patients who manage to perform the 
exercise test only very shortly (which was not the case in our study). Giardini et al. hypothesized 
that hypoxemia might be the cause for this non-linear relationship [8]. 
There are a limited number of studies on global ventricular function, and volumes in 
patients after Fontan operation, as assessed with MRI. Recently, the Pediatric Heart Network [4] 
reported on a large cohort of children after Fontan operation. In this study, a subgroup of 161 
children underwent MRI. Data in the Network study are not easily comparable to other data, 
since they were indexed to BSA1.3 and a reference group is lacking. Anderson et al. showed a 
decrease in end-diastolic volume with increasing age, and an increase in mass/volume ratio [4]. 
There was no increase in ventricular mass over time as assessed with MRI. Echocardiographic data 
in that study suggest that the end-systolic volume is relatively large compared to end-diastolic 
volume [4], which is in accordance with our findings. Eicken et al. reported normal volumes, nor-
mal mass, and decreased EF in patients ten years after Fontan completion (atriopulmonary con-
nection, right atrium to RV conduit, or TCPC) [18]. After Fontan completion, dramatic changes in 
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ventricular geometry occur [19, 20]. In the early post-operative period, there is a decrease in ven-
tricular dimensions and an inappropriate degree of ventricular hypertrophy. Although others have 
shown normalization of ventricular volumes and mass with increasing follow-up time [18, 20], 
we demonstrated higher end-diastolic volumes, higher end-systolic volumes, higher ventricular 
mass, and lower EF than in the control group. Our observations that the ventricle operates at an 
increased end-systolic volume with normal systolic blood pressure suggest that arterial elastance 
is increased. Recently, Senzaki et al. found a higher ventricular afterload in Fontan patients com-
pared to patients with a two-ventricle circulation [21]. These observations support experimental 
data from Szabo et al., who demonstrated contractility-afterload mismatch in an animal model 
of the Fontan circulation [22]. Earlier, we demonstrated well-preserved contractility with stress-
testing [15]. This might explain the increase in ventricular mass (and increase in mass/volume ratio 
compared to controls) we found in this group. As in patients with aortic valve stenosis, we found 
an inverse correlation of ventricular mass with EF [23]. In isolated aortic valve stenosis, increased 
LV mass predicts the presence of systolic dysfunction and heart failure, and LV hypertrophy as a 
reaction to increased afterload may be maladaptive rather than beneficial [23]. Penny et al. linked 
ventricular hypertrophy to diastolic dysfunction in Fontan patients, with evidence for the develop-
ment of incoordinate ventricular relaxation [24]. The effects of increased ventricular mass and the 
effects of contractility-afterload mismatch on the long-term function of the single ventricle have 
to be investigated. Furthermore, together with the study by Senzaki et al. [21], the present study 
provides data that suggests further clinical trials are required to investigate the effects of long-
term afterload reduction on systemic ventricular function in the Fontan circulation.
Several groups have investigated BNP or NT-pro-BNP levels at short-term to mid-term 
follow-up after Fontan operation [25-29]. In these studies, levels were increased compared to 
control groups, but there seemed to be low clinical value of BNP or NT-pro-BNP for diagnostic or 
prognostic purposes [27]. Only Hjortdal et al. found normalization of neurohormones late after 
Fontan operation [29]. Law et al. concluded that BNP could discriminate between patients with 
systemic ventricular failure (elevated BNP) and isolated cavopulmonary failure (BNP not elevated) 
[28]. Man and Cheung found a correlation between BNP and variables of diastolic function (the 
majority of patients had had an atriopulmonary connection) [25].
Under pathological conditions, production of BNP rises strongly in both atria and ven-
tricles. In our study group systemic ventricular EDVI was only slightly higher than in the control 
group. Therefore, BNP release from ventricular myocardial stretch is not to be expected. In this 
study, the number of patients with an NT-pro-BNP level above the upper limit of normal was 
small, preventing us from proper analysis of NT-pro-BNP usefulness for risk stratification in Fon-
tan patients.
Study limitations
This study is limited by the size and characteristics of the study group. Due to small numbers, com-
parisons between different Fontan types, or between different systemic ventricular morphologies 
should be made with caution. As in most studies in Fontan patients, the study group is heteroge-
neous and therefore conclusions might not be applicable to all categories of patients. This group 
is not a representative random sample of the entire TCPC population, since we have excluded pa-
tients with a pacemaker and patients with neurologic complications. This prevents us from making 
firm conclusions on the rhythm status of this patient group. 
Conclusions
Mid-term after Fontan operation under five years of age, patients are in acceptable clinical condi-
tion with preserved global ventricular function, moderately decreased exercise capacity, and NT-
pro-BNP levels within normal range. However, systemic ventricular mass is elevated after Fontan 
operation, pointing towards contractility-afterload mismatch. The long-term consequences of this 
phenomenon for ventricular function need further investigation.
Acknowledgement: we would like to thank Dirk J. Duncker, MD, PhD (department of experimental 
cardiology, Erasmus MC, Rotterdam, the Netherlands) for his contribution in the discussion on 
afterload mismatch.
Chapter 3 Clinical outcome after Fontan operation at young age
56 57
References
[1] De Leval MR, Kilner P, Gewillig M, Bull C. Total cavopulmonary connection: a logical alternative to 
atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical 
experience. J Thorac Cardiovasc Surg 1988;96:682-695.
[2] D’Udekem Y, Iyengar AJ, Cochrane AD, Grigg LE, Ramsay JM, Wheaton GR, et al. The Fontan proce-
dure: contemporary techniques have improved long-term outcomes. Circulation 2007;116:I157-164.
[3] Giannico S, Hammad F, Amodeo A, Michielon G, Drago F, Turchetta A, et al. Clinical outcome of 193 
extracardiac Fontan patients: the first 15 years. J Am Coll Cardiol 2006;47:2065-2073.
[4] Anderson PA, Sleeper LA, Mahony L, Colan SD, Atz AM, Breitbard RE, et al. Contemporary out-
comes after the Fontan procedure: a Pediatric Heart Network multicenter study. J Am Coll Cardiol 
2008;52:85-98.
[5] Koch A, Zink S, Singer H. B-type natriuretic peptide in paediatric patients with congenital heart dis-
ease. Eur Heart J 2006;27:861-866.
[6] Reybrouck T, Mertens L, Brusselle S, Weymans M, Eyskens B, Defoor J, et al. Oxygen uptake versus 
exercise intensity: a new concept in assessing cardiovascular exercise function in patients with con-
genital heart disease. Heart 2000;84:46-52.
[7] Baba R, Nagashima M, Goto M, Nagano Y, Yokota M, Tauchi N, et al. Oxygen uptake efficiency slope: 
A new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake 
and minute ventilation during incremental exercise. J Am Coll Cardiol 1996;28:1567-1572.
[8] Giardini A, Specchia S, Gargiulo G, Sangiorgi D, Picchio FM. Accuracy of oxygen uptake efficiency 
slope in adults with congenital heart disease. Int J Cardiol 2009;133:74-79.
[9] Robbers-Visser D. Boersma E. Helbing WA. Normal biventricular function, volumes, and mass in 
children aged 8 to 17 years. J Magn Reson Imaging 2009;29:552-559.
[10] Mir TS, Flato M, Falkenberg J, Haddad M, Budden R, Weil J, et al. Plasma concentrations of N-
terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age 
and gender. Pediatr Cardiol 2006;27:73-77.
[11] Albers S, Mir TS, Haddad M, Laer S. N-Terminal pro-brain natriuretic peptide: normal ranges in the 
pediatric population including method comparison and interlaboratory variability. Clin Chem Lab 
Med 206;44:80-85.
[12] Connolly D, Rutkowski M, Auslender M, Artman M. The New York University Pediatric Heart Failure 
Index: A new method of quantifying chronic heart  failure severity in children. J Pediatr 2001;138:644-
648.
[13] Gelatt M, Hamilton RM, McCrindle BW, Gow RM, Williams WG, Trusler GA, et al. Risk factors for 
atrial tachyarrhythmias after the Fontan operation. J Am Coll Cardiol 1994;24:1735-1741.
[14] Paridon SM, Mitchell PD, Colan SD, Williams RV, Blaufox A, Li JS, et al. A cross-sectional study of 
exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol 
2008;52:99-107.
[15] Robbers-Visser D, ten Harkel DJ, Kapusta L, Strengers JL, Dalinghaus M, Meijboom FJ, et al. Useful-
ness of cardiac magnetic resonance imaging combined with low-dose dobutamine stress to detect an 
abnormal ventricular stress response in children and young adults after Fontan operation at young 
age. Am J Cardiol 2008;101:1657-1662.
[16] Robbers-Visser D, Helderman F, Strengers JL, Kapusta L, van Osch-Gevers L, Pattynama PM, et 
al. Pulmonary artery size and function after Fontan operation at young age. J Magn Reson Imaging 
2008;28:1101-1107.
[17] Ohuchi H. Yasuda K, Hasegawa S, Miyazaki A, Takamuro M, Yamada O, et al. Influence of ventricular 
morphology on aerobic exercise capacity in patients after the Fontan operation. J Am Coll Cardiol 
2001;37:1967-1974.
[18] Eicken A, Fratz S, Gutfried C, Balling G, Schwaiger M, Lange R, et al. Hearts later after Fontan opera-
tion have normal mass, normal volume, and reduced systolic function: a magnetic resonance imaging 
study. J Am Coll Cardiol 2003;42:1061-1065.
[19] Rychik J, Jacobs ML, Norwood WI, Jr. Acute changes in left ventricular geometry after volume reduc-
tion operation. Ann Thorac Surg 1995;60:1267-1273.
[20] Fogel MA, Weinberg PM, Chin AJ, Fellows KE, Hoffman EA. Late ventricular geometry and perfor-
mance changes of functional single ventricle throughout staged Fontan reconstruction assessed by 
magnetic resonance imaging. J Am Coll Cardiol 1996;28:212-221.
[21] Senzaki, Masutani S, Ishido H, Taketazu M, Kobayashi T, Sasaki N, et al. Cardiac rest and reserve 
function in patients with Fontan circulation. J Am Coll Cardiol 2006;47:2528-2535.
[22] Szabo G, Buhmann V, Graf A, Melnitschuk S, Bahrle S, Vahl CF, et al. Ventricular energetic after the 
Fontan operation: contractility-afterload mismatch. J Thorac Cardiovasc Surg 2003;125:1061-1069.
[23] Kupari M, Turto H, Lommi J. Left ventricular hypertrophy in aortic valve stenosis: preventive of pro-
motive of systolic dysfunction and heart failure. Eur Heart J 2005;26:1790-1796.
[24] Penny DJ, Rigby ML, Redington AN. Abnormal patterns of intraventricular flow and diastolic filling af-
ter the Fontan operation: evidence for incoordinate ventricular wall motion. Br Heart J 1991;66:375-
378.
[25] Man BL, Cheung YF. Plasma brain natriuretic peptide and systemic ventricular function in asymptom-
atic patients late after the Fontan procedure. Heart and Vessels 2007;22:398-403.
[26] Larsson DA, Meurling CJ, Holmqvist F, Waktare JE, Thilen UJ. The diagnostic and prognostic value 
of brain natriuretic peptides in adults with a systemic morphologically right ventricle or Fontan-type 
circulation. Int J Cardiol 2007;114:345-351.
[27] Ohuchi H, Takasugi H. Ohashi H, Yamada O, Watanabe K, Yagihara T, et al. Abnormalities of neu-
rohormonal and cardiac autonomic nervous activities relate poorly to functional status in Fontan pa-
tients. Circulation 2004;110:2601-2608.
[28] Law YM, Ettedgui J, Beerman L, Maisel A, Tofovic S. Comparison of plasma B-type natriuretic peptide 
levels in single ventricle patients with systemic ventricular failure versus isolated cavopulmonary fail-
ure. Am J Cardiol 2006;98:520-524.
[29] Hjortdal VE, Stenbog EV, Ravn HB, Emmertsen K, Jensen KT, Pedersen EB, et al. Neurohormonal 
activation later after cavopulmonary connection. Heart 2000;83:439-443.
Chapter 4
Usefulness of cardiac magnetic resonance imaging combined with low-
dose dobutamine stress to detect an abnormal ventricular stress response 
in children and young adults after Fontan operation at young age
Daniëlle Robbers-Visser, MDa, b; Derk Jan ten Harkel, MD, PhDa; Livia Kapusta, MD, PhDc; 
Jan L.M Strengers, MD, PhDd; Michiel Dalinghaus, MD, PhDa; Folkert J. Meijboom, MD, PhDe; 
Peter M. Pattynama, MD, PhDb; Ad J.J.C. Bogers, MD, PhDf; Willem A. Helbing, MD, PhDa, b
a Department of Pediatric Cardiology, Erasmus MC – Sophia Children’s Hospital, Rotterdam, 
 the Netherlands 
b Department of Radiology, Erasmus MC, Rotterdam, the Netherlands 
c Children’s Heart Center, UMC St Radboud, Nijmegen, the Netherlands 
d Department of Pediatric Cardiology, University MC Utrecht – Wilhelmina Children’s Hospital, 
Utrecht, the Netherlands
e Department of Cardiology, Erasmus MC, Rotterdam, the Netherlands 
f Department of Cardiothoracic Surgery, Erasmus MC, Rotterdam, the Netherlands
Am J Cardiol 2008;101:1657-1662
Chapter 4 Clinical outcome after Fontan operation at young age
60 61
Abstract
Objective: to study factors leading to decreased global ventricular performance with stress after 
Fontan operation, the stress response of functionally univentricular hearts was assessed at rest 
and during low-dose dobutamine stress using cardiovascular magnetic resonance (CMR) imaging.
Methods: thirty-two patients after Fontan completion at young age were included (27 total 
cavopulmonary connection, 5 atriopulmonary connection, mean age 13.3 (range 7.5 – 22.2) years, 
23 boys, median follow-up after Fontan operation 8.1 (range 5.2-17.8) years). A multiphase short 
axis stack of ten to twelve contiguous slices of the systemic ventricle was obtained at rest and 
during low-dose dobutamine stress CMR imaging (7.5 μg/kg/min maximum). 
Results: with stress-testing, heart rate, ejection fraction (EF), and cardiac index increased adequately 
(p < 0.001). There was an abnormal decrease in end-diastolic volume and an adequate decrease in 
end-systolic volume (p < 0.001). Stroke volume did not change with stress-testing (p = 0.15). At rest 
dominant left ventricles had a higher EF than dominant right ventricles (p = 0.01), but this difference 
disappeared with stress-testing. 
Conclusions: the functionally univentricular heart after Fontan completion at young age has an 
adequate increase in EF with beta-adrenergic stimulation. However, as a result of impaired preload 
with stress, only an increase in heart rate can increase cardiac output. 
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Introduction
It is well known that patients after Fontan operation have a diminished exercise capacity [1-4]. Im-
pairment in preload reserve is thought to be an important factor contributing to this impairment, 
and has been demonstrated with exercise testing and invasive methods [1, 2, 5, 6]. A decrease in 
global ventricular function has been reported as another important determinant of the impaired 
exercise capacity in Fontan patients [7, 8]. Cardiovascular magnetic resonance (CMR) imaging has 
proved to be a valuable tool in the follow-up of patients with complex congenital heart disease 
and is the gold standard for assessing global ventricular function [9]. Furthermore, CMR has shown 
its ability to detect an abnormal ventricular stress response with physical or pharmacological 
stress-testing in patients with congenital heart disease [10, 11]. Global ventricular function and 
contractility at rest and with stress-testing have not been studied in patients at mid-term follow-
up after Fontan operation at young age, operated on according to current treatment strategies. 
Therefore CMR imaging combined with low-dose dobutamine was used to study the effects of 
pharmacological stress on global ventricular function in patients mid-term after atriopulmonary 
or total cavopulmonary connection at young age.
Materials and Methods
Patients
A cross-sectional study of patients after Fontan completion was performed. The following inclu-
sion criteria were used: 1) patients after initial Fontan completion, who were seen for regular 
follow-up at three tertiary referral centers, 2) age at Fontan completion ≤ seven years, 3) dura-
tion of follow-up since Fontan completion ≥ five years. Exclusion criteria: 1) contra-indications 
for CMR imaging, 2) mental retardation. Medical records were reviewed for patient characteristics, 
anatomical, and operative details. The study was approved by the Dutch Central Committee on 
Research involving Human Subjects and institutional review boards. All subjects and/or their parents 
(if required) gave informed consent. 
MRI
A Signa 1.5 Tesla whole-body MR imaging system was used (General Electric, Milwaukee, WI, 
USA). Dedicated phased-array cardiac surface coils were placed over the thorax. Patients were 
monitored by vector cardiogram gating and blood pressure monitoring. 
A multi-phase, multi-slice volumetric data set was acquired using a fast 2D cine scan 
employing steady-state free precession. Ten to twelve contiguous slices were planned parallel to 
the atrioventricular valve plane of the systemic ventricle to cover the heart from base to apex. 
Imaging parameters: slice thickness 7 to 10 mm, inter-slice gap 0 mm, field of view 280-370 mm, 
phase field of view 0.75, matrix 160 x 128 mm, repetition time 3.5 ms, echo time 1.5 ms, flip angle 
45°, mean in-plane resolution 2 mm2. All images were acquired without breath-hold and built up 
during multiple heartbeats to eliminate the effects of respiration on caval vein and pulmonary 
artery flow dynamics, using three signal-averages. Two short-axis stacks were obtained: during 
rest and during low-dose dobutamine stress. 
For internal validation of ventricular stroke volume at rest and during stress, flow mea-
surements were done in the ascending aorta with velocity-encoded phase-contrast imaging (2D 
fast spoiled gradient echo, repetition time =5-6 ms, echo time =3 ms, flip angle=20o, 7 mm slice 
thickness, 6 views/segment, scanning matrix of 256 *128, 3 signal-averages, no breath-hold). To 
evaluate the effect of dobutamine stress on systemic venous return index, flow measurements 
in both caval veins were done, using the flow imaging parameters specified. Duration of the total 
scan protocol was 60-75 minutes.
When the study protocol had been completed at rest, dobutamine-hydrochloride (Cen-
trafarm Services, Etten-Leur, the Netherlands) was administered by continuous infusion into a 
large antecubital vein at 7.5 μg/kg/min. This dosage was chosen since it is known from studies 
in healthy children that important changes in systolic function, diastolic function, and afterload 
occur from 5 μg/kg/min, and that the incidence rate of adverse symptoms increases significantly 
from 10 μg/kg/min [12, 13]. When a steady state in heart rate and blood pressure had been ob-
tained, a second short-axis stack and flow measurements were acquired using the imaging param-
eters specified above. Dobutamine infusion was lowered to 5 μg/kg/min if any of the following 
events occurred: a rise in heart rate, systolic, or diastolic blood pressure of more than 50%; or a 
decrease in heart rate, systolic, or diastolic blood pressure of more than 20%. The test was discon-
tinued if the patient suffered significant discomfort.
Analysis was performed on a commercially available Advanced Windows workstation 
(General Electric Medical Systems, Milwaukee, WI, USA). The ventricular volumetric data set was 
quantitatively analyzed using the AW 5.1 version of the MR Analytical Software System (Medis 
Medical Imaging Systems, Leiden, the Netherlands). Using manual detection of endocardial and 
epicardial borders in end-systole and end-diastole, the following parameters were calculated: end-
diastolic and end-systolic volume indexed for body surface area (EDVI and ESVI respectively), 
stroke volume index (SVI), ejection fraction (EF), cardiac index and mass index of the systemic 
ventricle [14]. Ventricular volumes and mass were defined as the sum of the volumes and mass 
of the systemic ventricle and a hypoplastic chamber, if present. Flow images were quantitatively 
analyzed using the Flow analysis software package V3.1 (Medis Medical Imaging Systems, Leiden, 
the Netherlands).
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Calculations
Stress response of the systemic ventricle was defined as the relative change in EDVI ((EDVIrest – 
EDVI
stress
)/EDVI
rest
 * 100%), and EF ((EF
rest
 – EF
stress
)/EF
rest
 * 100%) with stress-testing. To estimate 
the effect of low-dose dobutamine stress-testing on contractility and afterload, the following ap-
proximations were used: contractility ≈ mean arterial pressure / ESVI [15], and afterload ≈ mean 
arterial pressure / CI [16].
Echocardiography
For assessment of diastolic function at rest, systemic atrioventricular flow and pulmonary venous 
flow were obtained with conventional Doppler echocardiography on an iE33 echocardiography 
system (Philips Medical Systems, Bothell, WA, USA) or System Five model (GE/Vingmed Inc., Hor-
ton, Norway). Pulmonary venous flow was recorded in the orifice of the right upper pulmonary 
vein using the apical 4-chamber view, placing the sample volume within 1 cm of the venoatrial 
junction. We measured the peak velocity of the antegrade systolic wave and early diastolic wave, 
and the peak velocity of the late diastolic retrograde wave. Systemic atrioventricular flows were 
obtained with pulsed wave Doppler at the leaflet tips. We measured E and A wave velocities, and E 
to A wave (E/A) ratio. Patient data were compared to data of 152 healthy children from our depart-
ment database (mean age 12 (range 8-18) years). 
Statistical analysis
Results are expressed as frequencies, mean (standard deviation) or as median (range). Paired data 
analysis was performed using the paired t-test. Comparisons between two groups were performed 
using the student t-test or the Mann-Whitney U test when appropriate. Linear regression analysis 
was performed for comparison of ventricular SVI, and aortic SVI, and systemic venous return 
per cardiac cycle. Variability between ventricular SVI,aortic SVI, and systemic venous return per 
cardiac cycle was expressed relative to the ventricular SVI ± two standard deviations by Bland-
Altman analysis [17]. Twenty-five percent randomly selected rest and stress short axis sets were 
re-analyzed for assessment of intra- and interobserver variability and a coefficient of variation 
was calculated. Univariable analysis was performed to study the association of operation and 
follow-up details and ventricular stress response. A p-value < 0.05 was considered to indicate 
statistical significance.
Results
Patients
Sixty-eight patients were eligible for participation in this study. Thirty-two patients gave informed 
consent. Statistical analysis did not show any differences between participants and non-respond-
ers when compared for patient characteristics and clinical status at most recent follow-up. Char-
acteristics of the 32 patients are summarized in table 1. At the latest follow-up before this study, 
none of the patients had a residual outflow tract obstruction on echocardiography.
Table 1. Patient characteristics
Male/female  25/9
Age (years) 13.4  (4.2, range 7.5-22.2) 
Follow-up time since Fontan completion (years) 8.2  (5.2-17.8)
Oxygen saturation at follow-up (%) 95  (3.4)
Age at Fontan (years) 3.5  (1.5)
Dominant ventricle  
 Right ventricle 11
 Left ventricle 18
 Undefined 3
Fontantype  
 Total cavopulmonary connection 27
  Lateral tunnel 22 (3 fenestrated)
  Extracardiac conduit 5
 Atriopulmonary connection 5
Pre-Fontan surgery  
 Pulmonary artery banding 8
 Blalock-Taussig shunt 15
 Norwood 4
 Bidirectional Glenn 24
Post-Fontan intervention  
 Extracardiac conduit replacement  1
 Atrial level shunt closure 2
 Closure of tricuspid valve 1
 Damus-Kaye-Stansel anastomosis 1
 Graft replacement of ascending aorta and aortic valve 1
MRI
CMR scanning was well tolerated by all patients and none of the subjects experienced any discom-
fort necessitating termination of the study. Dobutamine was administered safely to all subjects 
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with no side-effects, apart from one patient with a minor headache. In eight patients, dobutamine 
was lowered to 5 μg/kg/min because of an increase in heart rate of > 50%. The 32 datasets were of 
sufficient quality to be included in the study. Results of the study are summarized in table 2. With 
dobutamine stress-testing, mean heart rate increase was 33 ± 19% . There was a decrease in EDVI 
in all patients when compared to rest (figure 1a). SVI did not change with stress-testing (figure 1c). 
The increase in EF was 22 ± 12% (figure 1b). 
 Coefficients of variation for intra-observer variability at rest were: EDV 4.9%, EF, 5.9%, 
and mass 5.4%. With stress-testing, these coefficients were: EDV 3.4%, and EF 2.1%. Coefficients 
of variation for interobserver variability at rest were: EDV 4.8%, EF, 4.7%, and mass 8.5%. With 
stress-testing, these coefficients were: EDV 11.1%, and EF 4.6%.
Aortic flow measurements were successful in 28 patients. Flow measurements failed because of 
technical problems with the CMR scanner (n = 2), graft replacement of the ascending aorta and 
aortic valve (n = 1), unknown cause (n = 1). Linear regression analysis showed a good correlation 
between SVI in the aorta and SVI measured with the ventricular volumetric data set (R = 0.95; 
y = 0.93x + 3.1, standard error of estimate = 4.1 ml). The limits of agreement analysis demon-
strated a mean difference of 0.20 (4.1) ml. 
Table 2. Ventricular volumetric results of the systemic ventricle at rest and during dobutamine stress
Variables Rest Dobutamine stress p-value
Heart rate (beats/min) 71 (12) 94 (17) < 0.001
Mean arterial pressure (mm Hg) 80 (9) 92 (9) < 0.001
End-diastolic volume index (ml/m2) 78 (17) 64 (16) < 0.001
End-systolic volume index (ml/m2) 34 (15) 20 12) < 0.001
Stroke volume index (ml/m2) 44 (13) 43 (12) 0.0153
Ejection fraction (%) 57 (13) 69 (13) < 0.001
Cardiac index (l/min/m2) 3.0 (0.7) 3.9 (0.8) < 0.001
Mass index (gr/m2) 73 (19)  
Contractility (mm Hg/ml/m2) 2.8 (1.2) 5.9 (2.9) < 0.001
Afterload (mm Hg/l/min/m2) 29 (9) 25 (6) 0.002
We compared patients with a dominant right ventricle (n = 11) to patients with a domi-
nant left ventricle (n = 18). Three patients with an undefined systemic ventricle were not included 
in this analysis. Results of the comparison are displayed in table 3. In summary, at rest, patients 
with a dominant right ventricle had a higher ESVI and a lower EF than patients with a dominant left 
ventricle. With stress-testing, the relative increase in EF was higher in patients with a dominant 
right ventricle (p = 0.033). Both at rest and during stress, there was a statistically significant dif-
ference in contractility in favor of dominant left ventricles.
At rest, flow measurements of both caval veins were successful in 24 patients. Flow mea-
surements failed because of technical problems with the CMR scanner (n = 2), flow artifacts (n = 2), 
or unknown cause (n = 4, significant underestimation of the flow volume). The latter could be ex-
plained by the fact that 2D flow measurements were performed in an area with non-laminar flow. 
Seven of the younger patients did not complete the full protocol at stress because of the long total 
scan time, resulting in seventeen flow measurements in both caval veins with stress-testing. There 
was a good correlation between ventricular SVI and systemic venous return per cardiac cycle 
(R = 0.95; y = 1.1x – 2.8; standard error of estimate = 4.2 ml). The limits of agreement analysis 
demonstrated a mean difference of 0.33 (3.9) ml. Both at rest and during stress, superior vena cava 
flow accounted for 40% of the systemic venous return. With dobutamine stress-testing, systemic 
Figure 1. Values of ventricular volumes and 
function at rest and with low-dose dobuta-
mine stress testing. Figure 1a: end-diastolic 
volume index (ml/m2). Figure 1b: stroke 
volume index (ml/m2). Figure 1c: ejection 
fraction (%)
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venous return per cardiac cycle did not change. Total systemic venous return increased from 2.8 
(0.6) l/min/m2 to 3.5 (0.7) l/min/m2 (p < 0.001).
Table 3. Comparison of volumetric data and stress response of dominant right and left ventricles
 Variables Right ventricle Left ventricle p-value
Rest Heart rate (beats/min) 74 (13) 68 (12) NS
 End-diastolic volume index (ml/m2) 82 (17) 77 (17) NS
 End-systolic volume index (ml/m2) 42 17) 30 (12) 0.014
 Stroke volume index (ml/m2) 40 (14) 48 (12) NS
 Ejection fraction (%) 50 (14) 62 (11) 0.011
 Cardiac index (l/min/m2) 2.9 (0.6) 3.2 (0.8) NS
 Mass index (gr/m2) 74 (14) 71 (23) NS
 Contractility (mm Hg/ml/m2) 2.1 (0.6) 3.1 (1.2) 0.02
 Afterload (mm Hg/l/min/m2) 30 (8) 28 (8) NS
Stress Heart rate (beats/min) 100 (24) 90 (12) NS
 End-diastolic volume index (ml/m2) 65 (15) 63 (17) NS
 End-systolic volume index (ml/m2) 24 (14) 17 (9) NS
 Stroke volume index (ml/m2) 40 (13) 46 (13) NS
 Ejection fraction (%) 63 15) 73 (10) NS
 Cardiac index (l/min/m2) 3.7 (0.3) 4.0 (1.0) NS
 Contractility (mm Hg/ml/m2) 4.7 (2.0) 7.0 (3.1) 0.02
 Afterload (mm Hg/l/min/m2) 25 (4) 25 (7) NS
 Decrease in end-diastolic volume index (%)  21  (6) 18 (10) NS
 Increase in ejection fraction (%) 29 (11) 19 (12) 0.01
Echocardiography
Pulmonary venous flow and systemic atrioventricular flow velocity data were available in 29 pa-
tients. In three patients, analysis was not possible due to inferior image quality. In Fontan patients, 
mean atrial reversal flow velocity was 0.28 m/s (0.05), mean systolic flow velocity was 0.55 m/s 
(0.15), and mean diastolic flow velocity was 0.64m/s (0.26). In the reference population these data 
were 0.22 m/s (0.09), 0.50 m/s (0.11), and 0.64 m/s (0.12) respectively (p = non significant for all 
variables). Systemic atrioventricular E-wave velocity, A-wave velocity, and E/A-ratio were statisti-
cally significantly different in the patient population. In patients, E-wave velocity was lower (0.81 
(0.20) vs. 1.00 (0.16) m/s in controls), A-wave velocity was higher (0.57 (0.17) vs. 0.48 (0.13) m/s in 
controls), and E/A ratio was lower (1.50 (0.46) vs. 2.22 (0.59) in controls) than in healthy controls. 
Univariable analysis did not identify any factors in patient characteristics or the patient’s medical 
history that were of influence on the stress response (the relative decrease in EDVI and the relative 
increase in EF) of the systemic ventricle. The following variables were included in this analysis: 1. 
for pre-Fontan procedures: age; pre-Fontan volume unloading (yes/no); hemoglobin level; duration 
of intensive care stay; duration of total hospital stay; 2. for Fontan completion: systolic pressure, 
and end-diastolic pressure of the systemic ventricle, and systolic, diastolic and mean aortic pres-
sure at pre-Fontan catheterization; age; hemoglobin level; oxygen saturation; aortic cross-clamp 
time; total bypass time; duration of thoracic drainage; duration of intensive care stay; duration 
of total hospital stay; 3. post-Fontan: age at follow-up; follow-up time after Fontan completion.
Discussion
The results of this study of patients having had a Fontan operation for a univentricular heart at 
young age show that – with low-dose dobutamine stress-testing – EF increases adequately, dem-
onstrating a good contractile capacity, and SVI does not change. This is caused by an abnormal de-
crease in EDVI with stress, while ESVI decreases adequately. Consequently, the systemic ventricle 
increases its output only by increasing heart rate. The normal response to low-dose dobutamine 
stress in children, and young adults, studied with echocardiography and CMR imaging shows no 
change in EDVI, a decrease in ESVI, and an increase in SVI [12, 13, 18].  
In Fontan patients, reduced preload reserve with dobutamine stress-testing could be re-
sponsible for the abnormal stress response. The concept of impaired preload reserve in the Fontan 
circulation is well known [1, 2, 5, 6]. Senzaki et al. demonstrated a limited preload reserve with 
low-dose dobutamine stress-testing, by analyzing ventricular performance and hemodynamics 
in Fontan patients during cardiac catheterization [5, 6]. During stress, parameters of preload de-
creased, cardiac index increased, and afterload did not change. In multivariate analysis, the limited 
stress response could only be attributed to limited preload reserve [6]. The design of these studies 
did not allow further analysis of the causes of impaired preload reserve. Apart from the lack of a 
subpulmonary ventricle, pathophysiological explanations for this reduced reserve can be sought 
in alterations in either a) ventricular diastolic function b) venous capacitance vasculature, c), caval 
vein and pulmonary artery flow dynamics, d) function of the atrial baffle in case of TCPC, or e) 
combinations of these factors.
Echocardiographic indices of diastolic function are abnormal after Fontan operation, 
compatible with reduction of ventricular compliance in addition to persisting abnormalities of re-
laxation [19]. In our patient group, echocardiographic indices of systemic atrioventricular flow in-
dicated impairment in relaxation. However, we do not consider this diastolic dysfunction of great 
importance for the observed decrease in EDVI with stress-testing, since others have shown that 
the effect of diastolic dysfunction on ventricular filling during dobutamine stress-testing is negli-
gible [5, 6]. Furthermore, low-dose dobutamine is considered to improve diastolic relaxation [20].
With regard to the peripheral vasculature Kelley et al. found evidence of an increased 
venous tone in Fontan patients [21]. This led to limitations in the ability to mobilize blood from 
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capacitance vessels with exercise testing. Two other studies demonstrated the effect of supine 
leg exercise and respiration on systemic venous flow dynamics in patients without evidence of 
residual obstruction in the Fontan connection [22, 23]. An increase in total systemic venous return 
was mainly attributable to the increase in heart rate with exercise testing [22]. Inferior vena cava 
flow increased more than superior vena cava flow with supine leg exercise, and it was concluded 
that the peripheral pump is probably the most important factor for increasing systemic venous 
return [23]. However, from the same data, it could also be concluded that only redistribution of 
cardiac output to the lower body half was the cause of the increase in inferior vena cava flow. In 
our study with pharmacological stress, systemic venous return also increased despite the lack of 
physical exercise and was solely caused by the increase in heart rate.
Recently, Whitehead et al. studied the effects of increased inferior vena cava flow on 
power losses in the total cavopulmonary connection with computational fluid dynamics [24]. In 
their study, power loss increased in a nonlinear fashion with physiologic increases in inferior vena 
cava flow (as with lower limb exercise), and there was a dramatic increase in resistance index in 
the total cavopulmonary connection, These observations point towards another potential contri-
bution to impaired preload reserve, which is the inability to increase flow through the atrial baffle 
with stress-testing. 
In our study, there was an adequate decrease in ESVI with stress-testing, implicating that 
systemic ventricular failure is not the underlying mechanism of the abnormal stress response. EF 
at rest was slightly higher than in a recent study by Eicken et al (57% and 51% respectively) [25]. In 
our study, however, patients were younger, age at Fontan completion was lower, and the majority 
of the patients had had a total cavopulmonary connection, all possible explanations for this dif-
ference in EF. We observed a statistically significant difference in global ventricular performance 
and contractility in favor of dominant left ventricles. Heart rate, afterload, and stroke volume did 
not differ between dominant right and left ventricles, suggesting a difference in loading condi-
tions between these two groups. Interestingly, dominant right ventricles had a more pronounced 
increase in EF during stress-testing, whereby the difference in EF between dominant left and right 
ventricles disappeared. In general, it can be concluded from our results, that almost ten years after 
Fontan completion, the systemic ventricle has a good contractile response with stress-testing and 
that the reported disadvantage of having a dominant right ventricle could not be demonstrated 
[26, 27].
Study limitations
This study was limited by the conditions inherent to CMR imaging. CMR imaging is not suitable for 
patients with anxiety, claustrophobia or implantable devices. Our preference to perform this study 
in non-sedated children, limited the inclusion to patients over seven years of age. Another limita-
tion of this study was the small size of the study group. However, all patients showed the same 
reaction to dobutamine stress (figure 1), but it was not possible to distinguish between patients 
with different types of Fontan operations.
Since our CMR scanner is not suitable for supine leg exercise, the effects of exercise on 
ventricular systolic function and systemic venous return had to be simulated with pharmacologi-
cal stress. Parameters on contractility and afterload could only be estimated, as is a limitation of 
every non-invasive study. It could be argued that the non-physiologic form of stress of this study 
contributed to the impaired preload. However, both Gewillig et al. and Kondoh et al. also found 
that stroke volume did not increase with supine bicycle exercise testing [1, 2], implicating that the 
contribution of respiration and the peripheral muscle pump to maintaining preload is negligible. 
Conclusions
The functionally univentricular heart after Fontan completion at young age has an adequate in-
crease in EF with beta-adrenergic stimulation. However, as a result of impaired preload with stress, 
only increasing heart rate can increase cardiac output.
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Abstract
Objective: To assess pulmonary artery size (PA), flow variables, and wall shear stress (WSS) in 
patients after Fontan operation at young age. 
Methods: Flow in the branch PA was obtained with phase contrast velocity-encoded cardiovascu-
lar magnetic resonance imaging in fourteen patients before and after low-dose dobutamine stress 
(7.5 μg/kg/min) and in seventeen healthy controls at rest.  
Results: At rest, stroke index, total flow, average, and peak flow rate were all statistically sig-
nificantly lower in patients than in controls (p<0.001). With stress-testing, all variables increased 
in patients (p<0.001), apart from stroke index, that did not change. At rest, branch PA area did 
not differ between patients and controls. Distensibility was lower in patients than in controls 
(p<0.001). With stress-testing, area, and distensibility did not change. At rest, WSS was lower in 
patients than in controls (p<0.001). WSS increased with stress-testing (p<0.001), but not to the 
same levels as during resting conditions of the control group.
Conclusion: PA size is normal long-term after Fontan operation at young age. Flow variables, 
distensibility, and WSS are significantly lower compared to healthy controls, and do not show 
adequate reactions with stress-testing, which is suggestive of pulmonary artery endothelial and/
or vascular dysfunction.
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Introduction
After Fontan completion for a functionally univentricular heart, the systemic venous return is di-
rectly connected to the pulmonary arteries (PA’s), resulting in substantial or total loss of pulsatile 
flow into the lung [1-4]. The long-term effects of this abnormal flow pattern on PA growth and 
function are a matter of concern. Several groups have studied the effects of a bidirectional Glenn 
or Fontan pathway on PA growth and diameters [5-7], but have shown equivocal results. 
Wall shear stress (WSS), the force per unit area induced by the relative movement of 
blood and endothelium, is an important determinant of vascular function [8], and altered levels 
of WSS are associated with a variety of disease processes [9-11]. WSS is inversely related to vessel 
diameter and alterations in WSS induce vascular remodeling [9]. After Fontan operation, increased 
WSS was found in one study [12] and endothelial dysfunction has been reported that may inter-
fere with the normal remodeling process of the PA [2, 13, 14]. 
Recent studies on the effects of exercise on caval vein and pulmonary artery flow after 
Fontan operation have emphasized the need for evaluation of the Fontan circulation under exer-
cise conditions [15, 16]. In Fontan patients, PA flow has been studied directly after supine bicycle 
exercise with magnetic resonance imaging [16]. However, this study did not look into the reaction 
of the PA’s on an increase in flow. Therefore, the objectives of this study were: 1. to assess the size 
of a branch of the PA, its local flow pattern, and the local WSS after Fontan operation performed 
at young age using phase contrast velocity-encoded cardiovascular magnetic resonance imaging; 
2. to simulate the effects of exercise on the PA’s with low-dose dobutamine stress.
Materials and Methods
Subjects 
Fourteen patients were included in this study (table 1). All patients had been subject to an atriopulmo-
nary connection (APC) or to a total cavopulmonary connection (TCPC), completed before seven years 
of age. Follow-up time after Fontan completion was at least five years. In two patients, the initial TCPC 
was fenestrated, but the fenestration had been interventionally closed during follow-up. Patients did 
not have contra-indications for magnetic resonance imaging or dobutamine administration. Medical 
records were reviewed for anatomical and operative details. Mean PA pressure before Fontan comple-
tion was 10.0 mm Hg (7-14 mm Hg, n = 12). Mean PA pressure after Fontan completion was 10.5 mm 
Hg (6-16 mm Hg, n = 8). These invasive measurements were obtained 2.3 (1.2-5.6) years after Fontan 
completion and 4.9 (2.0-13.4) years before participation in this study. The post-operative measure-
ments were part of standard invasive investigations at least one year after Fontan completion.
Seventeen healthy children (nine boys) were included as controls for this study. Mean age 
was 13.3 (2.3) years, mean body surface area (BSA) was 1.54 (0.20) m². There was no statistically 
significant difference between the controls and patients in age, gender and BSA. The study was ap-
proved by institutional review boards and by the Dutch Central Committee on Research involving 
Human Subjects. All subjects and/or their parents (if required) gave informed consent.
Table 1. Characteristics of the patients 
   Patients
Total (male)  14  (9)
Age (years)  11.9  (7.5-20.1)
BSA (m2)  1.35  (0.93-2.09)
Follow-up after Fontan completion (years) 8.2  (5.4-16.8)
Age at Fontan completion (years)  3.5  (1.0-6.8)
Fontan type: APC 3
 TCPC, lateral tunnel 8
 TCPC, extracardiac conduit 3
Dominant ventricle: Right 4
 Left 10
Pre-Fontan procedures: BT-shunt 6
 PA-banding 2
 Norwood 1
 Glenn anastomosis 9
 Branch pulmonary artery augmentation 2
Post-Fontan procedures: Bentall procedure 1
 Atrial level shunt closure 2
 Extracardiac conduit replacement 1
Data are given as frequencies, or median (range). Abbreviations: APC = atriopulmonary connection, BT-shunt
= Blalock-Taussig shunt, PA-banding = pulmonary artery banding, TCPC = total cavopulmonary connection.
Magnetic resonance imaging
A Signa 1.5 Tesla whole-body MR imaging system was used (General Electric, Milwaukee, WI, USA) 
for all patients, in combination with a dedicated phased-array cardiac surface coil that was placed 
over the thorax. All patients were monitored by vector cardiogram gating and blood pressure 
monitoring. 
The PA’s were localized on an axial set through the thorax, using a steady-state free 
precession sequence. On this axial localizer, the PA’s were cut longitudinally (figure 1a). The subse-
quent image together with the axial localizer was used to plan a flow measurement perpendicular 
to the flow, using phase-contrast velocity-encoded imaging. The imaging plane was set halfway 
between the origin (i.e. point of the Fontan anastomoses in patients) and the first branching point 
of the PA (figure 1b). The branching points could be well visualized and there was no evidence of 
proximal PA stenosis on this double-oblique localizer. Flow measurements were obtained over one 
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cardiac cycle, and were divided in 24 phases. Imaging parameters were TR=5-6 ms, TE=3 ms, flip 
angle=20o, 7 mm slice thickness, 6 views/segment, scanning matrix of 256 *128. 
 
Figure 1. SSFP images of the PA’s on an axial localizer (1a) of a healthy control (left), patient with an APC 
(middle), and patient with a TCPC (right). The line indicates the imaging plane in the RPA (left panel), and LPA 
(middle and right panel) for the subsequent localizer (1b). On this double oblique image, the flow measure-
ments were planned halfway the origin of the PA and the first branching point (line).
It is known that the better the velocity encoding matches the real velocity in the region of 
interest, the more precise the measurement becomes [17]. In patients, unidirectional velocity encod-
ing was set at 30 cm/s and adjusted in case of aliasing. The maximal velocity encoding used was 80 
cm/s. To minimize the effect of breathing, flow measurements were made without breath-hold, us-
ing three signal-averages. When the study protocol had been completed, dobutamine-hydrochloride 
(Centrafarm Services, Etten-Leur, the Netherlands) was administered by continuous infusion into 
an antecubital vein at 7.5 μg/kg/min. After fifteen minutes, when a new steady state in heart rate 
and blood pressure had been obtained, a second flow measurement was acquired using the imaging 
parameters specified above. Dobutamine infusion was lowered to 5 μg/kg/min if any of the following 
events occurred: a) heart rate, systolic, or diastolic blood pressure of more than 150% baseline; b) 
heart rate, systolic, or diastolic blood pressure of less than 80% baseline [18]. 
In healthy controls, flow measurements in the PA’s were performed as part of another 
study protocol. In this study, unidirectional velocity encoding was 150 cm/s and acquisitions were 
taken with breath-hold in end-expiration. Flow measurements were done at rest only. Difference 
in acquisition parameters between the patient and control group were accepted, since others have 
demonstrated clinically non-significant differences in absolute blood flow and peak velocity in the 
branch PA’s between expiratory breath-hold versus free-breathing acquisitions [19, 20].
Image analysis
CMR studies were analyzed on a commercially available Advanced Windows workstation (General 
Electric Medical Systems, Milwaukee, WI, USA) using the Flow analysis software package V3.1 (Me-
dis Medical Imaging Systems, Leiden, the Netherlands). The following variables were determined: 
time averaged intraluminal area; maximal and minimal intraluminal area; peak flow rate, minimal 
and time averaged flow rate; stroke index (stroke volume divided by BSA), and total flow per min-
ute indexed for BSA.  
Calculations
To compare our results to the results of a previous study [12], distensibility of the PA was approxi-
mated by the formula: (maximal area – minimal area)/maximal area.
 
WSS determination 
WSS was determined according to the method of Wentzel et al [10]. All 24 phases of the velocity 
measurement were processed to obtain WSS data. We applied a moving average filter (3 x 3) to 
reduce noise. Shear rate, being the change in velocity per unit distance, was calculated according 
to the following method: for each pixel the velocity value of the left and right neighbor pixel, and 
the upper and lower neighbor pixel were taken and half of the velocity difference was divided by 
the pixel size. This resulted in a velocity gradient in two orthogonal directions for each pixel. Those 
two velocity gradients were squared. The final shear rate for each pixel was taken as the square 
root from the squared sum of these values. To determine the shear rate at the vessel wall, we 
separated the wall in twelve parts. Each part was determined by the outer 10% of the vessel radius 
and 30° in the circumferential direction. The highest shear rate found in each part was considered 
representative for the wall shear rate in the corresponding part. The wall shear rate (s-1) was mul-
tiplied with the viscosity (3 N·s/m²) to get the WSS (N/m2). Average WSS per cardiac phase was 
the arithmetic mean from the WSS of the twelve parts. Mean WSS of the whole cardiac cycle was 
the arithmetic mean from the average WSS of all 24 phases.
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Statistical analysis
Data are expressed as frequencies, mean (standard deviation), or median (range) as appropriate. 
Comparisons between groups were made using the appropriate t-test. A p-value < 0.05 was con-
sidered to indicate statistical significance.
Results
The study protocol was well tolerated and completed by all subjects. In three patients, dobuta-
mine infusion was lowered to 5 μg/kg/min, since heart rate was > 150% baseline with a dosage of 
7.5 μg/kg/min, although this was well tolerated.  
In patients, flow measurements in the right pulmonary artery (RPA) were not always pos-
sible due to the short distance between the connection with the superior vena cava and the first 
branching point. Therefore, all flow measurements were additionally performed in the left pulmo-
nary artery (LPA). In eight patients, there was an adequate flow measurement in the RPA. Statistical 
analysis of flow variables did not show any difference between the RPA and LPA (table 2).
In the control group, the first branching point of the LPA was closer to the bifurcation 
than the branching point of the RPA. This led to difficulties with WSS determination in half of the 
controls, since – because of vessel movement during the cardiac cycle – the flow signal of the LPA 
was disturbed by flow signals of branch vessels. Therefore, all flow measurements were done in 
the RPA. Statistical analysis of flow variables in the RPA and LPA of the controls also did not show 
any difference (table 2). In table 3, the results of measurements in a branch PA are shown (i.e. the 
RPA for healthy controls and the LPA for Fontan patients).
Flow measurements
At rest, stroke index, total flow, average flow rate, and peak flow rate were statistically significant-
ly higher in controls than in Fontan patients (table 3). With dobutamine stress-testing in Fontan 
patients, stroke index did not change. Total flow per minute increased significantly with increased 
heart rate (table 3). However, all variables remained below the levels of controls during rest. 
Pulmonary artery area and distensibility 
At rest, average area of the branch PA halfway the origin and the first branching point did not differ 
between patients and controls. In contrast, there was a statistically significantly higher maximal 
area in the controls compared to patients, which was partly related to a higher distensibility in 
the control group (table 3). With stress-testing in patients, area and distensibility did not change, 
despite an increase in blood flow (table 3). 
WSS determination
At rest, WSS was significantly lower in the patient group compared to controls. When the spatial 
average WSS per cardiac phase was plotted against cardiac phase, three distinct patterns were 
visible in controls, TCPC patients and APC patients, in agreement with the flow patterns in these 
groups (figure 2). In controls, peak WSS occurred at peak systole, while in TCPC patients, there was 
only little variation in WSS throughout the cardiac cycle. In contrast, in APC patients, there was an 
increase in WSS in late diastole, coinciding with atrial contraction. When WSS was plotted against 
area of the branch PA, Fontan patients showed a WSS that was too low for the area (figure 3). 
With stress-testing in patients, WSS increased but not to the level of the controls at rest (table 3). 
Figure 2. WSS (2a) and flow rate (2b) 
throughout the cardiac cycle of repre-
sentative study subjects. 
Abbreviations: APC = atriopulmonary 
connection, TCPC = total cavopulmo-
nary connection, WSS = wall shear 
stress. 
Figure 3. WSS versus branch PA dia-
meter. Triangles represent the control 
group, squares the Fontan group. 
Abbreviations: PA = pulmonary artery, 
WSS = wall shear stress.
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Discussion
In this study, we have demonstrated that normal PA areas after Fontan operation coincide with a 
decreased distensibility, and WSS. Furthermore, pulsatility of different parameters (flow, WSS) has 
been reduced considerably. We propose that these observations are suggestive of endothelial and/
or vascular dysfunction in Fontan patients.
In the present study, loss of pulsatility was demonstrated by the flow curves and WSS 
curves as presented in figure 2. Loss of pulsatility has been linked to pulmonary endothelial dys-
function in a few recent studies [2, 4]. After a bidirectional Glenn procedure, Kurotobi et al. [2] 
found a significant correlation between loss of pulsatility and significantly impaired endothelium-
dependent relaxation (by acetylcholine) in the lower lobe PA. Others have observed an abnormal 
pulmonary vascular response to exogenous nitric oxide in Fontan patients, in some part related to 
lack of pulsatility in the pulmonary circulation [13].
The long-term effects of total or substantial loss of pulsatility of flow in the PA’s after 
Fontan operation remain unclear. Results from a few studies focusing on the pulmonary vascula-
ture in Fontan patients are suggestive of pulmonary endothelial dysfunction, particularly in the 
nitric oxide pathway. Pulsatile stretch and WSS are important for the release of nitric oxide by the 
endothelium [21, 22]. Nitric oxide, a locally acting vasodilator, contributes to the maintenance of 
low pulmonary vascular resistance in healthy children [23]. Low pulmonary vascular resistance 
might be essential for optimal functioning of the Fontan circulation. 
 Previous studies have measured decreased PA sizes after Fontan operation [5-7, 12]. 
However, in these studies, PA size was determined at different locations than in the present study. 
Furthermore, Reddy [5], Buheitel [6], and Tatum [7] determined maximal PA diameter on angio-
grams, Morgan [12] determined maximal PA area on CMR flow measurements (perpendicular to 
the axial axis of the vessel). It is known that the cross-sectional area of a PA is not a perfect circular 
shape, but rather oval shaped. Determination of the diameter on angiograms in postero-anterior 
projections can therefore give an inaccurate estimate of the real diameter or area of the vessel. 
In our study, we used the average and maximal cross-sectional area of the branch PA (halfway 
between the origin and the first branching point) on CMR flow measurements. Although there was 
a statistically significant difference in maximal area, time averaged area did not differ between 
patients and controls. In our opinion, average PA area is a more representative measure of PA size. 
Pulmonary artery flow, in Fontan patients, is not primarily in systole, but continuously throughout 
the cardiac cycle. Although pressure was not measured, it is to be expected that this signal will 
follow the flow signal. Hence, a lower maximal area of a PA in a Fontan patient reflects the lack of 
pulsatility of pressure and an impaired distensibility of the vessel, but does not necessarily mean 
the vessel is too small. Therefore, we did not calculate the McGoon ratio or the Nakata index in 
this study group, since both these parameters use maximal PA diameter.
In our study, lower distensibility in Fontan patients at rest might be explained by the 
decreased pressure range after the Fontan operation. Distensibility is, however, not only affected 
by pulse pressure but also by properties of the vessel wall. Hence, the current findings might also 
be explained by altered muscle mechanics due to different tone of the smooth muscle cells. Tone 
of the smooth muscle cells is partly determined by the blood flow. However, with an increase in 
blood flow during low-dose dobutamine stress, distensibility did not change, arguing against an 
important effect of blood flow on distensibility. In healthy adults, pulmonary arteries distend ≈ 
2% of their initial diameter with every millimeter mercury increase in transmural pressure with 
increased flow during exercise [24]. Possibly, the PA is already maximally dilated at rest to ensure 
adequate pulmonary blood flow and cannot expand with increased flow. A second explanation 
might be endothelial dysfunction, preventing the vessel from dilating. This might explain the in-
ability to increase stroke index with stress-testing and therefore, cardiac index can only be in-
creased by increasing heart rate. 
In our study, time and spatially averaged WSS was significantly lower in the Fontan pa-
tients than in the control group, which is consistent with a reduced blood flow at rest, while ves-
sel area was normal. Throughout the cardiac cycle, distinct WSS-patterns were seen in healthy 
controls, TCPC patients and APC patients, comparable with the flow curves in these groups (figure 
2). Physiologic and pulsatile WSS constitutes the most potent stimulus for continuous production 
of nitric oxide by the endothelium [11]. Low WSS reduces the bioavailability of nitric oxide by de-
creasing expression of nitric oxide synthase. This will lead to an increase in pulmonary vascular re-
sistance, as has been demonstrated in patients late after Fontan-type operation by Khambadkone 
et al [13]. Levy et al. demonstrated weak expression of nitric oxide synthase in Fontan patients 
with a good surgical outcome, but over expression of nitric oxide synthase in patients after Fontan 
failure [14]. They hypothesized that this over expression could be due to an attempt to improve 
the pulmonary vascular resistance and facilitate the Fontan circulation. The mechanism, however, 
cannot be explained by the low WSS in this circulation and warrants further investigation.
Recently, Cheng et al. postulated that average WSS is not constant throughout the vas-
cular tree – as has been assumed – but is inversely related to the vessel diameter [9]. This new 
theory explains the variation in average WSS observed in vessels of varying sizes. In our study 
group, average WSS in Fontan patients was too low for the corresponding area when compared to 
controls (figure 3). According to the theory of Cheng, WSS in these Fontan patients should either 
be higher, or vessel area should be larger. The mismatch between blood flow and area may indicate 
a lack of appropriate vascular remodeling by WSS. 
When comparing our results to the results of the study of Morgan, also investigating PA 
size, blood flow, and WSS in Fontan patients [12], we found: 1) a higher total flow and branch PA 
flow in controls and patients, 2) no difference in PA area between patients and controls, 3) sig-
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nificantly lower distensibility in patients, 4) lower WSS in patients at rest and even during stress 
with different WSS patterns. The findings by Morgan et al. are somewhat unexpected and coun-
terintuitive in light of the current knowledge on the pulmonary circulation after Fontan operation. 
Important differences in study group and methods might explain these discrepant findings. In our 
study, patients were younger at Fontan completion, follow-up age was lower, and follow-up time 
after Fontan completion was longer. Flow measurements were planned on a double-oblique cross-
section of the PA – halfway between the origin and the first branching point – to plan the mea-
surements perpendicular to the flow, and to limit influences of bifurcations on the flow pattern. 
In the study by Morgan [12], WSS was determined immediately after the bifurcation of the main 
PA, which is an area with swirling flow, possibly responsible for the increase in WSS they found. 
In our group of patients, all after Fontan completion at young age and in which the ma-
jority has had a TCPC, average PA area is normal; an important finding for patients operated on 
according to this treatment strategy nowadays. The implications of the results that are suggestive 
of PA endothelial dysfunction and inappropriate vascular remodeling should be made with cau-
tion. The inability of the pulmonary vascular bed to expand with increasing blood flow might be an 
important limitation for maintenance of adequate ventricular preload on the long-term. However, 
more information is needed on the long-term effects of this pulmonary vascular dysfunction, e.g. 
the effects on the peripheral pulmonary vasculature and resistance, and will require serial follow-
up. CMR imaging is a safe, non-invasive, and easily applicable modality for this assessment of PA 
size and function in selected patients.
Study limitations
This study is limited by the small size and inhomogeneity of the study group, preventing us from 
analyzing the effects of diagnosis, pre-Fontan procedures, and Fontan type on the measured vari-
ables. In theory, endothelial function can be different in patients with an APC, because of the 
different flow profile and higher energy losses. Our results are not applicable to patients with 
different operative courses (e.g. Fontan completion at older age). Although there was no clinical 
evidence of increased PA pressure or resistance, this has not been assessed invasively. 
Acquisition parameters were different between patients and controls. This could introduce 
an error in the comparison of WSS in patients and controls. However, studies have shown differences 
of only 1 to 10% in flow velocity between free breathing and breath-hold acquisitions [19, 20]. Since 
the error in WSS is proportionate to the error in flow velocity, and differences in flow velocity be-
tween patients and controls were much higher in this study, we consider this error negligible.
Adenosine, a vasodilator commonly used for myocardial perfusion imaging in patients 
with coronary artery disease, may be a better pharmacological agent to test a vessel’s distensibil-
ity. However, since our objective was to simulate physical exercise, we chose to use dobutamine 
for its positive inotropic and chronotropic effects.
Velocity-encoding in three directions might be more accurate and informative on the 
flow pattern. All flow measurements were planned in the branch PA before the first branching 
point. The smaller peripheral pulmonary vasculature was not visualized and therefore absence of 
stenosis in this area cannot be excluded, even as possible effects on blood flow and endothelial 
function in the proximal branch PA. Temporal resolution of the flow measurements can be im-
proved and results in more accurate measurements [25]. However, this also increases acquisition 
time. Depending on the study subject, an acceptable balance between temporal and spatial reso-
lution and acquisition time should be sought.
Conclusions
Long-term after Fontan completion at young age, patients have a normal average PA size when 
compared to controls. However, pulmonary blood flow, distensibility, and WSS are all decreased 
in these patients and do not show adequate reactions with low-dose dobutamine stress testing, 
suggesting endothelial and/or vascular dysfunction. 
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Abstract
Objective: to assess normal values for biventricular function, volumes, and mass with current 
CMR imaging sequences in children.  
Methods: inclusion of 60 healthy children aged 8-17 years. A short axis set of contiguous slices 
was acquired with CMR imaging employing steady-state free precession. Biventricular end-dia-
stolic volume (EDV), end-systolic volume (ESV), ejection fraction (EF), and mass were determined. 
Uni- and multivariable linear regression analyses were performed to study the interrelation of age, 
gender, and body surface area (BSA) on biventricular volumes and mass. The coefficient of varia-
tion was calculated for intra- and interobserver variability.
Results: EF did not differ between boys and girls (mean LV-EF 69 ± 5 (SD) %, mean RV-EF 65 ± 
5 %). BSA had good (EDV, mass) and modest (ESV) correlation with biventricular measurements. 
Gender appeared a significant modifier of these relations, whereas age had no independent con-
tribution. The intra-and interobserver coefficient of variation was in the range 2.1 to 13.9% for 
biventricular EDV, ESV, and mass.
Conclusions: this study reveals gender-specific normative data for biventricular function, vol-
umes, and mass in children aged 8-17 years that can be used as reference data in the follow-up of 
pediatric cardiac patients.
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Introduction
Assessment of global ventricular function is important in the follow-up of patients with congeni-
tal and acquired heart disease. Cardiovascular magnetic resonance (CMR) imaging is an accurate, 
reproducible, and non-invasive method for the assessment of both right and left ventricular func-
tion, which has been validated extensively [1]. In congenital heart disease, it is the only non-
invasive technique that allows adequate measurement of right ventricular size and function [2]. 
CMR imaging contributes to decision-making and timing of (re) interventions, and as such has 
become an internationally accepted and widely used clinical tool, for which clear guidelines have 
been established [1]. 
Although CMR imaging is increasingly being implemented in the follow-up of pediat-
ric patients with congenital and acquired heart disease, normative data on ventricular volumes, 
function, and mass for this population are lacking. Currently, normal values from small studies, 
employing gradient-echo MRI sequences are used [2, 3]. In recent years, however, steady-state free 
precession (SSFP) gradient echo sequences have become the standard method for assessment of 
ventricular function and volumetric parameters with CMR imaging [1]. Compared to the previously 
used spoiled gradient-echo sequences, SSFP provides better blood-myocardial contrast, higher 
image quality and faster acquisition times [4]. Better blood-myocardial contrast in SSFP imaging 
results in statistically significantly higher end-diastolic volumes (EDV) and end-systolic volumes 
(ESV), lower mass and lower ejection fraction (EF) [5, 6]. Therefore, SSFP derived data cannot be 
compared to data obtained with spoiled gradient echo sequences. In addition, SSFP has a lower 
interobserver variability and better reproducibility compared to gradient-echo [4-7]. Therefore, it 
has been suggested that this technique allows considerable reduction in subject numbers to prove 
a hypothesis in research studies and study groups can be up to 90% smaller than with echocar-
diography for establishing significant differences [8, 9]. Although SSFP has become the method of 
choice for CMR imaging at 1.5T, spoiled gradient echo sequences are more useful at 3T, where SSFP 
yields more artefacts [10]. 
Besides different MRI sequences, the few studies measuring ventricular function, vol-
umes, and mass in small groups of healthy children have used different acquisition techniques 
(free breathing instead of breath hold techniques, different image orientation) then are commonly 
used in a clinical setting nowadays [2, 3]. 
Lack of adequate normative data in the pediatric population limits optimal use of this im-
aging modality in the follow-up of patients with congenital and acquired heart disease throughout 
childhood. Although a study of Lorenz [3] demonstrated no difference between adults and chil-
dren in biventricular volumes, function, and mass indexed for body surface area (BSA), this study 
group comprised only eight children in the age range seven to twenty years. The assumption that 
adult normal values indexed for BSA can be used as reference data for the pediatric population 
needs further investigation. Therefore, the objective of this study was to obtain normal values 
for biventricular function, volumes, and mass in healthy children using CMR imaging employing a 
steady-state free precession gradient echo sequence, and to evaluate their relationship with age, 
gender, and body size.
Materials and Methods
Subjects 
Sixty healthy children (30 boys), aged 8-17 years, were included in this study. Health status was 
evaluated by questionnaire and physical examination. All children under the age of thirteen under-
went echocardiography as part of another study protocol prior to the CMR study. The participants 
were divided in three groups of twenty children (ten boys): 8 to 11 years (group A), 12 to 14 years 
(group B), and 15 to 17 years of age (group C). The age distribution of our study group was rep-
resentative of the age distribution of patients in whom CMR imaging was requested in our daily 
clinical practice. The number of twenty children per group was based on the study by Bellenger et 
al. (8) who calculated a minimal sample size of ten to fifteen subjects to detect clinically relevant 
changes in ventricular volumes, function, and mass with CMR imaging. All children performed less 
than six hours of structured exercise per week. The study was approved by the institutional review 
board, and all subjects and their parents gave written informed consent.
CMR study
CMR imaging was performed using a Signa 1.5 Tesla whole-body MR imaging system (General 
Electric, Milwaukee, WI, USA). Dedicated phased-array cardiac surface coils were placed over the 
thorax. All patients were monitored by vector cardiogram gating and respiratory monitoring.
All studies were obtained by a single experienced operator. Standard scout images were 
made to obtain a four chamber view of the heart. A multi-phase, multi-slice volumetric data-set 
was acquired using a fast 2-dimensional cine scan employing SSFP. The first slice was positioned at 
and parallel to the atrioventricular valve plane of the left ventricle in end-diastole, perpendicular 
to the long axis of the left ventricle. Ten to twelve slices were planned from base to apex, cover-
ing the entire ventricles in end-diastole. Depending on heart size, slice thickness varied to obtain 
a comparable number of slices in all subjects. The field of view was chosen as the minimum field 
of view that did not lead to phase wrap in the region of interest. The imaging parameters were: 
repetition time 3.5 ms, echo time 1.5 ms, flip angle 45°, bandwidth 111 Hz, slice thickness 7 to 10 
mm, inter-slice gap 0 mm, field of view 280-370 mm, phase field of view 0.75, matrix 160 x 128 
mm, 1 signal average. All images were obtained during breath-hold in end-expiration. Respiration 
was monitored during acquisition. In case of unsuccessful breath-hold, the image was repeated. 
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CMR analysis 
The CMR studies were analyzed on a commercially available Advanced Windows workstation 
(General Electric Medical Systems, Milwaukee, WI, USA). The ventricular volumetric data set was 
quantitatively analyzed using the AW 5.1 version of the MR Analytical Software System (Medis 
Medical Imaging Systems, Leiden, the Netherlands). Currently, there are no programs that can 
adequately perform automated right ventricular contour detection, and therefore we used manual 
detection of endocardial and epicardial borders in end-systole and end-diastole. The following 
parameters were calculated: biventricular EDV, ESV, stroke volume (SV), EF, and mass [11]. 
End-diastole and end-systole were visually defined on multiple midventricular slices. 
When there was any doubt on the exact phase, multiple adjacent phases were used for border de-
tection and the calculated largest and smallest volumes were chosen as the EDV and ESV respec-
tively. Major papillary muscles were outlined separately [5-7, 12, 13]. The interventricular septum 
was included in the left ventricular mass. In the basal slices, the following criteria for inclusion in 
the ventricular volume were used: 1) when the cavity was only partially surrounded by ventricular 
myocardium in end-systole or end-diastole, only the part up to the junction with atrial tissue was 
included in the ventricular volume [6]; 2) when the pulmonary or aortic valve was visible in the 
basal slice, contours were drawn up to the junction with the semilunar valves [6, 13]. In the apical 
area, major trabeculations and the moderator band were included in the left or right ventricular 
mass [13].
Ventricular volume was calculated as the sum of the ventricular cavity areas multiplied 
by the slice thickness. Ventricular mass was calculated as the difference between the epicardial 
and endocardial contours multiplied by the slice thickness and a specific gravity of ventricular 
mass of 1.05 g/ml [14]. Papillary muscles were excluded from the ventricular volumes and included 
in the ventricular mass.
All data sets were analyzed by one experienced observer. For intra-observer variability, 
fifteen randomly selected studies were reanalyzed after a minimal period of four weeks. For in-
terobserver variability, a second experienced observer analyzed another fifteen randomly selected 
studies and measured the aforementioned parameters independently and blinded to previous re-
sults.
Statistical analysis 
Data are expressed as frequencies, or mean ± standard deviation. Group comparisons were per-
formed using chi-squared tests for categorical variables and analysis of variance for continuous 
variables. Uni- and multivariable linear regression analyses were performed to study the interrela-
tion of age, gender, BSA, height and weight on biventricular EDV, ESV, and mass. Gender was also 
studied as an effect modifier of these relations. We report R2, i.e. the percentage of the variability 
of the data that is explained by the association between variables. Intra- and interobserver vari-
ability was assessed using the method of Bland-Altman [15]. The coefficient of variation, i.e. the 
standard deviation of the difference of the two measurements divided by the mean of the two 
measurements, and multiplied by 100%, was calculated to study the percentage of variability of 
the measurements.
Results
Characteristics of the study population are listed in table 1. In each age group, there was an even 
distribution of boys and girls. As can be expected, there was a statistically significant difference 
in anthropometric variables between age groups. In girls, this difference was most pronounced 
between group A and B. In boys, this difference was also evident between group B and C.
EF did not differ between boys and girls in all age groups (mean LV-EF 69 ± 5 (SD)%, 
mean RV-EF 65 ± 5 %). Univariable linear regression analysis demonstrated a good correlation of 
BSA with biventricular EDV and left ventricular mass (R2 0.65 to 0.72, table 2). BSA had a modest 
correlation with biventricular ESV and right ventricular mass (R2 0.48 to 0.53) (table 2). Gender 
appeared a significant modifier of these relations (p<0.005), whereas age had no independent con-
tribution (0.304). When height and weight were separately introduced in the regression model, R2 
of biventricular volumes were higher than in a model with BSA (table 2, outer right columns). R2 for 
biventricular mass, however, was slightly lower for height and weight separately. 
Gender-specific regression lines with 95% confidence bands for the mean values, and 
95% prediction bands for the absolute values of biventricular volumes and mass are displayed 
in figures 1 to 3. The model containing gender and BSA was used for reference data, since 1) this 
model has a good R2; 2) calculating BSA is common practice in pediatrics; 3) the model can be 
displayed in a two dimensional plot (when compared to the model containing height and weight 
separately). The regression equations representing the lines in figures 1-3 are given in table 2.
In table 3, indexed values for biventricular EDV, ESV and mass are displayed for the three 
age groups and for gender. When comparing the age groups, the only statistically significant differ-
ences where found for LV mass index (group A vs group C, p = 0.027) and for RV mass index (group 
A vs group B, p = 0.035). For all variables, except for left ventricular ESVI (p = 0.060), there was a 
statistically significant difference between boys and girls. Indexed values showed a good correla-
tion with gender (p = 0.002) and weight (p = 0.007). Therefore, when indexing only for BSA, as is 
commonly used, one should realize that there is an insufficient correction for weight. 
Intra-observer agreement was good with the highest variation in measurements in left 
and right ventricular ESV and right ventricular mass (table 4). Interobserver agreement demon-
strated more variation for all variables, and, again, the highest variation was found in measure-
ments of left and right ESV, and left and right ventricular mass. 
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Discussion
In our study biventricular EF, as a global measure for ventricular function, remained constant 
throughout growth and was not gender-specific. In the BSA range from 1.0 to 2.0 m2, there was a 
linear relation between biventricular volumes and mass that was significantly modified by gender. 
Up until now, normal values from very small pediatric study groups or from adult stud-
ies have been used in pediatric CMR imaging. When compared to the studies from Lorenz (3) and 
Helbing et al [2], biventricular volumes indexed for BSA were between 9 and 33% higher in our 
study (table 5). These two studies used older gradient echo sequences, or different image orienta-
tions, and did not identify the gender difference, and therefore cannot be used for reference data 
nowadays. Studies with spoiled gradient echo sequences can be used as reference data for studies 
using the same sequences, for example with acquisition at 3T.
Compared to studies in young adults [6, 12, 16, 17], mean values for indexed volumes, 
and mass were almost always lower in our study. Compared to the study by Tandri [16], however, 
right ventricular indexed volumes were higher in our study (table 5). 
The results of our study show significant and clinically relevant gender differences in 
biventricular volumes and mass with increasing BSA, as has been demonstrated by other in adults 
[6, 12, 13, 17]. The effects of gender on cardiac size have also been assessed with 2-dimensional 
Figure 2. Gender-specific regression lines (bold lines) with 95% confidence bands (dashed lines), and 95 % 
prediction bands (dotted lines) for right ventricular volumes. Abbreviations: BSA = body surface area; RVEDV 
= right ventricular end-diastolic volume; RVESV = right ventricular end-systolic volume.
Figure 1. Gender-specific regression lines (bold lines) with 95% confidence bands (dashed lines), and 95 % 
prediction bands (dotted lines) for left ventricular volumes. Abbreviations: BSA = body surface area; LVEDV = 
left ventricular end-diastolic volume; LVESV = left ventricular end-systolic volume.
Figure 3. Gender-specific regression lines (bold lines) with 95% confidence bands (dashed lines), and 95 % 
prediction bands (dotted lines) for left (upper panels) and right (lower panels) ventricular mass. Abbreviations: 
BSA = body surface area; LV = left ventricular; RV = right ventricular.
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and 3-dimensional echocardiography [18, 19]. Gender differences in left ventricular mass are ap-
parent from puberty, with higher masses in boys than in girls. This difference continues to exist 
in adulthood [20]. It has been suggested that the effect of sexual maturation on left ventricular 
mass is mediated through hormonal changes that also influence body size, particularly acquisi-
tion of fat free mass [21]. The effects of gender on right ventricular measurements have been 
assessed in adults [16, 17], but not in subjects less than eighteen years of age. Gender differences 
in RV volumes are apparent in subjects up to 80 years of age, with higher volumes in men than in 
women [16, 17].
The best means by which to adjust for the impact of body size on the size of cardiovas-
cular structures remains unclear. Several groups have studied the correlation of vascular or ven-
tricular size with BSA or functions of BSA [22-24]. Recently, Sluysmans and Colan demonstrated 
that indexing dimensions of vascular structures for BSA does not adequately account for the de-
pendence of vascular size on BSA [22]. In their analysis, indexing with the square root of BSA fully 
accounted for the variance in aortic root annulus. However, others have shown good correlations 
of vascular and ventricular dimensions with a cube root function of BSA [24]. These analyses did 
not include gender in their model. 
In our study, we demonstrated a linear relation between BSA (in the range 1.0 to 2.0 m2) 
and biventricular volumes and mass that is modified by gender. We also demonstrated that when 
indexing for BSA, there is an insignificant correction for weight in the model. A model correcting 
for BSA and gender, however, is easily applicable and explains up to 81% of the variability of the 
variables. 
Outside the BSA range 1.0 to 2.0 m2, the relation between BSA and volumes and mass is 
probably different from the one we found in our study (especially in children with a BSA < 1.0 m2). 
This has to be investigated, but is hampered by the need of performing CMR studies under general 
anaesthesia in very young, healthy children. The reason we studied children aged 8-17 years, is 
that the majority of our patients in whom clinical CMR imaging becomes relevant is in this age 
range. We believe that our reference data with gender-specific regression lines are easily appli-
cable in the follow-up of pediatric cardiac patients since calculating BSA is standard practice in 
pediatrics and no further calculations are needed.
Intra-observer variability for the absolute values of clinically relevant variables was good, 
with the smallest variations in both left and right ventricular EDV, SV, and EF. These variables also 
showed the smallest variation for interobserver variability. The results of intra- and interobserver 
variability analysis in this study are comparable to the results of other studies with SSFP for all 
variables [6, 25-28]. Therefore, CMR imaging is an accurate and reliable method for follow-up of 
these variables and can adequately assess changes in ventricular size and global ventricular per-
formance. Ta
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For intra-observer variability, the largest amount of variation was found in biventricular 
ESV and right ventricular mass. Although two observers extensively discussed criteria for bor-
der detection beforehand, these variables together with left ventricular mass showed the largest 
variation in interobserver variability analysis. When critically reviewing the individually traced 
contours afterwards, the variation could be explained by different interpretations in the basal slice 
and in the apical slices. 
In the basal area, even small differences in inclusion or exclusion of certain areas can 
result in large differences in absolute volumes and remains an area in which there may be much 
discussion if image acquisition in the short axis plane is used. For the right ventricle, assessment 
in the short axis orientation complicates identification of the position of the pulmonary and tri-
cuspid valves. The axial orientation facilitates detection of the atrioventricular valve border and 
has a lower intra-observer and interobserver variability than the short axis method [27]. However, 
acquisition in short axis orientation has two advantages: (1) only one data set is required for bi-
ventricular measurements; (2) there is less partial volume effect of blood and myocardium on the 
inferior wall of the RV compared to the axial orientation [27]. 
Three-dimensional volumetric analysis, also using the vertical and horizontal long axis 
planes for adequate delineation of the atrioventricular valve plane, will facilitate border delinea-
tion in the basal area [29], even more so in patients with complex congenital heart disease. In the 
apical area, trabeculations complicate exact border delineation between blood and myocardium. 
In patients with congenital heart disease, edge detection can be even more complicated. Varia-
tions within and between observers will remain an important issue to be taken into consideration 
when evaluating follow-up data of myocardial mass. Despite these shortcomings, follow-up studies 
in patients with congenital heart disease are feasible when side-by-side comparisons are made to 
ascertain identical image analysis.
The results of our study show acceptable 95% confidence intervals for the mean values 
of biventricular volumes and mass, and wide 95% prediction intervals for the absolute values of 
biventricular volumes or mass (figures 1 to 3). This could be due to the relatively small sample size 
of this study. However, when comparing our results to adult CMR studies with larger sample sizes 
[12, 16, 17], e.g. 120 and 487 subjects, the range of biventricular volumes and mass is comparable. 
Therefore, we consider our results representative normal values for this age group.
For biventricular volumes and mass, the regression lines for the mean values can be used 
to predict the values for individuals and are helpful in follow-up studies. For a given BSA, volumes 
or mass should be within the 95% prediction bands (presented in figures 1-3) to be considered 
normal. During follow-up, with a higher BSA, the 95% prediction interval changes. The slope of 
the line connecting two measurements can be compared with the given slope of the regression 
line. If the slope of a line connecting two measurements from a patient differs from the slope (and 
its 95% confidence interval) as presented in table 2, this can be considered a significant increase 
or decrease of the variable with increasing BSA. This interpretation might be helpful in timing of 
(re) interventions.
Study limitations
The imaging parameters used in this study have been implemented because of the combination of 
acceptable scanning time per image and acceptable spatial resolution, and are therefore applicable 
in daily clinical practice with pediatric patients. Spatial resolution, however, can be improved and 
yield better contrast between blood and myocardium and less variability in study results. The 
results of this study are, thus, applicable to studies with comparable imaging parameters. When 
comparing results from different studies, special attention should be made to the image analysis, 
since there are many different criteria used for border detection (selection of the basal slice, inclu-
sion or exclusion of trabeculae, papillary muscles, etc.).
Conclusions
Assessment of biventricular volumes, function, and mass in 60 healthy children aged 8-17 years, 
reveals normative data for this group with good intra-observer and interobserver variability. Gender 
is a significant modifier of the relation between BSA and biventricular volumes and mass in children. 
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Abstract
Objective: to assess intra-observer and interobserver variability of biventricular function, volumes 
and mass in a heterogeneous group of patients with CHD using CMR imaging.
Methods: Thirty-five patients with CHD (7 – 62 years) were included in this study. A short axis 
set was acquired using a steady-state free precession pulse sequence. Intra-observer and inter-
observer variability was assessed for left ventricular (LV) and right ventricular (RV) volumes, func-
tion and mass by calculating the coefficient of variability. 
Results: Intra-observer variability was between 2.9% and 6.8% and interobserver variability was 
between 3.9% and 10.2%. Overall, variations were smallest for biventricular end-diastolic volume 
and highest for biventricular end-systolic volume. 
Conclusions: Intra-observer and interobserver variability of biventricular parameters assessed by 
CMR imaging is good for a heterogeneous group of patients with CHD. CMR imaging is an accurate 
and reproducible method and should allow adequate assessment of changes in ventricular size and 
global ventricular function.
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Introduction
Assessment of ventricular function is important in the follow-up of patients with congenital and 
acquired heart disease. Cardiovascular magnetic resonance (CMR) imaging is frequently used for 
the assessment of both left ventricular (LV) and right ventricular (RV) size and function, because it 
is an accurate and non-invasive method, which has been validated extensively [1]. 
Reproducibility of CMR measurements plays an important role in establishing the fea-
sibility of CMR imaging in clinical practice. Whether differences in measurements are caused by 
progression of disease or could be explained by intra-observer or interobserver variability is of 
crucial importance, because CMR imaging has a main contribution to decision making and timing 
of (re) interventions.
There are several reports on the reproducibility of CMR measurements, but most have 
been done in healthy patients or patients with acquired heart disease [2-11]. Only a few studies 
measured reproducibility in patients with CHD [12-15]. These studies were performed using gradi-
ent echo imaging pulse sequences [12] or only examined a selected group of patients (tetralogy of 
Fallot (TOF), atrial septal defect (ASD) or systemic RV) [13-15]. Intra-observer and interobserver 
variability has never been studied in a heterogeneous group of patients with CHD, representative 
for the total spectrum in a clinical program. 
In patients with CHD, the RV is often involved in the disease process. The geometric 
shape of the RV can be altered by abnormal volume- and/or pressure loading conditions, e.g. 
caused by pulmonary regurgitation in patients with TOF, or due to extensive trabeculation with 
hypertrophy, as in patients with intra-atrial correction of transposition of the great arteries (TGA). 
In theory, the complex geometry of the RV in patients with CHD can potentially lead to higher 
intra-observer and interobserver variability, compared to measurements in healthy volunteers. 
The objective of this study was to assess intra-observer and interobserver variability of 
biventricular function, volumes and mass in a heterogeneous group of patients with CHD using 
CMR imaging. 
Material and Methods
Subjects
Thirty-five patients with CHD (26 males, 9 females; mean age 22 ± 13 years, range 7 – 62 years) 
were included in this study. The subjects were selected from the total group of patients with CHD 
in whom CMR imaging was requested in daily clinical practice in 2007. The study was approved by 
the institutional review board. 
The characteristics of the study population are displayed in table 1. The distribution of 
diagnoses in our study group was representative of the distribution of diagnoses in the total group 
of subjects with CHD undergoing CMR imaging in 2007. 
Table 1. Characteristics of the study population
Characteristic Value
Gender (male / female) 28/9
Age (years) 22.2 ± 13.2  (6.8 – 61.6)
Heart rate (beats per minute) 76 ± 11 (62 – 101)
Diagnosis
- Aortic stenosis (repaired/unrepaired) n = 5  (4/1)
- ASD (unrepaired) n = 1 
- ccTGA, PA, VSD (repaired)     n = 1
- DORV, VSD, coarctation (repaired) n = 1
- Fontan circulation (dominant RV/dominant LV) n = 10  (3/7)
- Intra-atrial correction of TGA n = 3
- PA, VSD (repaired) n = 3
- Pulmonary stenosis (repaired) n = 1
- Tetralogy of Fallot (repaired) n = 8
- VSD (unrepaired) n = 2
Reported data are expressed as mean ± SD (range). Abbreviations: ASD = atrial septal defect; ccTGA = congeni-
tally corrected transposition of the great arteries; PA = pulmonary atresia; VSD = ventricular septal defect; 
DORV = double outlet right ventricle; RV = right ventricle; LV = left ventricle; TGA = transposition of the great 
arteries.
CMR image acquisition
CMR imaging was performed using a Signa 1.5 Tesla whole-body MR imaging system (General 
Electric, Milwaukee, WI, USA). An 8-channel phased-array cardiac surface coil was placed on top 
and beneath the chest. All patients were monitored by vector cardiogram gating and respiratory 
monitoring. Studies were performed by experienced MR-technicians, supervised by one of the 
four physicians (SEL, DR-V, AM, WAH), or by the physicians themselves. Standard scout images 
were made to obtain a four-chamber view of the heart. A short axis set, using steady-state free 
precession (SSFP) cine imaging, was acquired from base to apex. An average of thirteen contiguous 
slices were planned on the four-chamber image, parallel to the atrioventricular valve plane of the 
LV in end-diastole. Typical imaging parameters were: repetition time 3.4 ms, echo time 1.5 ms, flip 
angle 45º, receiver bandwidth 125 kHz, slice thickness 7–10 mm, inter-slice gap 0–1 mm, field of 
view 380 x 380 mm, phase field of view 0.75 and matrix 164 × 128 mm. All images were obtained 
during breath-hold in end-expiration.
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CMR analysis 
The CMR studies were analyzed on a commercially available Advanced Windows workstation 
(General Electric Medical Systems, Milwaukee, WI, USA), equipped with Q-mass (version 5.2, Me-
dis Medical Imaging Systems, Leiden, the Netherlands). 
The ventricular volumetric data set was quantitatively analyzed using manual outlining 
of endocardial and epicardial borders in end-systole and end-diastole. The following parameters 
were calculated: biventricular end-diastolic volume (EDV), end-systolic volume (ESV), stroke vol-
ume (SV), ejection fraction (EF) and mass. Criteria for border detection were used as described by 
Robbers-Visser et al. [11] Specifically: end-diastole and end-systole were visually defined on mul-
tiple midventricular slices. In the basal slices, the following criteria were used: 1) when the cavity 
was only partially surrounded by ventricular myocardium, only the part up to the junction with 
atrial tissue was included in the ventricular volume; 2) when the pulmonary or aortic valve was vis-
ible in the basal slice, contours were drawn up to the junction with the semilunar valves [16]. The 
interventricular septum was included in the left ventricular mass. Major papillary muscles and tra-
beculations were excluded from the ventricular volumes and included in the ventricular mass [17]. 
Ventricular volume was calculated as the sum of the ventricular cavity areas multiplied 
by the slice thickness. Ventricular mass was calculated as the difference between the epicardial 
and endocardial contours multiplied by the slice thickness and a specific gravity of the myocar-
dium of 1.05 g/ml. [18] 
All data sets were analyzed by one observer (SEL). For intra-observer variability, studies 
were reanalyzed after an average period of six months. For interobserver variability, a second ob-
server (DR-V) analyzed all studies and measured the aforementioned parameters independently 
and blinded to previous results.
Statistical analysis 
Data are expressed as frequencies, or mean ± standard deviation. Intra- and interobserver vari-
ability was assessed using the method of Bland-Altman [19]. The coefficient of variability, i.e. the 
standard deviation of the difference of the two measurements divided by the mean of the two 
measurements, and multiplied by 100%, was calculated to study the percentage of variability of 
the measurements. A p-value < 0.05 was considered statistically significant.
Results
The intra-observer and interobserver variability data are displayed in table 2. Intra-observer vari-
ability was between 2.9% and 6.8%, with the smallest variation in measurements of LV and RV 
EDV (2.9% and 3.0% respectively). The highest variation was found in LV ESV (6.8%) and RV mass 
(5.7%). Interobserver agreement demonstrated more variation for all variables and was between 
 
6
Ch
ap
te
r 
7 
Ta
bl
e 
2.
 In
tr
a-
ob
se
rv
er
 a
nd
 in
te
ro
bs
er
ve
r v
ar
ia
bi
lit
y 
an
al
ys
is
  
 
LV
-E
D
V
 
LV
-E
SV
 
LV
-S
V
 
LV
-E
F 
LV
-m
as
s 
RV
-E
D
V
 
RV
-E
SV
 
RV
-S
V
 
RV
-E
F 
RV
-m
as
s 
In
tr
a-
ob
se
rv
er
  
 
 
 
 
 
 
 
 
 
 
M
ea
n 
di
ff
er
en
ce
 ±
 S
D
 
1.
6 
± 
3.
9 
1.
9 
± 
3.
4 
-0
.4
 ±
 3
.4
 
-0
.9
 ±
 2
.3
 
0.
6 
± 
4.
1 
0.
9 
± 
5.
3 
3.
4 
± 
3.
4 
-2
.5
 ±
 4
.4
 
-1
.6
 ±
 1
.9
 
0.
1 
± 
4.
7 
Li
m
its
 o
f a
gr
ee
m
en
t  
-6
.3
 to
 9
.4
 
-4
.9
 to
 8
.8
 
-7
.2
 to
 6
.5
 
-5
.6
 to
 3
.7
 
-7
.6
 to
 8
.9
 
-9
.7
 to
 1
1.
5 
-3
.3
 to
 1
0.
2 
-1
1.
4 
to
 6
.4
 
-5
.4
 to
 2
.1
 
-9
.3
 to
 9
.5
 
M
ea
n 
va
lu
e 
± 
SD
 
13
4.
9 
± 
42
.5
 
50
.3
 ±
 1
9.
2 
84
.7
 ±
 2
7.
8 
62
.9
 ±
 6
.4
 
12
5.
2 
± 
47
.3
 
17
9.
3 
± 
84
.8
 
86
.9
 ±
 5
1.
9 
92
.3
 ±
 3
7.
2 
53
.8
 ±
 9
.5
 
81
.8
 ±
 4
4.
6 
Co
ef
fic
ie
nt
 o
f v
ar
ia
bi
lit
y 
 
2.
9%
 
6.
8%
 
4.
1%
 
3.
7%
 
3.
3%
 
3.
0%
 
3.
9%
 
4.
8%
 
3.
5%
 
5.
7%
 
In
te
r-
ob
se
rv
er
  
 
 
 
 
 
 
 
 
 
 
M
ea
n 
di
ff
er
en
ce
 ±
 S
D
 
0.
3 
± 
5.
8 
1.
6 
± 
5.
1 
-1
.1
 ±
 4
.4
 
-0
.9
 ±
 2
.5
 
-0
.3
 ±
 7
.5
 
4.
0 
± 
7.
1 
6.
8 
± 
6.
4 
-2
.6
 ±
 5
.2
 
-2
.7
 ±
 3
.0
 
2.
4 
± 
5.
0 
Li
m
its
 o
f a
gr
ee
m
en
t  
-1
1.
2 
to
 1
1.
9 
-8
.6
 to
 1
1.
8 
-9
.9
 to
 7
.6
 
-5
.9
 to
 4
.1
 
-1
5.
3 
to
 1
4.
8 
-1
0.
2 
to
 1
8.
1 
-6
.1
 to
 1
9.
6 
-1
3.
0 
to
 7
.8
 
-8
.7
 to
 3
.4
 
-7
.5
 to
 1
2.
4 
M
ea
n 
va
lu
e 
± 
SD
 
13
5.
0 
± 
41
.6
 
49
.7
 ±
 1
8.
9 
85
.4
 ±
 2
8.
0 
63
.5
 ±
 6
.9
 
12
5.
3 
± 
47
.6
 
17
7.
6 
± 
83
.7
 
83
.8
 ±
 5
0.
9 
93
.9
 ±
 3
7.
4 
55
.2
 ±
 9
.8
 
80
.6
 ±
 4
5.
6 
Co
ef
fic
ie
nt
 o
f v
ar
ia
bi
lit
y 
4.
3%
 
10
.2
%
 
5.
1%
 
3.
9%
 
6.
0%
 
4.
0%
 
7.
7%
 
5.
5%
 
5.
5%
 
6.
2%
 
Re
po
rt
ed
 d
at
a 
ar
e 
ex
pr
es
se
d 
as
 m
ea
n 
± 
SD
. C
oe
ff
ic
ie
nt
 o
f v
ar
ia
bi
lit
y:
 e
xp
re
ss
ed
 a
s 
a 
pe
rc
en
ta
ge
 o
f t
he
 S
D
 o
f t
he
 d
iff
er
en
ce
 d
iv
id
ed
 b
y 
th
e 
m
ea
n 
of
 th
e 
tw
o 
m
ea
su
re
m
en
ts
. V
ol
um
et
ric
 v
ar
ia
bl
es
 in
 
m
ill
ili
te
rs
, m
as
s 
va
ri
ab
le
s 
in
 g
ra
m
s.
 A
bb
re
vi
at
io
ns
: L
V 
= 
le
ft
 v
en
tr
ic
le
; E
D
V 
= 
en
d-
di
as
to
lic
 v
ol
um
e;
 E
SV
 =
 e
nd
-s
ys
to
lic
 v
ol
um
e;
 S
V 
= 
st
ro
ke
 v
ol
um
e;
 E
F 
= 
ej
ec
tio
n 
fr
ac
tio
n;
 R
V 
= 
ri
gh
t v
en
tr
ic
le
.  
Chapter 7 Observer variability of biventricular function in CHD
118 119
3.9% and 10.2%. The smallest variation was found in LV EF (3.9%) and RV and LV EDV (4.0% and 
4.3% respectively). The highest variation was found in measurements of LV and RV ESV (10.2% 
and 7.7% respectively) and LV and RV mass (6.0% and 6.2% respectively). 
Discussion
In our study, intra-observer and interobserver variability for all variables was good. Overall, the 
variations were smallest for biventricular EDV and highest for biventricular ESV. Although we ex-
pected higher intra- and interobserver variability in the RV, because of its complex shape and 
heavy trabeculations, we did not find a difference in results for both ventricles. Our results are 
comparable to those of other studies who reported on reproducibility with SSFP CMR imaging [3-
4, 6-8, 10-11, 13, 15] (table 3 and table 4). 
Recently, Mooij et al. [13] reported on reproducibility in patients with RV dilation (unre-
paired ASD (n = 20); TOF (n = 20)) and in a normal RV group (n = 20). Variability for all patients 
ranged from 3.6% – 13.0%. Mooij et al. examined a selected group of patients, whereas our study 
population consisted of a more heterogeneous group of patients with CHD, representative for the 
total spectrum in a clinical program. Valsangiacomo – Buechel et al. [14] reported that observer 
variability, in ten children with TOF, ranged from < 1 to 5% for intra-observer analysis and from < 
1 to 13% for interobserver analysis. Although we cannot compare all our reported results to theirs, 
this seems comparable to our results.
Similar to our results, other authors found the largest amount of intra-observer or in-
terobserver variation in biventricular ESV [4, 8, 10, 13]. One of the possible explanations is the 
smaller absolute value of ESV. Similar absolute measurement errors will therefore lead to higher 
observer variation in ESV, compared to for example EDV. Another source of error is the endocardial 
border detection, which is more difficult in end systole due to more densely packed trabeculations 
and papillary muscles [15].
Image analysis 
A critical review of contours traced revealed that the interobserver variation for both ventricles was 
mainly caused by different interpretations in the basal slice and in the apical slices. Guidelines for im-
age analysis might be helpful, but are still a subject of debate. Most authors agree on criteria on how 
to draw contours in the basal slice [4, 6, 9, 16, 20]. However, there is less consensus about inclusion or 
exclusion of papillary muscles and trabeculations [3, 6, 15-16]. It is important that the used criteria for 
border detection are described in reports, because inclusion or exclusion of papillary muscles and tra-
beculations cause differences in measurements of biventricular dimensions and function [15]. To reduce 
observer variability, it is important to have clear guidelines for methods of delineation in routine clinical 
practice as well as in research projects, since different observers may develop slightly different habits.  
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The basal slice will remain an area in which there may be discussion if image acquisition 
in the short axis plane is used, particularly for the RV. Alternative imaging orientations have been 
studied, as well as methods to improve image analysis and assessment of volumes and mass. 
For example, Alfakih et al. [2] found that observer variability for RV measurements in the axial 
orientation was slightly lower compared to results of the short axis orientation. Strugnell et al. 
[21] reported on a modified RV short axis orientation, which is aligned to the outflow of the RV. 
This method demonstrated a closer agreement between the RV and LV stroke volumes compared 
to the current method. However, observer variability analysis was not performed and should be 
assessed to establish the real advantage of this new method. Both the axial orientation as well as 
the modified RV short axis orientation makes detection of the atrioventricular valve border easier. 
However, the major advantage of the use of the short axis orientation is that only one data set is 
required for both LV and RV measurements. Furthermore, in the axial orientation, the partial vol-
ume effect of blood and myocardium on the inferior wall of the RV can make it difficult to identify 
the blood / myocardial boundary [2].
Kirschbaum et al. [22] have reported that identification of the mitral valve plane and apex 
on long-axis images in addition to short axis contours reduces the interstudy variability for all 
parameters in LV functional assessment, when compared with using short axis images alone. This 
method might be applicable for the RV as well. 
Van der Geest et al. [20] suggested that semiautomated contour detection is less ham-
pered by random variabilities. At present, semiautomatic contour detection algorithms are only 
available for the LV and still require manual correction in a significant number of slices [10, 20]. 
Further analysis and improvement of these algorithms is needed to demonstrate a reduction in 
observer variation. 
Catalano et al [23]. and Corsi et al. [24] reported on a technique for volumetric surface 
detection (VoSD) and quantification of biventricular volumes without tracing and geometric ap-
proximations. The VoSD method showed lower observer variation for all parameters compared to 
the short axis method. Although limitations clearly exist, this technique might improve reproduc-
ibility of biventricular assessments [23-24].
 
Study limitations 
The size and variation of our population prevented subgroup analysis. The amount and size of tra-
beculations and papillary muscles might be a cause of differences in variation between subgroups. 
In theory, the extensive trabeculations and large papillary muscles in patients with intra-atrial 
correction of TGA can potentially lead to higher observer variability compared to patients, in 
whom the shape of the RV is less altered by abnormal loading conditions. In patients after Fon-
tan operation, the interpretation of the basal slice might be more difficult due to the abnormal 
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anatomy, which can potentially lead to higher observer variability too. 
Another issue that should be taken into consideration when evaluating follow-up data, is 
that variation in CMR measurements could also be caused by interoperator variation, introduced 
during CMR planning, as reported by Danilouchkine et al. [25]. In research protocols it is favourable 
to have all studies carried out by the same operator, but in routine clinical practice, this is more 
difficult to achieve. In our center, image acquisition is perfomed according to a standard protocol 
and studies are carried out by experienced technicians, under direct supervision of an experienced 
CMR cardiologist / radiologist, to reduce operator variability.
Conclusions
Variations within and between observers and operators will remain an important issue to be taken 
into consideration when evaluating follow-up data of MRI measurements, especially in patients in 
whom CMR imaging contributes to decision-making and timing of (re) interventions as in patients 
with CHD. Our results show that intra-observer and interobserver variability of biventricular pa-
rameters assessed by CMR imaging, using SSFP, is good in a heterogeneous group of patients with 
CHD. CMR imaging is an accurate and reliable method for follow-up of biventricular function and 
mass and should allow adequate assessment of changes in ventricular size and global ventricular 
function. 
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Abstract
Objective: to report our experiences regarding safety and intra-observer and interobserver vari-
ability of low-dose DCMR in complex CHD. 
Methods: In 91 patients, 110 low-dose DCMR studies were performed with acquisition of a short 
axis set at rest, and during dobutamine administration (7.5 μg/kg/min maximum). We assessed 
biventricular end-diastolic volumes, end-systolic volumes, stroke volumes, ejection fraction and 
ventricular mass. Intra- and interobserver variability for all variables was assessed by calculating 
the coefficient of variation (%), i.e. the standard deviation of the difference divided by the mean of 
2 measurements multiplied by 100%.
Results: In three patients minor side effects occurred (vertigo, headache, bigeminy). Ten patients 
experienced an increase in heart rate of >150% from baseline, although well tolerated. For all 
variables, intra-observer variability was < 10% at rest and during stress. At rest, interobserver 
variability was 10.5% maximal. With stress-testing, only variability of biventricular end-systolic 
volumes (ESV) exceeded 10%. 
Conclusions: In patients with complex CHD low-dose DCMR is feasible, and safe. Intra-observer 
variability is low for rest and stress measurements. Interobserver variability of biventricular ESV is 
high with stress-testing. Whether this limits the potential usefulness of DCMR for risk assessment 
during follow-up has to be assessed.
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Introduction
Assessment of ventricular function with stress-testing is safe and widely applied in adult patients 
with coronary artery disease [1]. It is used to study wall motion abnormalities under stress condi-
tions. Stress-testing is able to reveal symptoms not apparent at rest, and can give information 
on prognostic factors [1-3]. Dobutamine stress echocardiography has been widely used for this 
purpose, and its use has been extended to pediatric patients with coronary artery abnormalities, 
e.g. patients after Kawasaki disease or after arterial switch operation for transposition of the great 
arteries [4,5]. Stress echocardiography has several limitations, such as poor acoustic windowing, 
high interobserver variability, and high interoperator variability [6]. Cardiovascular magnetic reso-
nance (CMR) imaging combined with dobutamine stress (DCMR) can overcome these limitations 
and has a higher sensitivity and specificity for identifying coronary artery disease as compared to 
dobutamine stress echocardiography [7]. 
In patients with complex congenital heart disease (CHD) several groups have studied 
the stress response of the heart, predominantly looking at the change in ventricular volumes and 
ejection fraction during stress-testing. Wall motion analysis is of lesser importance in this patient 
group with few coronary artery abnormalities. In several small studies abnormal stress responses 
of ventricular and vascular function have been reported [8-18]. These abnormal stress responses 
are of special interest since they are potential surrogate markers related to primary endpoints 
relevant for assessment of long-term outcome, such as death or functional impairment.  
Although the clinical usefulness of the abnormal stress responses in patients with com-
plex CHD with DCMR imaging still has to be assessed in follow-up studies, it is important to 
know the reliability of the measurements and the safety of the technique. The intra-observer 
and interobserver variability of CMR measurements of biventricular function, volumes, and mass 
have been assessed in patients and controls at rest and multiple studies have shown a good re-
producibility of these measurements [19,20]. Reproducibility of these measurements obtained 
during stress-testing in patients with complex CHD has only been assessed in one study [9]. The 
objective of this study was to assess the intra-observer and interobserver variability, and, in ad-
dition, to report on the adverse effects of low-dose DCMR imaging in pediatric and adult patients 
with complex CHD.
Materials and Methods
Patients
We included 91 patients who had undergone 110 low-dose DCMR studies between September 
2002 and August 2008. Most of these studies were performed in research protocols and the re-
sults of ventricular and vascular responses have been previously published [8-11]. Low-dose DCMR 
studies that were performed for research purposes conformed to the ethical guidelines of the 
1975 Declaration of Helsinki as reflected in a priori approval by the Dutch Central Committee on 
Research involving Human Subjects and the institutional review board. All subjects and/or their 
parents (if required) gave written informed consent. The study group included 54 patients after 
repair of tetralogy of Fallot, and 37 patients with a functionally univentricular heart after Fontan 
operation [8-11]. Characteristics of the study population are displayed in table 1 and 2. Median 
age at study was 14.2 (6.8-25.5) years. We obtained patient demographics, diagnosis, maximal 
dobutamine dosage, and occurrence of adverse effects. 
Table 1. Patient and study characteristics
Characteristic Patients
Number (male) 91  (63)
Tetralogy of Fallot/Fontan (n) 54/37
Age at 1st study (years) 14.2  (6.8-25.5)
Follow-up since repair/palliation (years) 12.5  (5.1)
Repeat studies (n) 19
Interval 1st and 2nd study (years) 5.0  (0.3)
Systolic blood pressure rest (mm Hg) 115  (9)
Systolic blood pressure stress (mm Hg) 133  (14)
Heart rate rest (beats per minute) 75  (13)
Heart rate stress (beats per minute) 91  (17)
Adverse effects (n) 3
 Vertigo (n) 1
 Bigeminy (n) 1
  Minor headache (n) 1
Studies discontinued (n) 2
Dobutamine lowered to 5 μg/kg/min (n) 10
Data are given as frequencies, median (range), or mean (standard deviation) as appropriate.
Table 2. Diagnoses in patients after Fontan operation
Diagnosis Number
Tricuspid atresia 10
Pulmonary atresia/intact ventricular septum 3
Double inlet left ventricle 6
Double outlet right ventricle 7
Hypoplastic left heart syndrome 5
Other complex CHD 6
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CMR study
The study protocol and image analysis have been previously reported [8-11]. In summary, all pa-
tients underwent CMR imaging at a Signa 1.5 Tesla whole-body MR imaging system (General 
Electric, Milwaukee, WI, USA). A multi-phase, multi-slice volumetric data set was acquired using a 
fast 2D cine scan employing steady-state free precession. Contiguous slices were planned starting 
at and parallel to the atrioventricular valve plane of the systemic ventricle to cover the heart from 
base to apex. Imaging parameters: slice thickness 7 to 10 mm, inter-slice gap 0 mm, field of view 
280-370 mm, phase field of view 0.75, matrix 160 x 128 mm, repetition time 3.5 ms, echo time 1.5 
ms, 12 views/segment, flip angle 45°, mean in-plane resolution 2 mm2, range of temporal resolu-
tion 22-37 ms. When the study protocol had been completed at rest, dobutamine-hydrochloride 
(Centrafarm Services, Etten-Leur, the Netherlands) was administered by continuous infusion into 
a large antecubital vein at 7.5 μg/kg/min. In healthy children important changes in systolic func-
tion, diastolic function, and afterload occur from 5 μg/kg/min, and the incidence rate of adverse 
symptoms increases significantly from 10 μg/kg/min [21,22]. Therefore, a dobutamine dosage of 
7.5 μg/kg/min was considered safe and effective. When heart rate and blood pressure were at 
steady state, a second short-axis stack was acquired. Dobutamine infusion was lowered to 5 μg/
kg/min whenever heart rate, systolic blood pressure, or diastolic blood pressure increased to more 
than 150% from baseline or decreased to less than 80% from baseline. The test was discontinued 
in the event of arrhythmias or significant patient discomfort. Dobutamine was administered for 
ten minutes to reach a new steady state and another ten minutes for image acquisition.
Image analysis
From the short-axis set biventricular end-diastolic volume (EDV), end-systolic volume (ESV), 
stroke volume (SV), ejection fraction (EF), and mass were assessed with manual contour detection. 
Criteria for border detection have been previously described [23]. For intra-observer variability, 
25 randomly selected studies (15 tetralogy of Fallot, 10 Fontan studies) were reanalyzed after a 
mean period of eleven months (SD 11, range 1-38 months). For interobserver variability, a second 
experienced observer analyzed these 25 studies and measured the aforementioned parameters 
independently and blinded to previous results. The two observers who were involved in these 
analyses (DR-V and SEL) have 3.5 years and 1.5 years CMR experience in patients with complex 
CHD respectively.
Statistical analysis
Data with a normal distribution are expressed as mean value ± one standard deviation, whereas 
the median (range) is shown for data with a non-normal distribution. Dichotomous data are pre-
sented as counts and percentages. Intra- and interobserver variability were assessed using the 
method of Bland-Altman [24]. The coefficient of variation, i.e. the standard deviation of the dif-
ference of the two measurements divided by the mean of the two measurements, and multiplied 
by 100%, was calculated to study the percentage of variability of the measurements. A p-value 
< 0.05 was considered to indicate statistical significance.
Results
Minor side effects occurred in three patients. In one patient with vertigo, the CMR study was 
discontinued subsequently. Another patient with bigeminy completed the first study. Due to inad-
equate triggering during the bigeminy, images were of insufficient quality for analysis. She expe-
rienced the same side effect during a repeat study five years later and the study was discontinued 
for this reason. One patient with minor headache completed the whole study. All side effects 
disappeared shortly after discontinuation of dobutamine administration. In ten Fontan patients, 
dobutamine was lowered to 5 μg/kg/min because of an increase in heart rate of more than 150% 
from baseline, although this was well tolerated. In conclusion, of 110 studies two studies were 
discontinued because of minor side effects, only one study was of insufficient image quality.
Table 3 and 4 show the intra-observer and interobserver variability for the rest and stress 
measurements. At rest intra-observer variability was good with the coefficient of variation be-
tween 2.3 and 8.7 %. During stress-testing, intra-observer variability was between 3.0 and 7.0%. 
The highest variation was found in biventricular ESV and mass. At rest, interobserver variability 
was between 3.6 and 10.5% and again, the highest variation in biventricular ESV and mass. With 
stress-testing, the coefficient of variation of all variables stayed < 10%, except for biventricular 
ESV. The latter increased to ≥ 14.9%, which was significantly higher compared to the rest mea-
surements (p = 0.04 for intra-observer variability, p = 0.004 for interobserver variability).
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Discussion
Although the first report on stress imaging in patients with CHD involved echocardiography [25], 
its implementation has been largely hampered by the limitations of the acoustic window that 
occur in this patient group. Suboptimal image acquisition and suboptimal image quality are com-
mon in patients with complex cardiac anatomy. Combined with an abnormal orientation of the 
heart and great vessels in the chest, and the problems encountered in imaging the single and 
right ventricle [26,27], this has led to limited use of stress echocardiography in CHD. CMR imaging 
overcomes these limitations in this patient gro up. In this report, we demonstrated the feasibility 
of low-dose DCMR imaging in selected pediatric and adult patients with complex CHD. Intra-
observer and interobserver variability for biventricular function, volumes, and mass were good. In 
addition, low-dose DCMR imaging was safe, with a low incidence of minor adverse effects. 
In this study, the incidence of adverse effects was 4%. The reported effects (bigeminy, 
headache, vertigo) were not severe, and all disappeared shortly after discontinuation of dobuta-
mine administration. Major side effects, such as ventricular arrhythmias or even death, have been 
described in adult patients with coronary artery disease, receiving high doses of dobutamine of up 
to 40 μg/kg/min [1,2]. High-dose dobutamine stress imaging is rarely used in children and patients 
with CHD [13,28-30]. It is usually performed to induce wall motion abnormalities in patients with 
coronary artery abnormalities [4,13]. In both echocardiographic and CMR studies, no major side 
effects have been reported in pediatric patients using high-dose dobutamine. However, minor side 
effects, such as headache, nausea, has been reported in up to 20% [4]. DCMR imaging has been 
combined with low-dose dobutamine stress-testing in patients with complex CHD in most studies 
[8-12,14-18].
In other studies performing low-dose dobutamine stress imaging in patients with CHD, 
the reported incidence of arrhythmias is low. Of these, all occurred with a dobutamine dosage of 
≥ 10 μg/kg/min, as has been demonstrated in healthy children [12,16,21,22,28]. In the study by 
Fratz et al. three of 23 patients experienced arrhythmias at 10 μg/kg/min that disappeared at 5 
μg/kg/min [12]. In another study, the reported arrhythmia occurred at a dobutamine dosage 15 
μg/kg/min necessitating termination of that particular DCMR study [16]. At a dobutamine dosage 
of 20 μg/kg/min, one of 21 patients with tetralogy of Fallot had a monomorphic non-sustained 
ventricular tachycardia of fifteen beats [28]. 
Different dobutamine dosages are used in other studies performing low-dose DCMR im-
aging in patients with CHD, ranging from 5 to 15 μg/kg/min[12,14-18]. In our experience, a dobu-
tamine dosage of 7.5 μg/kg/min is safe, with a low incidence of only minor adverse effects. It is 
high enough to elicit a significant cardiovascular response and to demonstrate abnormal stress re-
sponses in patients with CHD [8-11]. Although in 27% of Fontan patients dobutamine was lowered 
to 5 μg/kg/min because of an increase in heart rate of > 150% from baseline, we do not think this 
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is a contra-indication for this dosage in these patients since it was well tolerated without patient 
discomfort. Standardization of low-dose dobutamine stress protocols will facilitate comparison of 
different stress responses in different types of CHD.
Intra-observer and interobserver variability of biventricular function, volumes and mass 
with CMR imaging at rest have been reported in healthy subjects and in patients with tetralogy 
of Fallot [19,20,23]. The results of these studies are comparable to our results in table 3. When 
comparing intra-observer variability of rest and stress measurements, in general, the variability 
of LV measurements was lower during stress-testing, and the variability of RV measurements was 
somewhat higher during stress-testing, but still <10%. Interobserver variability of biventricular SV 
and EF improved with stress-testing or was comparable to the rest measurements. Interobserver 
variability of biventricular EDV and ESV was higher with stress-testing, with the highest increase in 
the variability for biventricular ESV (table 3 and 4). This was an unexpected finding as we observed 
a better blood-myocardial contrast in end-systole during stress-testing when compared to rest. 
This could be explained by the fact that with increased heart rates during stress-testing, there is 
a faster inflow of unsaturated blood into the region of interest which will yield more signal during 
acquisition. However, during stress-testing, biventricular ESV decreased significantly, so that small 
differences in consecutive measurements (with a comparable standard deviation of the difference 
for LV ESV at rest and during stress), result in an increase in the coefficient of variation. For clini-
cal evaluation, EDV and EF are important parameters to study cardiac functional status with MRI 
in patients with CHD [31,32]. Therefore, with the current experiences, we do not think the higher 
variability of biventricular ESV during stress-testing limits the potential clinical usefulness of low-
dose DCMR imaging. However, as stated before, the clinical usefulness of the abnormal stress 
responses in patients with complex CHD with DCMR imaging still has to be assessed and it might 
be possible that the stress response of RV ESV or LV ESV turns out to be an interesting parameter. 
The use of reliable automatic contour detection, that is not available for complex CHD up until 
now, will be an important improvement in diminishing observer variability.
Conclusions
In patients with complex CHD CMR imaging combined with low-dose dobutamine stress-testing 
is feasible, safe, and can be performed in selected pediatric and adult patients. Intra-observer vari-
ability is low for both rest and stress measurements. With stress-testing, interobserver variability 
of biventricular ESV increases significantly. Whether this limits the potential usefulness of DCMR 
imaging for risk assessment during follow-up has to be assessed. 
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Abstract 
In patients with coronary artery disease, stress imaging is able to demonstrate wall motion ab-
normalities and coronary perfusion abnormalities not apparent at rest, and it can provide infor-
mation on prognostic factors. In patients with congenital heart disease, stress imaging is used to 
determine contractile reserve, wall motion abnormalities, and global systolic function, but also to 
assess diastolic function, and vascular function. In these patients the majority of studies induced 
stress using pharmacological agents, mainly low-dose to high-dose dobutamine. The clinical use-
fulness of abnormal stress responses found in patients with congenital heart disease has to be 
addressed in follow-up studies. The abnormal stress responses might serve as surrogate endpoints, 
predicting primary endpoints at an early stage, that are useful for risk stratification in this growing 
patient population. This review describes the stress imaging studies performed in patients with 
congenital heart disease so far, with a special emphasis on echocardiography and cardiac magnetic 
resonance imaging.
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Introduction
In 1979, Wann et al. identified exercise-induced wall motion abnormalities with 2-dimensional 
echocardiography in patients with ischemic heart disease [1]. From then on assessment of ventric-
ular function with stress imaging has been widely applied in patients with coronary artery disease 
[2]. In these patients, stress imaging is able to demonstrate wall motion and coronary perfusion 
abnormalities not apparent at rest, and can provide information on risk factors and prognostic 
factors [2-4]. The use of stress imaging has been extended to patients with dilated or hypertrophic 
cardiomyopathy, valvular heart disease and congenital heart disease. In patients with dilated or 
hypertrophic cardiomyopathy, stress imaging is used to assess wall motion abnormalities, outflow 
tract pressure gradients, and contractile reserve, i.e. the change in ventricular ejection fraction 
with stress-testing [5]. In patients with congenital heart disease, stress imaging is used to de-
termine contractile reserve, wall motion abnormalities, and global systolic function, but also to 
assess diastolic function, and vascular function. In this review, we will discuss the use, limitations, 
and future applications of stress imaging in patients with congenital heart disease with an empha-
sis on echocardiography and cardiovascular magnetic resonance imaging.
Stressors 
Physical exercise
Physical exercise is the ‘ideal’ stressor. It results in the combined activation of cardiac, 
pulmonary, vascular, neurohormonal, muscular, and metabolic systems involved in the adaptations 
to stress. Common tools to perform physical exercise during imaging procedures are the treadmill, 
bicycle ergometer, or handgrip. Specific magnetic resonance-compatible supine or upright bicycle 
ergometers have been used for exercise testing in combination with magnetic resonance imaging. 
It is of importance to consider the posture of the patient during stress-testing, since this has a 
significant effect on central hemodynamics, with lower cardiac output, higher stroke volumes, and 
lower heart rates in supine compared to upright position [6]. 
Different stress protocols have been described during stress imaging in patients with 
congenital heart disease. Examples are: 1) exercise to a certain percentage of their maximal ex-
ercise capacity or oxygen consumption [7-9]; 2) symptom-limited exercise [10-12]; 3) exercise 
at 0.5 and 2.5 W/kg [13-16]. Physical exercise has several limitations. Maximal physical stress is 
dependent on the patient’s motivation and cooperation, and cannot be attained in patients with 
certain neurologic or orthopedic co-existing diseases. Hyperventilation during physical exercise 
hinders breath-hold during image acquisition. In combination with echocardiography, image ac-
quisition during physical exercise is difficult and therefore acquisition usually takes place directly 
after exercise. This is applicable to magnetic resonance imaging specifically [8, 9, 16-18], although 
with real-time imaging this limitation has been overcome and scanning during rapid breathing is 
feasible, even in patients with complex congenital heart disease [14, 15]. 
Pharmacological stress
During the 1980’s pharmacological agents were introduced to overcome the limitations 
of physical exercise [19, 20]. Pharmacological stressors have extended the use of stress imaging 
to patients with constraints that preclude adequate exercise. The most commonly used drugs are 
adenosine, dipyridamole, and dobutamine. 
Adenosine and dipyridamole are coronary vasodilators that generate a reduced oxygen 
supply in myocardial areas supplied by stenotic coronary arteries, and are used for coronary per-
fusion imaging. Adenosine is a naturally occurring substance in the body that causes coronary 
vasodilatation through activation of A2-receptors. This results in increased blood flow in normal 
coronary arteries compared to stenotic coronary arteries (“steal phenomenon”), resulting in a 
perfusion mismatch. It does not necessarily cause ischemia. Adenosine has a very short half-life 
of only two seconds and therefore needs to be administered through continuous intravenous infu-
sion. The adenosine dose rate used for stress-testing is 0.14 mg/kg/min over six minutes or until 
significant patient discomfort, whichever comes first. Common side effects are flushing, dyspnea, 
chest pain, gastro-intestinal discomfort, headache, and light-headedness. Most side effects disap-
pear shortly after discontinuation of adenosine administration and do not require medical treat-
ment. Adenosine is contra-indicated in patients with active restrictive airway disease, second or 
third degree atrioventricular block, and in patients taking dipyridamole. Since theophylline and 
caffeine are adenosine receptor antagonists, abstention of these substances is required 24-48 
hours before stress testing with adenosine or dipyridamole. In patients with congenital heart dis-
ease, adenosine has been rarely used for stress imaging, since coronary artery abnormalities are 
not common.
Dipyridamole inhibits reuptake of adenosine by vascular endothelial cells and indirectly 
causes coronary vasodilatation. Dipyridamole has a considerably longer half-life than adenosine 
and hemodynamic effects can persist up to 30 minutes. Dipyridamole is administered in a dose 
rate of 0.56 mg/kg over four minutes. Side effects and contraindications for the use of dipyridam-
ole are similar to those of adenosine. 
Dobutamine increases myocardial oxygen demand similar to physical exercise, and is 
used to study contractile reserve and wall motion abnormalities. Dobutamine is a synthetic cate-
cholamine with positive inotropic and, to a lesser extent, chronotropic effects. In healthy children, 
positive inotropic effects occur from 1 to 2 μg/kg/min with dose-dependent increases in measures 
of systolic ventricular function [21], while chronotropic effects are seen from 5 to10 μg/kg/min 
[22]. Dobutamine is also known to enhance diastolic function and to decrease preload and after-
load [23]. In normal subjects, during dobutamine infusion, stroke volume increases, end-diastolic 
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volume does not change, end-systolic volume decreases, and ejection fraction increases [24]. The 
half-life of dobutamine is only two minutes and therefore it should be given through continu-
ous intravenous infusion. In patients with congenital heart disease, different dosages are used to 
answer different research questions. Low-dose or moderate-dose dobutamine is used to assess 
cardiac contractile reserve. Dobutamine infusion is started at 2.5 or 5 μg/kg/min, and increased 
every three to five minutes with 2.5 or 5 μg/kg/min to 5 to 20 μg/kg/min. High-dose dobutamine 
is used to detect wall motion abnormalities in patients with coronary artery abnormalities, as in 
patients after Kawasaki disease or after arterial switch operation for transposition of the great 
arteries. Infusion rates usually start at 10 μg/kg/min, and are increased every three to five minutes 
with 10 μg/kg/min until the heart rate is 85% of the maximal predicted heart rate for age or to 40 
μg/kg/min maximum. If 85% of the maximal predicted heart rate for age is not reached at 40 μg/
kg/min, atropine can be administered in conjunction with dobutamine to reach the target heart 
rate. Heart rate, blood pressure, and (if possible) heart rhythm are continuously monitored during 
dobutamine stress-testing. Common minor side effects, such as headache, nausea, hypertension, 
hypotension, and hemodynamically insignificant arrhythmias, can occur in up to 20% of children 
[25]. Major side effects have not been reported in patients with congenital heart disease. Side 
effects of atropine are dry mouth, tachycardia, and hallucinations. Side effects of both dobuta-
mine and atropine can be treated with β-blockers or calcium antagonists that should be readily 
available during stress-testing. Dobutamine administration is contra-indicated in patients with a 
mechanical obstruction of systemic ventricular filling or ejection, in patients with second or third 
degree atrioventricular block, and in patients with a history of sustained ventricular tachycardia.
The majority of studies with stress imaging in patients with congenital heart disease 
has been performed with pharmacological stress, almost exclusively using dobutamine. Only one 
study reported on the safety and feasibility of adenosine-stress cardiovascular magnetic reso-
nance imaging in pediatric patients with congenital aortic stenosis or after arterial switch opera-
tion for transposition of the great arteries [26]. High-dose dobutamine stress imaging has only 
been performed in a limited number of studies with congenital heart disease patients [27-30]. In 
studies performing low-dose dobutamine stress imaging, different dobutamine dosages are used, 
ranging from 5.0 to 20 μg/kg/min. In our experience, a dobutamine dosage of 7.5 μg/kg/min is 
safe, with a low incidence of only minor adverse effects. Furthermore, it is sufficiently high to 
elicit a significant cardiovascular stress response in patients [31-34]. Arrhythmias are side effects 
of special concern in this group of patients with congenital heart disease. Although the incidence 
of arrhythmias is low in the studies performed so far, most occurred with a dobutamine dosage of 
at least 10 μg/kg/min [35-38]. In patients after Fontan operation for a functionally univentricular 
heart, dobutamine administration at 7.5 μg/kg/min provoked an increase in heart rate of more 
than 150% from baseline in 10 of 37 patients [34]. This was well tolerated and lowering the dobu-
tamine dosage to 5 μg/kg/min was sufficient to decrease the heart rate and successfully complete 
the study protocol, i.e. with images adequate for analysis.
Imaging modalities
Radionuclide myocardial perfusion imaging
Positron emission tomography and single-photon emission computed tomography allow 
evaluation of myocardial perfusion and the effects of myocardial hypoperfusion on metabolic 
activity and myocardial contractility [39]. Positron emission tomography and single-photon emis-
sion computed tomography cameras capture the photons emitted by radiopharmaceuticals (e.g. 
nitrogen-13 labeled ammonia, and technetium-99m tetrophosmin or sestamibi) and translate the 
information into digital data representing the magnitude and location of the emission in the heart. 
Positron emission tomography has a better performance on spatial and temporal resolution, with 
less attenuation of the emitted signal than single-photon emission computed tomography. In chil-
dren and patients with congenital heart disease, positron emission tomography and single-photon 
emission computed tomography are rarely used and predominantly in patients with coronary 
artery disease [40-45]. These studies assessed myocardial perfusion and coronary flow reserve at 
rest and during adenosine or dipyridamole infusion. Although these studies have shown signs of 
coronary damage or decreased coronary vasoreactivity, use of these imaging modalities is limited 
because of concerns on radiation exposure in young children. Furthermore, coronary artery ab-
normalities can also be assessed with radiation-free imaging modalities, such as echocardiography 
and cardiovascular magnetic resonance imaging.
Echocardiography
Conventional echocardiography, M-mode, Doppler and tissue Doppler imaging have all 
been performed in combination with stress in patients with various forms of congenital heart 
disease [7, 10-13, 27-29, 35, 36]. Although the first report on stress imaging in patients with con-
genital heart disease involved echocardiography, its implementation has been largely hampered 
by the limitations of the acoustic window that occur in this patient group. Suboptimal image 
acquisition and suboptimal image quality are common in patients with complex cardiac anatomy. 
Combined with an abnormal orientation of the heart and great vessels in the chest, and the prob-
lems encountered in imaging the single and right ventricle [46, 47], this has led to limited use of 
stress echocardiography in congenital heart disease. 
Magnetic resonance imaging
In patients with coronary artery disease, echocardiography was the imaging modality of 
choice for stress imaging up until the early 1990’s. In 1992 the use of dobutamine stress cardio-
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vascular magnetic resonance imaging was introduced [48], and has proven to be a valuable tool to 
detect ischemia in patients with known or suspected coronary artery disease [3, 49]. Dobutamine 
stress cardiovascular magnetic resonance imaging can assess wall motion abnormalities, contractile 
reserve, abnormalities of diastolic function, and vascular function. It has a sensitivity and speci-
ficity comparable to dobutamine stress echocardiography for identifying coronary artery disease 
[49]. Cardiovascular magnetic resonance imaging overcomes the limitations of echocardiography in 
selected patients with congenital heart disease [50]. A few groups have reported on the use of this 
modality to evaluate the reaction of the cardiovascular system in congenital heart disease patients 
under stress conditions [8, 9, 14-16, 18, 26, 30-34, 37, 38, 50-54]. These studies have shown abnor-
mal systolic, and diastolic function, and abnormal vascular responses to stress in these patients that 
help understand the pathophysiological processes. An important advantage of dobutamine stress 
cardiovascular magnetic resonance imaging is that all these parameters can be obtained in one single 
study. Disadvantages of cardiovascular magnetic resonance imaging are the exclusion of patients 
with claustrophobia, severe obesity, and magnetic resonance-incompatible devices, and the need for 
sedation or general anaesthesia in young children (usually under five to six years of age). 
Stress imaging in children and patients with congenital heart disease
Stress echocardiography
The first report of stress-testing (supine exercise) combined with echocardiography in 
children with left-sided cardiac disease was published in 1980 [7]. Thereafter stress echocardiog-
raphy combined with dobutamine was used to assess contractile reserve in children with thalas-
semia major, children after Kawasaki disease, after chemotherapy for childhood cancer, or heart 
transplantation [24, 25, 55-58]. These studies showed that dobutamine stress echocardiography 
might reveal important information on subclinical global ventricular dysfunction or coronary ar-
tery disease in these patients. 
Only a few studies have reported on stress echocardiography in patients with congenital 
heart disease. More recently, this technique has also been applied to patients with complex con-
genital heart disease, e.g. patients after atrial correction or arterial switch operation for transposi-
tion of the great arteries, or after Fontan operation, and patients with tetralogy of Fallot [10-13, 
27-29, 35, 36]. The results of these studies are summarized in table 1. Half of these studies have 
been performed in combination with physical exercise. The other 50% has been performed using 
dobutamine stress-testing, with dosages ranging from 20 to 40 μg/kg/min. With dobutamine infu-
sions of at least 20 μg/kg/min no major side effects have been reported. Hui et al. reported a high 
incidence of hypertension (in 23 of 31 patients) [35]. However, their definition of hypertension was 
an increase in systolic blood pressure of > 30% from baseline, while others defined hypertension 
as an increase in systolic blood pressure of > 50% from baseline [24]. 
Outcomes of these studies cannot be easily compared. There is a wide variety in patient 
age, diagnoses, type of measurements with echocardiography, and type of stressor. All studies 
demonstrated abnormal ventricular and/or vascular responses with stress-testing. Some studies 
identified these abnormal responses as predictors of exercise capacity [11, 27]. In general, the 
clinical relevance of these abnormal findings with stress-testing is unknown. Standardized stud-
ies using identical stressors and identical methods of measurement are needed to determine the 
clinical relevance in patients with congenital heart disease. Furthermore, the combination of new 
techniques, such as 3-dimensional echocardiography, with its capability for assessment of ven-
tricular volumes and dyssynchronicity, and of tissue Doppler and speckle tracking techniques with 
stress imaging need further exploration.
Stress cardiovascular magnetic resonance imaging 
A few groups have performed stress cardiovascular magnetic resonance imaging in pa-
tients with congenital heart disease. Table 2 is an overview of the stress cardiovascular magnetic 
resonance studies that have been performed in patients with different types of congenital heart 
disease. In more than 200 patients, these studies showed the feasibility and safety of stress car-
diovascular magnetic resonance imaging. Unfortunately, as in stress echocardiography studies, 
differences in patient groups, age ranges, measurement types, and stress protocols preclude direct 
comparison of outcomes of these studies.
Stress cardiovascular magnetic resonance studies in congenital heart disease have been 
performed predominantly in three patient groups: 1) patients with a pressure overloaded right 
ventricle (congenitally corrected transposition of the great arteries , pulmonary artery stenosis, 
Eisenmenger syndrome) [8, 37, 38, 50-54]; 2) patients with a volume overloaded right ventricle 
(after correction for tetralogy of Fallot) [9, 31, 32, 54]; and 3) patients with a potentially impaired 
ventricular preload as a result of atrial baffle reconstruction (after Fontan operation or atrial cor-
rection for transposition of the great arteries) [14-16, 33, 34, 38, 50, 51, 53]. 
In patients with a pressure overloaded right ventricle, dobutamine stress cardiovascular 
magnetic resonance imaging demonstrated abnormal responses of the systemic right ventricle. In 
patients with congenitally corrected transposition of the great arteries, different stress responses of 
the systemic right ventricle have been reported, according to the type of repair. In studies by Tulevski 
et al. and Dodge-Khatami et al. stroke volume did not increase with dobutamine stress cardiovascu-
lar magnetic resonance imaging [38, 52]. The latter study did report a normal stress response (with 
an increase in stroke volume) in unoperated patients with congenitally corrected transposition of 
the great arteries compared to patients after physiologic repair. Fratz et al. also demonstrated an in-
crease in stroke volume with dobutamine stress cardiovascular magnetic resonance imaging in unop-
erated patients with congenitally corrected transposition of the great arteries [37]. Dodge-Khatami 
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suggested that unoperated patients, with a favorable anatomy, may never require an operation 
and that dobutamine stress cardiovascular magnetic resonance imaging might be helpful in identi-
fying patients who will need anatomic correction [52]. In patients with pulmonary artery stenosis 
and in those with Eisenmenger syndrome, end-diastolic volume was significantly larger compared 
to controls, but ejection fraction was normal at rest. With stress-testing, end-diastolic volume, 
end-systolic volume, and stroke volume all decreased, and ejection fraction did not change, clearly 
demonstrating the highly abnormal response of these right ventricles to stress [38]. 
Several studies have reported on the biventricular stress response in patients with a vol-
ume overloaded right ventricle. In a study by Roest et al. supine bicycle exercise demonstrated 
a decrease in pulmonary regurgitation with stress-testing, and a normal left ventricular stress 
response in patients with tetralogy of Fallot [9]. Van den Berg and coworkers reported on the re-
sults of low-dose dobutamine stress cardiovascular magnetic resonance imaging in patients after 
contemporary repair of tetralogy of Fallot [31, 32]. They showed well-preserved functional reserve 
in all patients despite important pulmonary regurgitation and right ventricular dilatation as well 
as an abnormal relaxation with stress-testing in patients with end-diastolic forward flow, that was 
not appreciated at rest. Many of these patients with normal contractile reserve had right ventricu-
lar volumes that would have made them candidates for pulmonary valve replacement according 
to right ventricular volume criteria [31, 59]. This demonstrates the potential added value of stress 
imaging in clinical decision-making.
In patients with an impaired ventricular preload as a result of atrial baffle reconstruction, 
several study groups have performed various stress cardiovascular magnetic resonance studies. 
Pedersen, Hjortdal, and Robbers-Visser and coworkers studied the systemic venous return, pulmo-
nary arterial circulation, and systemic ventricular function [14-16, 33, 34]. Pedersen and Hjortdal 
performed branch pulmonary artery and caval vein flow measurements immediately after exer-
cise or during exercise using real-time cardiovascular magnetic resonance imaging [14-16]. In these 
studies, the technique was feasible and all children (mean age between nine and twelve years old) 
were able to perform and complete the protocol. They demonstrated that an increase in cardiac 
output with exercise is predominantly caused by an increase in heart rate and that the influence 
of inspiration on systemic venous return is less pronounced during exercise. 
Using pharmacological stress with dobutamine at 7.5 μg/kg/min, Robbers-Visser et al. 
demonstrated an abnormal decrease in end-diastolic volumes and no increase in stroke volumes 
with stress-testing in patients after Fontan operation at young age [34]. Secondly, they showed 
abnormal reactions of flow variables, distensibility, and wall shear stress with stress-testing in 
the branch pulmonary arteries in Fontan patients [33]. These results demonstrate that low-dose 
dobutamine stress cardiovascular magnetic resonance imaging revealed abnormal findings that 
were not apparent at rest and that could help in understanding the pathophysiology of this group 
of congenital heart disease and the progression of dysfunction during follow-up in these patients.
In patients after atrial switch operation for transposition of the great arteries stroke 
volume did not increase with pharmacological stress-testing [37, 38, 50, 51]. Roest and coworkers 
demonstrated a smaller increase in stroke volume in patients after atrial switch when compared to 
healthy subjects, and a prolonged stroke volume recovery using supine bicycle exercise testing [8]. 
In patients after intra-atrial correction for transposition of the great arteries, heart rate increase 
is significantly higher when compared to patients with congenitally corrected transposition of the 
great arteries or healthy subjects, probably as a compensatory mechanism for the lack of increase 
in stroke volume with stress-testing [37, 38]. 
Recently, Strigl et al. were the first to publish their data on the feasibility of high-dose do-
butamine stress cardiovascular magnetic resonance imaging in pediatric patients and young adults 
with (suspected) coronary artery abnormalities, looking at wall motion abnormalities [30]. In 28 
patients, they reported no major adverse effects and high-quality imaging of all ventricular wall 
segments in patients from less than one year of age. However, only one patient had an inducible 
wall motion abnormality, and they recommended further exploration of high-dose dobutamine 
stress cardiovascular magnetic resonance in pediatric patients.  
The type of stressor should be taken into account when comparing the results of stress 
studies. Coma-Canella et al. showed a different response in healthy volunteers to physical ex-
ercise and to dobutamine stress [60]. Global and regional ejection fraction increased more with 
dobutamine than with physical exercise. Oosterhof et al. demonstrated a discrepancy in response 
to physical exercise and low-dose dobutamine stress in patients after intra-atrial correction for 
transposition of the great arteries, whilst in controls the response to both stressors was compara-
ble [51]. They suggested that this disagreement was the result of differences in preload and after-
load. However, both dobutamine and physical exercise increase contractility, and decrease preload 
and afterload [22, 61]. Secondly, there are some differences in acquisition parameters between 
the dobutamine and physical exercise studies that might explain discrepancies. Furthermore, the 
results are based on only 5 patients and additional studies are needed to clarify this phenomenon.
Although the aforementioned studies showed pathophysiologically relevant observa-
tions in patients with various types of congenital heart disease, the clinical significance of these 
abnormal responses still has to be assessed. In congenital cardiology, surrogate endpoints for 
clinical trials are necessary. Primary endpoints (such as death and major complications) are rare, 
requiring large study populations or prolonged study length to acquire adequate statistical power, 
while the patient population is relatively small [62]. Surrogate endpoints are expected to predict a 
primary endpoint, and have a higher incidence in the patient population under investigation. Thus, 
surrogate endpoints facilitate clinical trials in congenital cardiology by reducing the numbers of 
subjects needed and by reducing the length of the study. The abnormal stress responses found in 
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patients with congenital heart disease are potential surrogate endpoints for this purpose and their 
clinical usefulness has to be addressed in follow-up studies.
Future applications
As for echocardiography, standardized dobutamine stress cardiovascular magnetic resonance 
studies using identical stressors and identical methods of measurement are needed to determine 
the clinical relevance of the abnormal stress responses in patients with congenital heart disease. 
Future applications of dobutamine stress cardiovascular magnetic resonance imaging in patients 
with congenital heart disease might involve the assessment of pressure-volume loops. Pressure-
volume loops give information on myocardial contractility, ventricular pump function, and ventri-
culo-arterial coupling, that might help explain the pathophysiological processes in cardiac func-
tion in patients with congenital heart disease [63]. Kuehne and co-workers demonstrated the 
feasibility of magnetic resonance-derived pressure volume loops in the right ventricle of patients 
with chronic pressure overload [64]. 
Magnetic resonance tissue-tagging with radiofrequency signals destroys the spins in a 
selected plane, resulting in a line or grid of signal void on the image [65]. These lines or grids de-
form with ventricular contraction and relaxation and this allows quantification of strain, i.e. the 
deformation of an object normalized to its original shape, as a measure of regional myocardial 
function. In combination with stress-testing, this technique could reveal important regional func-
tional information in patients with complex congenital heart disease. In patients with coronary 
artery disease the response of systolic strain to low-dose dobutamine has a significant promise in 
discriminating between viable and non-viable myocardium [66]. 
Lastly, in pathways with complex flow patterns, e.g. in the Fontan circulation, or intra-atrial 
baffles, three-directional flow measurements can give important additional information on shear 
stress and energy dissipation and the influence of increased flow during stress on these variables.
Conclusions
Stress imaging is a tool that has been used in patients with congenital heart disease in a limited 
way, compared to its implementation in patients with coronary artery disease. Several studies 
have shown its feasibility and safety. Stress imaging is able to assess systolic, diastolic, and vas-
cular responses in patients with various types of complex congenital heart disease. At present, 
magnetic resonance imaging has been used more often for this purpose than echocardiography. 
The clinical relevance of these findings needs to be investigated in standardized study protocols. 
The abnormal stress responses can potentially be used for risk assessment in the follow-up of 
patients with congenital heart disease.
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Abstract
Objective: to assess the incidence of mutations in NKX2-5 and GATA4 in patients with function-
ally univentricular hearts.
Methods: we included 38 non-related patients with non-syndromic functionally univentricular 
hearts, irrespective of their cardiac anatomy. Direct sequence analysis of all coding regions and 
intron-exon boundaries of the GATA4 and NKX2-5 genes was performed in each patient.
Results: no sequence variants in NKX2-5 were observed. In two patients mutations in GATA4 
were found. Both patients had right ventricular hypoplasia. In the first patient GATA4 analysis 
revealed two missense variants: 1) p.Val380Met (c.1138G>A, GATA4 exon 5); and 2) p.Pro407Gln 
(c.1220C>A, GATA4 exon 6). In the second patient GATA4 analysis resulted in the identification 
of the synonymous c.822C>T nucleotide change (p.=) in exon 3. In both cases, the mutations/
sequence variants were also identified in the mothers, who had a normal cardiac phenotype. One 
of these mutations, p.Pro407Gln, was predicted to alter protein function. 
Conclusions: P.Pro407Gln is probably a pathogenic mutation with intermediate penetrance. Fur-
ther investigation of GATA4 and NKX2-5 mutations in larger cohorts of patients with ventricular 
hypoplasia will contribute to elucidate the role of these genes in ventricular cardiogenesis.
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Introduction
Congenital heart disease (CHD) is the most common type of birth defect, and is the leading non-
infectious cause of death during the first year of life. The incidence of CHD is 0.8% and about 10% 
of these patients have functionally univentricular hearts [1]. Patients with functionally univen-
tricular hearts comprise a heterogeneous patient population who all have in common that their 
type of CHD precludes biventricular repair. Hypoplasia of the right or left ventricle is accompanied 
by anomalies of the atrioventricular valve apparatus and/or ventricular outflow tract. 
Although the etiology of cardiac malformations is still largely unknown, great progress in 
the identification of genetic factors has been made during the last decade as more than 40 differ-
ent genes have already been identified in human non-syndromic CHD. Several of these genes en-
code transcription factors involved in cardiac development. NKX2-5, a homeodomain containing 
transcription factor known to be involved in left ventricular development, contributes to various 
cardiac developmental pathways through interaction with a network of transcriptional regulators 
of heart morphogenesis, including GATA4, TBX5 and TBX20 [2-4]. 
In 1998 Schott et al. identified NKX2-5 as the first gene involved in human non-syndrom-
ic CHD [5]. Mutations in NKX2-5 cause a spectrum of CHD; from cardiac conduction abnormalities 
to cardiac septation defects, and ventricular outflow tract anomalies [6-9]. Although most NKX2-5 
mutations are found in familial atrioventricular block with atrial septal defect [5, 9, 10] and tetral-
ogy of Fallot [5, 6], association with hypoplasia of the left ventricle has also been described [6, 8]. 
GATA4 is a zinc finger transcription factor that interacts with multiple nuclear proteins, 
including NKX2-5, and regulates expression of other regulatory proteins, as well as downstream 
targets such as cardiac contractile protein genes [2]. GATA4 is also known to be involved in vari-
ous types of human CHD, including septation defects, and right ventricular hypoplasia [3, 11-14].
The incidence of NKX2-5 and GATA4 mutations is low in several reports including rela-
tively large groups of patients with various types of CHD [6, 8, 14]. These studies, however, includ-
ed no or only limited numbers of patients with functionally univentricular hearts. Both NKX2-5 
and GATA4 are known to be involved in left and right ventricular morphogenesis respectively [13, 
15]. In addition, cardiac septation and outflow tract anomalies are common in this patient popu-
lation. Therefore, we hypothesized an increased incidence of mutations in NKX2-5 and GATA4 in 
patients with a functionally univentricular heart.
Materials and Methods
Patients 
We included 38 non-related patients with non-syndromic functionally univentricular hearts and 
no known CHD in the family, irrespective of their cardiac anatomy. Cardiac anatomy was con-
firmed from echocardiography reports, cardiac catheterization reports and surgical reports if 
applicable. Figure 1 shows the details of the cardiac anatomy. There were fifteen patients with 
hypoplasia of the left ventricle, and twenty patients with hypoplasia of the right ventricle. In 
three patients, ventricular dominancy could not be determined. Parental DNA was analyzed when 
mutations were identified, and parents underwent cardiac screening, including physical examina-
tion, electrocardiogram and echocardiography, for analysis of their cardiac phenotype. The study 
was approved by the Dutch Central Committee on Research involving Human Subjects and insti-
tutional review boards. All subjects and/or their parents (if required) gave informed consent.
 
Figure 1. Anatomic subgroups of the patient population
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Genetic analyses 
Direct sequence analysis of all coding regions and intron-exon boundaries of the GATA4 (genbank 
reference NM_002052.2) and NKX2.5 (genbank reference NM_004387.2) genes was performed 
in each patient. Sequence analysis of M13-tagged PCR products was carried out on an ABI3730xl 
capillary sequencer using Big-Dye Terminator v 3.1 chemistry (Applied Biosystems) (Details of 
methods and primer sequences available on request.) Analysis of sequence data was performed 
using SeqScape analysis software (v2.5, Applied Biosystems). In addition to sequence analysis, 
quantitative PCR analysis (Q-PCR) of both coding exons of the NKX2.5 gene was carried out to 
detect possible genomic rearrangements.
Mutations were considered pathogenic when they were either truncating of splice-site 
mutations or when they segregated with disease in a family, were predicted to affect protein 
function according to protein analysis software (SIFT (Sorting Intolerant From Tolerant) [16] and 
PolyPhen [17]. Mutation nomenclature according to www.HGVS.org with the translation initiation 
ATG codon in exon1.
Results
No sequence variants in NKX2-5 were observed. In two of 38 patients (5.3%) mutations in GATA4 
were found. The first patient was diagnosed with tricuspid atresia, ventricular septal defect, and 
transposition of the great arteries. GATA4 analysis revealed two missense variants: 1) p.Val380Met 
(c.1138G>A, GATA4 exon 5); and 2) p.Pro407Gln (c.1220C>A, GATA4 exon 6). GATA4 analysis of 
the mother identified the presence of the c.1138G>A and c.1220C>A mutations, indicating that 
both variants are most likely on the same GATA4 allele. Both variants were absent in DNA from 
the father. Cardiac evaluation (physical examination, electrocardiography, and echocardiography) 
revealed no signs of a congenital heart defect in the mother. 
The second patient had pulmonary atresia, intact ventricular septal defect, with coro-
nary and aorta fistulae to the right ventricle. GATA4 analysis resulted in the identification of the 
synonymous c.822C>T nucleotide change (p.=) in exon 3. DNA analysis of the parents showed that 
the c.822C>T nucleotide change was also present in the mother. Analysis of paternal DNA showed 
absence of the variant. Cardiac evaluation of both parents (physical examination, electrocardiog-
raphy, and echocardiography) showed no abnormalities. 
Discussion
The current study sought to investigate the incidence of mutations in NKX2-5 and GATA4 in pa-
tients with functionally univentricular hearts. We did not identify mutations in NKX2-5. We found 
three mutations in GATA4, in two of 38 patients, that have been previously described in heteroge-
neous cohorts of patients with CHD, [11, 14, 18] but not in patients with functionally univentricu-
lar hearts. As in other studies, we demonstrated a low incidence of non-synonymous sequence 
variants of GATA4 in patients with non-syndromic CHD.
The p.Pro407Gln mutation, found in a patient with tricuspid atresia, ventricular septal 
defect and transposition of the great arteries, has previously been described in a patient with 
tetralogy of Fallot out of 486 Chinese Han patients with various types CHD, [11] and in one pa-
tient with tetralogy of Fallot out of 62 Chinese Uygur CHD patients [19]. Our study is the first 
to describe the p.Pro407Gln mutation in a patient with tricuspid atresia and transposition of the 
great arteries. Using prediction algorithms, this mutation is expected to alter protein function [16, 
17], confirming the conclusion from other studies [11, 19]. Although the mother of the patient is 
a healthy carrier of the mutation, this does not exclude a possible pathogenic character of this 
mutation. Missense mutations in sporadic patients with CHD whose unaffected family members 
also show the DNA variation can be considered as rare variants with intermediate penetrance, 
although additional functional analyses are necessary to clarify the meaning of these mutations. 
Furthermore, in our study as well as in other studies, the p.Pro407Gln mutation has not been 
found in large control panels. Two studies [3, 14] described GATA4 missense mutations in patients 
with atrial septal defects, that were also found in unaffected parents, indicating that these muta-
tions have reduced penetrance. 
The other non-synonymous amino acid change, p.Val380Met, identified in the same pa-
tient and his unaffected mother, is found both in patients with CHD and controls [18]. We conclude 
that this variant is most likely a polymorphism, that by itself is unlikely to cause CHD, although a 
contribution to polygenic CHD cannot be excluded.
In one patient with pulmonary atresia, intact ventricular septal defect, with coronary and 
aorta fistulae to the right ventricle we identified the synonymous c.822T>C mutation. Tomita-
Mitchell et al. described this synonymous sequence variant in three patients with tetralogy of 
Fallot/pulmonary atresia, double outlet right ventricle, and ventricular septal defect respectively 
[14]. This variant was not found on control chromosomes and is thought to affect an exonic splice 
enhancer motive [14]. The c.822T>C mutation was also found in patients with hypertrophic car-
diomyopathy [20], a disease that is increasingly associated with congenital cardiovascular malfor-
mations [21]. In our study this variant was also present in the healthy mother and absent in 185 
controls. Although it is unclear whether this variant is disease-related it could be a mutation with 
intermediate or low penetrance.
In general, the studies on GATA4 and/or NKX2-5 analysis in CHD involve only a limited 
number of patients with functionally univentricular hearts [6, 8, 11, 18, 19, 22, 23]. The focus 
has been on patients with septation defects and conotruncal anomalies, especially in studies on 
NKX2-5. In a study by Schluterman et al. [18] at least 25 of 157 CHD patients had a functionally 
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univentricular heart. In this study, the p.Val380Met mutation was also identified in two patients 
with CHD and three controls. None of the mutations in the study by Schluterman occurred in pa-
tients with functionally univentricular hearts. Thus, our study describes the first GATA4 mutations 
associated with this type of cardiac malformation.
NKX2-5 mutations have been found in patients with hypoplastic left heart syndrome. 
McElhinney et al.,including 80 patients with hypoplastic left heart syndrome in their entire cohort 
of 608 CHD patients, found the p.Arg25Cys mutation in one patient with hypoplastic left heart 
syndrome [6]. Elliot et al. reported a p.Thr178Met mutation in a patient with hypoplastic left heart 
syndrome [8]. Furthermore, Hinton et al.[24] demonstrated high heritability of hypoplastic left 
heart syndrome, suggesting that it is largely determined by genetic factors. Our study included 
only five patients with hypoplastic left heart syndrome. Analysis of larger cohorts will be neces-
sary to investigate the incidence and role of NKX2-5 mutations in this patient group. 
GATA4 is known to be involved in cases with right ventricular hypoplasia (in the context 
of double inlet left ventricle) [3, 13]. In our study, the two patients in whom sequence variants 
were identified both had a hypoplastic right ventricle (tricuspid atresia and pulmonary atresia/
intact ventricular septum). In larger cohorts, one would expect to find more GATA4 mutations in 
this patient group, as was also suggested by Rajagopal et al.[3]. 
Conclusions
We found three GATA4 mutations in two patients out of 38 patients with functionally univentricu-
lar hearts. Both patients had right ventricular hypoplasia confirming the importance of GATA4 in 
right ventricular development. One of these mutations, p.Pro407Gln, was predicted to alter pro-
tein function, confirming a previous conclusion by others. P.Pro407Gln is probably a pathogenic 
mutation with intermediate penetrance. From our study we conclude that NKX2-5 mutations are 
not a frequent cause of functionally univentricular hearts. Conversely, a relatively high percentage 
(5.3%) of GATA4 mutations in this patient population warrants molecular analysis of this gene 
in patients with a univentricular heart. Further investigation of GATA4 and NKX2-5 mutations in 
larger cohorts of patients with ventricular hypoplasia will contribute to elucidate the role of both 
genes in ventricular cardiogenesis. 
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Important advances in both operation techniques and peri-operative procedures have been made 
in the past twenty years in the care for patient with complex congenital heart disease. This means 
that physicians are increasingly encountering adolescents and young adults with complex congenital 
heart disease. Physicians, patients and their parents want to be informed on the long-term sequelae 
after palliation of these serious conditions, how to recognize them at an early stage with the best 
possible modality and how to intervene. In this thesis we addressed several of these issues, focusing 
on patients with a functionally univentricular heart, who have been palliated with the Fontan opera-
tion in its current modifications. For this purpose the following studies were performed:
- Analysis of morbidity and mortality in a study population of more than 200 patients af-
ter total cavopulmonary connection in three Dutch tertiary referral centers for pediatric 
cardiology and cardiothoracic surgery 
- Subgroup analyses in approximately 40 patients on clinical and hemodynamic status 
from five years after Fontan completion at young age, with a special emphasis on the use 
of cardiovascular magnetic resonance imaging
- Feasibility and usefulness of cardiovascular magnetic resonance imaging, whether or not in 
combination with low-dose dobutamine stress for assessing global ventricular function in 
patients with complex congenital heart disease, including assessment of normal values of 
biventricular function, volumes, and mass in 60 healthy children aged 8 to 17 years
In this section we will summarize our most relevant findings and our future perspectives on re-
search and patient care after Fontan operation.
Morbidity and mortality after total cavopulmonary connection
In chapter 2 our objective was to compare the outcome of the 2 co-existing modifications of 
staged total cavopulmonary connection: the intra-atrial lateral tunnel and extracardiac conduit. 
Since the introduction of the total cavopulmonary connection in the late 1980s, there is discus-
sion on the superiority of either the intra-atrial lateral tunnel or the extracardiac conduit over 
the other in terms of long-term sequelae. Special concerns are mortality, and the incidence of 
arrhythmias, re-operations, and/or thrombo-embolic events. Although there are multiple studies 
on outcome after Fontan operation, analyses usually include patients with older and currently 
abandoned modifications of the Fontan operation, and have a limited follow-up duration for total 
cavopulmonary connection. Since the introduction of the extracardiac conduit in the mid 1990s, 
follow-up data in this group are limited to a maximum of ten to twelve years. This limits follow-up 
analysis and comparison with the intra-atrial lateral tunnel.
In our study, we included more than 200 patients with a total cavopulmonary connec-
tion, 102 having had an intra-atrial lateral tunnel and 107 with an extra-cardiac conduit. Median 
follow-up of intra-atrial correction was 7.4 years (interquartile range 4.3-10.0 years), while median 
follow-up time of the extra-cardiac conduit was 3.8 years (interquartile range 1.6-5.6 years). At 
six-year follow-up after completion, overall outcome was good and there was no difference in the in-
cidence of Fontan failure – i.e. mortality or re-operation for revision of the Fontan circulation –, late 
re-operations or thrombo-embolic events between the two groups. Arrhythmias occurred more 
frequently in the patients with an intra-atrial lateral tunnel: freedom from arrhythmias at 6-year 
follow-up was 83% in the intra-atrial lateral tunnel group and 92% in the extra-cardiac conduit 
group. Multivariable Cox regression analysis, corrected for participating center and year of opera-
tion, identified only right ventricular morphology as a risk factor for arrhythmias. Arrhythmia may 
be a potential drawback of the intra-atrial lateral tunnel technique. An important limitation of the 
extracardiac technique is the lack of growth of the communication of the inferior caval vein and 
pulmonary artery [1]. Longer follow-up is required to determine the best option in these patients.
Clinical and hemodynamic status after Fontan operation
In chapter 3 we assessed the clinical condition in a group of 34 patients (aged 6.8 to 20.7 years) 
who had undergone a total cavopulmonary connection at young age (i.e. under 5 years of age) 
and who were at least five years after Fontan completion (median follow-up time 7.8 years, range 
5.0-17.8 years). Intra-atrial tunnel was performed in 27 patients; seven patients had an extracar-
diac conduit. These patients underwent a 12-lead electrocardiogram, 24-hour ECG-monitoring, 
bicycle exercise testing, cardiac magnetic resonance imaging, and NT-pro-BNP analysis. The latter 
is known to be increased in adult patients with heart failure, and closely correlates with ventricular 
function. Almost 70% of patients had preservation of sinus rhythm and 24-hour ECG-monitoring 
did not show signs of clinically significant arrhythmias or sinus node dysfunction. Global ventricu-
lar function – assessed with cardiac magnetic resonance imaging – was preserved, expressed by 
an ejection fraction of 59% compared to 69% in age and sex-matched controls. Exercise capacity 
was considerably lower in Fontan patients, with a maximal workload of 60% compared to height 
and sex-matched controls. NT-pro-BNP levels were within the normal range. However, ventricular 
mass was elevated compared to controles, pointing towards contractility-afterload mismatch.
The usefulness of cardiac magnetic resonance imaging was further explored in chapter 4, combin-
ing it with low-dose dobutamine stress-testing. In this thesis, we demonstrated preserved ven-
tricular function and contractile reserve with low-dose dobutamine stress testing in 32 patients 
from five years after Fontan completion (mean age 13.3 (range 7.5-22.2 years), median follow-up 
time 8.1 (range 5.2-17.8 years). There was an adequate increase of ejection fraction and heart rate, 
and an adequate decrease of end-systolic volumes. However, with stress-testing, end-diastolic 
volume could not be maintained and stroke volume did not increase. As is known from earlier 
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studies by others, low-dose dobutamine stress-testing in control subjects causes an increase in 
stroke volume and maintenance of end-diastolic volume. Our results in Fontan patients indicate 
that, with stress-testing, cardiac index can only be increased by increasing heart rate as a result 
of impaired preload.
The cause for the abnormal stress response in Fontan patients is multifactorial, but the pulmonary 
circulation is thought to be an important determinant of the long-term functioning of the single 
ventricle circulation. In chapter 5, we assessed pulmonary arterial function in fourteen patients 
at rest and during low-dose dobutamine stress-testing with cardiac magnetic resonance imag-
ing. We determined pulmonary artery size, flow variables and wall shear stress. We compared 
the outcomes of the variables at rest with matched healthy controls. At rest, stroke index, total 
flow, average flow, and peak flow rate were all statistically significantly lower in patients than in 
controls. With stress-testing, all variables increased in patients (p<0.001), apart from stroke index, 
that did not change. At rest, branch pulmonary artery area did not differ between patients and 
controls. Distensibility was lower in patients than in controls (p<0.001). With stress-testing, aver-
age pulmonary artery area and distensibility did not change despite an increase in flow volume. At 
rest, wall shear stress was lower in patients than in controls (p<0.001). Although wall shear stress 
increased with stress-testing (p<0.001), it did not reach the levels of the control group at rest. 
We concluded that pulmonary artery size is normal long-term after Fontan operation at young 
age. Flow variables, distensibility, and WSS are significantly lower compared to healthy controls, 
and do not show adequate reactions with stress-testing, which is suggestive of pulmonary artery 
endothelial and/or vascular dysfunction.
Cardiac magnetic resonance imaging in congenital heart disease
Cardiac magnetic resonance imaging is considered the gold standard for assessment of ventricular 
function. In preparation of the studies on clinical and hemodynamic status in Fontan patients we 
encountered important missing data for proper use of cardiac magnetic resonance imaging in pa-
tients with congenital heart disease. First of all, we missed normal values for ventricular volumes, 
function and ventricular mass in children and adolescents, assessed according to currently used 
MRI techniques. Secondly, there were no adequate studies on the intra-observer and interobserver 
variability for CMR assessment of ventricular volumes, function, and mass in patients with con-
genital heart disease. 
In chapter 6 we describe normal values in 60 healthy children, aged 8-17 years. We assessed 
biventricular volumes, ejection fraction and biventricular mass and we studied the interrelation 
of age, gender and body surface area on these parameters. We published gender-specific norma-
tive data, adjusted for body surface area in the range of 1.0 – 2.0 m2. Furthermore, we calculated 
coefficients of variation for intra-observer and interobserver variability, with good to acceptable 
results for clinical practice. 
Chapter 7 shows our results for intra-observer variability and interobserver variability of ven-
tricular volumes, function and mass assessed in a heterogeneous population with congenital heart 
disease. Again, we calculated coefficients of variation for biventricular end-diastolic volume, end-
systolic volume, ejection fraction and biventricular mass. Intra-observer variability and interob-
server variability were good (between 2.9-6.8% and 3.9-10.2% respectively), with the smallest 
variations in end-diastolic volumes and ejection fraction. The largest variations were found for 
end-systolic volumes and mass. We do not think the magnitude of the variabilities limits detection 
of changes in ventricular volumes and global ventricular function over time.
Chapter 8 describes the safety and intra-observer variability and interobserver variability of as-
sessment of ventricular function, volumes and mass of cardiac magnetic resonance imaging com-
bined with low-dose dobutamine stress-testing in patients with congenital heart disease. In a 
series of more than 100 low-dose dobutamine stress studies in 91 patients minor side effects 
occurred in only three patients. Intra-observer and interobserver variability were good, with the 
largest variability in end-systolic volumes, as described in chapter 6 and 7. 
Chapter 9 reviews the use and results of stress imaging in patients with congenital heart disease. 
We discuss the use of different types of stressors and imaging modalities and the results of stress 
studies (in combination with echocardiography and cardiac magnetic resonance imaging) in pa-
tients with congenital heart disease.
Future perspectives
The genetic basis of congenital heart disease
The genetic basis of congenital heart disease is still merely unknown. Most likely, a complex in-
terplay of genetic predisposition, timing and location of expression of genes contributing to heart 
formation and environmental factors contributes to non-syndromic congenital heart disease [2].
Chapter 10 previews to an issue, that is only starting to become a topical subject: to identify the 
underlying genetic abnormality or abnormalities in (complex) congenital heart disease and its 
implications for the individual patient and his or her family. In the last decade great progress has 
been made in the identification of genetic factors. Up until now, more than 40 candidate genes 
have been identified in human non-syndromic congenital heart disease. NKX2-5 and GATA4 are 
two transcription factors known to be involved in right and left ventricular morphogenesis. As 
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such, they may be considered candidate genes in the origin of functionally univentricular hearts 
with left or right ventricular hypoplasia. We explored the incidence of mutations in these two 
transcription factors in 38 patients with a functionally univentricular heart. We did not find mu-
tations in NKX2-5. Three GATA4 mutations were found in two patients with right ventricular hy-
poplasia, confirming the importance of GATA4 in right ventricular development. Pathogenicity of 
these mutations requires further confirmation. However, one of the mutations is predicted to alter 
corresponding protein function and might be pathogenic. 
Optimizing the total cavopulmonary connection
Intra-atrial lateral tunnel or extracardiac conduit?
The Fontan operation is a palliative procedure that has prolonged the life-span of patients with 
a functionally univentricular heart considerably [3]. Technical surgical preference and theoretical 
considerations with regard to long-term outcome dictate institutional choice for either of the cur-
rent modifications of the Fontan technique. More follow-up time is needed to answer the question 
if one of the two current modifications is superior to the other in terms of morbidity and mortal-
ity. Special interest concerning complications are the incidence of arrhythmias [4], thrombo-em-
bolic events and need for re-operations for the intra-atrial lateral tunnel and for the extracardiac 
conduit [5]. Furthermore, assessment of hydrodynamic efficiency of the intra-atrial lateral tunnel 
and extracardiac conduit in vivo is needed to adequately compare these two techniques [6]. Lastly, 
another issue to address is the influence of either modification on the function of the pulmonary 
circulation.
Function of the pulmonary vascular system
Reduced exercise capacity in Fontan patients is primarily caused by limitations in preload reserve. 
Contractile reserve, as was shown in this thesis, is intact in the majority of patients in the paedi-
atric and young adult age range. The inability of the pulmonary vascular system to augment blood 
flow during exercise prevents the increase in stroke volume. Combined with possible diastolic dys-
function and the high incidence of chronotropic incompetence, augmentation of cardiac output 
is limited during exercise. Exploring what happens in the pulmonary circulation during exercise 
seems to be a pivotal issue in understanding the pathophysiology of the Fontan circulation [7] and 
will guide future interventions and/or medical therapy with – for example – phosphodiesterase 
inhibitors [8, 9]. Cardiac magnetic resonance imaging can play an important role in this area of 
research, and has already proven to generate information on flow dynamics in the total cavopul-
monary connection acquired non-invasively [10, 11]. However, invasive studies, preferably in a 
limited number of patients, using cardiac catheterization are probably needed to verify the data 
acquired during cardiac magnetic resonance imaging [12].
Search for early signs of the failing Fontan
Improvement of care for patients with a functionally univentricular heart includes early recogni-
tion of those patients at risk for decline of function or adverse events. Ideally, this is a marker that 
can be obtained at a pre-symptomatic stage. In this thesis, we explored the feasibility, safety and 
variability of cardiac magnetic resonance imaging (at rest and during low-dose dobutamine stress) 
in patients with various types of congenital heart disease. Abnormal stress response assessed with 
cardiac magnetic resonance imaging in serial measurements might be a marker that can be used to 
identify patients with a predisposition for Fontan failure. This includes assessment of ventricular 
size – which relates to loading conditions, contractility and afterload – , and also for assessment of 
pulmonary artery function. Future studies should also include assessment of optimal dobutamine 
dose. Although physical stress might be the preferred stressor, particularly since this may result 
in the inclusion of the effects of respiration on ventricular and (pulmonary) vascular function, 
technical limitations with regard to (magnetic resonance) imaging techniques need to be solved 
for physical stress to be a feasible option.
In various disease states, biomarkers have been suggested to contribute to early de-
tection of clinically relevant problems [13, 14]. In this study the biomarker NT-pro BNP was not 
affected in our relatively small and homogeneous study population. Larger studies and markers 
including various pathways involved in functional failure of the Fontan circulation are required to 
explore the options of the use of biomarkers in this population.
Improvement of care for Fontan patients
The long-term outcome of patients with functionally univentricular hearts should be considered 
relatively unexplored territory. Although various studies have contributed to our knowledge of 
this problem, it should be acknowledged that treatment strategies have varied widely since the 
introduction of the original Fontan technique. This includes differences in indications, staging, 
age of completion of the Fontan operation and medical strategies to optimize outcomes. Most 
of the drug regimens used in clinical practice is not based on sound evidence with regard to their 
mechanism of action in these patients, have not been well studied or have even been proven inef-
fective. An important outcome measure is quality of life. Often, this parameter is not included or 
not well defined in study designs. Numbers of patients in single institutions are often very small. 
Multicenter, detailed, standardized and well-monitored long-term follow-up is required to answer 
the important questions of patients, their parents and providers of care. 
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In de afgelopen twintig jaar zijn belangrijke vooruitgangen geboekt in zowel operatietechniek als 
in peri-operatieve zorg bij patiënten met complex aangeboren hartafwijkingen. Dit betekent dat 
artsen in toenemende mate te maken kunnen krijgen met adolescenten en jong volwassenen met 
een complex cor vitium. Zowel artsen, patiënten en hun ouders willen informatie over de lange 
termijn gevolgen na palliatie van deze ernstige aangeboren afwijkingen. Daarnaast is het belangrijk 
te weten hoe deze gevolgen zo vroeg mogelijk kunnen worden herkend met de beste onderzoeks-
modaliteit en wat vervolgens de beste interventie is. In dit proefschrift hebben we enkele van 
deze aspecten onder de loep genomen bij patiënten met een complexe aangeboren hartafwijking 
en in het bijzonder bij patiënten met een functioneel univentriculair hart die een Fontan operatie 
hebben ondergaan zoals die tegenwoordig wordt uitgevoerd. De volgende studies zijn uitgevoerd 
en beschreven:
- analyse van morbiditeit en mortaliteit in een onderzoekspopulatie van meer dan 200 
patiënten na totale cavopulmonale connectie in drie Nederlandse tertiaire centra voor 
kindercardiologie en cardiothoracale chirurgie
- subgroepanalyses in ongeveer veertig patiënten betreffende klinische en hemodynami-
sche parameters vanaf vijf jaar na completering van de Fontan operatie op jonge leeftijd, 
bij wie in het bijzonder gebruik is gemaakt van cardiovasculaire MRI.
- onderzoek naar de uitvoerbaarheid en toepasbaarheid van cardiovasculaire MRI, al dan 
niet gecombineerd met lage dosering dobutamine stress, voor het bepalen van globale 
hartkamerfunctie in patiënten met complexe aangeboren hartafwijkingen. Voor opti-
maal vergelijk werden tevens normaalwaarden voor biventriculair volume, massa en 
functie bepaald in 60 gezonde kinderen in de leeftijd van acht tot en met zeventien jaar.
In dit hoofdstuk vindt u een samenvatting van onze belangrijkste bevindingen en onze gedachten 
over toekomstige onderzoeksmogelijkheden en patiëntenzorg na de Fontan operatie.
Morbiditeit en mortaliteit na totale cavopulmonale connectie
In hoofdstuk 2 beschrijven wij ons onderzoek naar het vergelijken van de uitkomst van twee naast 
elkaar bestaande modificaties van de totale cavopulmonale connectie: de intra-atriale laterale 
tunnel en de extra-cardiale conduit. Eind jaren tachtig werd de totale cavopulmonale connectie 
voor het eerst beschreven en sindsdien is er discussie of een van beide modificaties superieur is 
wat betreft gevolgen op de lange termijn. Hierbij wordt met name gedacht aan mortaliteit, het 
vóórkomen van ritmestoornissen en trombo-embolieën en re-operaties. Er zijn weliswaar reeds 
meerdere studies gepubliceerd over de uitkomsten na Fontan operatie, maar deze studies hebben 
meestal ook patiënten geïncludeerd die volgens inmiddels verlaten technieken zijn geopereerd. 
Daarnaast is de follow-up duur van patiënten met een totale cavopulmonale connectie beperkt. 
De extra-cardiale conduit, als modificatie van de totale cavopulmonale connectie, werd in het be-
gin van de jaren negentig geïntroduceerd. De follow-up duur van patiënten met deze modificatie is 
beperkt tot tien tot twaalf jaar. Hierdoor is een goed vergelijk met de intra-atriale laterale tunnel, 
welke enkele jaren langer “in gebruik” is, beperkt.
In onze studie zijn meer dan 200 patiënten geïncludeerd die een totale cavopulmonale connectie 
hebben ondergaan: 102 na intra-atriale laterale tunnel, 107 na extra-cardiale conduit. De mediane 
follow-up duur van patiënten met een intra-atriale laterale tunnel was 7.4 jaar (interquartile range 
4.3-10.0 jaar). De mediane follow-up duur van patienten met een extra-cardiale conduit was 3.8 
jaar (interquartile range 1.6-5.6 jaar). Zes jaar na Fontan completering was de algemene uitkomst 
goed en er was geen verschil in de incidentie van Fontan falen, gedefinieerd als mortaliteit of een 
re-operatie voor revisie van de Fontan circulatie, re-operatie voor andere indicaties of het vóór-
komen van trombo-embolieen bij vergelijk van patiënten met een intra-atriale laterale tunnel 
en patienten met een extra-cardiale conduit. Ritmestoornissen kwamen vaker voor bij patienten 
met een intra-atriale laterale tunnel dan bij patienten met een extracardiale conduit: afwezigheid 
van ritmestoornissen 6 jaar na completering van de Fontan circulatie was 83 % respectievelijk 
92%. Bij multivariate Cox regressie analyse, gecorrigeerd voor de deelnemende centra en jaar van 
operatie, werd een systeemkamer van het rechter kamertype geïdentificeerd als risicofactor voor 
ritmestoornissen. Het optreden van ritmestoornissen is een belangrijke factor die in overweging 
moet worden genomen wanneer men kiest voor een intra-atriale laterale tunnel. De extra-cardiale 
conduit heeft als beperking dat er geen groeipotentiaal is van de aansluiting met de vena cava 
inferior en de longslagader [1]. Langere follow-up duur is nodig om duidelijkheid te krijgen welke 
van de twee huidige modificaties de beste keus is voor patiënten.
Klinische en hemodynamische status praesens na Fontanoperatie
In hoofdstuk 3 is de klinische conditie bekeken van 34 patiënten (in de leeftijd van 6.8 tot 20.7 
jaar) die allemaal op jonge leeftijd (maximaal vijf jaar oud) een totale cavopulmonale connectie 
hebben gekregen (mediane follow-up duur 7.8 jaar, range 5.0-17.8 jaar). Bij 27 patiënten was een 
intra-atriale laterale tunnel aangelegd, bij de overige zeven een extra-cardiale conduit. Bij deze pa-
tiënten was een 12-afleidingen ECG gemaakt en een 24-uurs ECG analyse. Verder voerden zij een 
fietstest uit, werd naar hartfunctie gekeken met cardiale MRI en werd het NT-pro-BNP bepaald. 
NT-pro-BNP is verhoogd in volwassen patiënten met hartfalen en heeft een nauwe correlatie 
met ventrikelfunctie. Bijna 70% van de patiënten had sinusritme op moment van follow-up en bij 
24-uurs ECG analyse werden geen belangrijke ritmestoornissen of sinusknoopdysfunctie gezien. 
Globale kamerfunctie – zoals bepaald met cardiale MRI – was behouden met een ejectiefractie van 
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59% bij patiënten in vergelijking met een ejectiefractie van 69% bij controles die waren gematcht 
op leeftijd en geslacht. Inspanningscapaciteit was duidelijk lager bij patiënten, de maximale be-
lasting was 60% vergeleken met een controlepopulatie die was gematcht op lengte en geslacht. 
NT-pro-BNP waarden vielen binnen de normaalwaarden. Bij cardiale MRI werd gevonden dat de 
massa van de hartkamers verhoogd was vergeleken met een controlepopulatie, duidend op een 
mismatch tussen contractiliteit en afterload.
Het nut van het gebruik van cardiale MRI bij patiënten na Fontan operatie werd verder onderzocht 
in hoofdstuk 4, waarin cardiale MRI tijdens een lage dosering dobutamine stress werd uitgevoerd. 
In dit proefschrift hebben we laten zien dat er een behouden functie van de hartkamer is en een 
behouden contractiele reserve tijdens dobutamine stress. Dit onderzoek werd uitgevoerd bij 32 
patiënten van gemiddeld 13.3 jaar oud (range 7.5-22.2 jaar) en bij een mediane follow-up duur van 
8.1 jaar (range 5.2-17.8 jaar). Tijdens lage dosering dobutamine stress trad een adequate toename 
van de hartfrequentie en ejectiefractie op, en was er een adequate afname van het eind-systolisch 
volume in vergelijking met de waarden tijdens rust. Echter, tijdens dobutamine stress trad een ab-
normale afname van het eind-diastolisch volume op en was er geen toename van het slagvolume. 
In eerdere studies is reeds aangetoond dat tijdens lage dosering dobutamine stress bij gezonde 
personen een toename van slagvolume optreedt en dat er behoud is van eind-diastolisch volume. 
Onze resultaten bij Fontan patiënten laten zien dat tijdens stress toename van het hartminuutvo-
lume alleen kan worden bewerkstelligd door een toename van de hartfrequentie bij een beperking 
van de preload.
De oorzaak voor de abnormale reactie op stress bij Fontan patiënten is multifactorieel, maar aan-
genomen wordt dat de longcirculatie een belangrijke factor is voor het functioneren van de sys-
teemkamer van een functioneel univentriculair hart op lange termijn. In hoofdstuk 5 hebben we 
gekeken naar het functioneren van de arteriële longcirculatie met cardiale MRI, opnieuw zowel in 
rust als tijdens lage dosering dobutamine stress. Bij veertien patiënten hebben we gekeken naar 
afmeting van de longslagaders, bloedstroomvariabelen en shear stress. Voor vergelijk van de waar-
den in rust werd gebruik gemaakt van een gezonde controlepopulatie. In rust waren variabelen 
van de bloedstroom (een afgeleide van het slagvolume, de totale hoeveelheid flow per minuut, de 
gemiddelde flow en de piekstroomsnelheid) allemaal significant lager bij patiënten dan bij contro-
les. Tijdens dobutamine stress namen al deze variabelen toe bij de patiënten, behalve de afgeleide 
van het slagvolume. Deze laatste bleef onveranderd. In rust was er geen verschil tussen de opper-
vlakte van een doorsnede van de longslagader van patiënten en controles. Met dobutamine stress 
veranderde de oppervlakte en distensibiliteit van de longslagader niet bij patiënten, alhoewel het 
flow volume toenam. In rust was de waarde van shear stress – de wrijving tussen het stromende 
bloed en de vaatwand – bij patiënten lager dan bij controles. Tijdens dobutamine stress nam de 
shear stress toe bij patiënten, maar kwam zelfs niet op de waarde die bij controles in rust werd 
gemeten. De conclusies waren dat de afmeting van de longslagaders normaal is na Fontan operatie 
op jonge leeftijd. Echter variabelen van de bloedstroom, distensibiliteit en van shear stress zijn 
significant lager bij Fontan patiënten dan bij controles. Tevens is de reactie tijdens dobutamine 
stress abnormaal, hetgeen suggereert dat er sprake kan zijn van ofwel endotheeldysfunctie ofwel 
vaatwanddysfunctie.
Cardiale MRI bij aangeboren hartafwijkingen
Cardiale MRI wordt beschouwd als de gouden standaard voor het bepalen van hartkamerfunctie. 
Bij de voorbereidingen van de onderzoeken bij Fontan patiënten liepen we tegen het probleem aan 
dat er tot dan toe geen goede controledata in de literatuur voorhanden waren om cardiale MRI bij 
patiënten met een aangeboren hartafwijking goed te kunnen gebruiken. Ten eerste waren er geen 
normaalwaarden voor globale hartkamerfunctie, hartkamervolumes en hartkamermassa die wa-
ren bepaald bij kinderen en jong volwassenen met de huidige MRI technieken. Ten tweede ontbra-
ken gegevens over intra-observer en interobserver variabiliteit van bepaling van eerder genoemde 
parameters met cardiale MRI bij patiënten met aangeboren hartafwijkingen.
In hoofdstuk 6 beschrijven we normaalwaarden zoals bepaald bij 60 gezonde kinderen in de leef-
tijd van 8-17 jaar. We hebben gekeken naar het volume van beide hartkamers, massa van beide 
hartkamers en ejectiefractie. Daarnaast hebben we gekeken naar de relatie tussen deze waarden 
en leeftijd, geslacht en lichaamsoppervlakte. Met deze studie hebben we normaalwaarden gepu-
bliceerd voor jongens en meisjes en aangepast aan lichaamsoppervlakte in de waarden van 1.0-2.0 
m2. Bovendien hebben we de variatiecoefficiënt berekend bij de bepaling van intra-observer en 
interobserver variabiliteit, waaruit bleek dat de mate van variabiliteit acceptabel is voor een goed 
gebruik in de dagelijkse, klinische, praktijk.
Hoofdstuk 7 laat de resultaten zien van de bepaling van intra-observer en interobserver vari-
abiliteit voor hartkamervolume, -massa en –functie bij aangeboren hartafwijkingen. Opnieuw 
werden variatiecoefficiënten berekend voor biventriculair eind-diastolisch volume, eind-systolisch 
volume, ejectiefractie en massa. De mate van variabiliteit was het kleinst bij de bepaling van het 
eind-diastolisch volume en ejectiefractie. De grootste mate van variabiliteit werd gevonden bij de 
bepaling van eind-systolisch volume en massa. In het algemeen waren intra-observer en interob-
server variabiliteit acceptabel (respectievelijk 2.9-6.8% en 3.9-10.2% voor de verschillende para-
meters), waarbij wij denken dat de mate van variabiliteit geen belemmering is voor het detecteren 
van klinisch relevante veranderingen hartkamervolume en –functie in de tijd.
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In hoofdstuk 8 zijn de resultaten weergegeven van een studie naar de veiligheid en intra- en in-
terobserver variabiliteit bij het bepalen van hartkamervolume, -massa en ejectiefractie middels 
cardiale MRI in combinatie met een lage dosering dobutamine stress bij patiënten met een aan-
geboren hartafwijking. Meer dan 100 MRI-onderzoeken werden uitgevoerd bij 91 patiënten met 
een lage dosering dobutamine stress en bij slechts drie patiënten traden geringe bijwerkingen op 
(van hoofdpijn tot ventriculaire bigeminie). Intra- en interobserver variabiliteit waren goed met de 
grootste mate van variabiliteit bij het bepalen van het eind-systolisch volume, zoals beschreven 
in hoofdstuk 6 en 7. 
Hoofdstuk 9 laat een overzicht zien van het gebruik en de resultaten van cardiale beeldvorming in 
combinatie met fysieke of farmacologische stress bij patiënten met een aangeboren hartafwijking. 
Wij bespreken de verschillende manieren van stress, verschillende beeldvormingsmodaliteiten en 
de resultaten van de studies met echocardiografie en cardiale MRI bij patiënten met een aangebo-
ren hartafwijking zoals die tot dan toe waren gepubliceerd.
Toekomstperspectieven
De genetische basis van aangeboren hartafwijkingen
De genetische basis van aangeboren hartafwijkingen is tot op heden nog grotendeels onbekend. 
Meest waarschijnlijk is er sprake van een complex samenspel van genetische predispositie, om-
gevingsfactoren en expressie en lokatie van genen die betrokken zijn bij de vorming van het hart 
dat leidt tot niet-syndromale aangeboren hartafwijkingen [2]. Hoofdstuk 10 blikt vooruit op een 
onderwerp dat nog in de kinderschoenen staat, maar mogelijk in de toekomst belangrijk gaat wor-
den: het identificeren van de onderliggende genetische afwijking(en) bij (complexe) aangeboren 
hartafwijkingen en de implicaties hiervan voor de individuele patiënt en zijn/haar familie. In de 
laatste tien jaar is er veel vooruitgang geboekt bij het identificeren van genetische factoren. 
Tot op heden zijn meer dan 40 kandidaatgenen geïdentificeerd die betrokken zijn bij het 
ontstaan van niet-syndromale aangeboren hartafwijkingen bij mensen. NKX2-5 en GATA4 zijn twee 
transcriptiefactoren die betrokken zijn bij de morfogenese van de linker en rechter hartkamer. Ze 
kunnen beschouwd worden als kandidaatgenen voor het ontstaan van een functioneel univentri-
culair hart met onderontwikkeling van de rechter of linker hartkamer. Wij hebben gekeken naar de 
incidentie van mutaties van deze twee transcriptiefactoren bij 38 patiënten met een functioneel 
univentriculair hart. Er werden geen mutaties gevonden van NKX2-5. Bij twee patiënten werden 
in totaal drie GATA4 mutaties gevonden. Beide patiënten hadden een onderontwikkeling van de 
rechter hartkamer, een bevestiging van de betrokkenheid van GATA4 bij de morfogenese van de 
rechter kamer. Hoe pathogeen deze mutaties zijn, kan uit onze studie niet worden bepaald. Een 
voorspellingsalgoritme gaf echter aan dat één van de mutaties leidt tot een verandering van het 
corresponderende eiwit en zou in theorie een pathogene mutatie kunnen zijn. 
Optimaliseren van de totale cavopulmonale connectie
Intra-atriale laterale tunnel of extracardiale conduit?
De Fontan operatie is een palliatieve operatie die de levensduur van patiënten met een functio-
neel univentriculair hart aanzienlijk heeft verlengd [3]. De keuze voor een van beide hedendaagse 
modificaties van de Fontan operatie wordt bepaald door chirurgische voorkeur van techniek en 
theoretische overwegingen met betrekking tot de lange termijn resultaten. Er is meer follow-up 
tijd nodig om te kunnen bepalen of een van beide modificaties uiteindelijk superieur is wat betreft 
morbiditeit en mortaliteit. Hierbij wordt met name gekeken naar de incidentie van ritmestoornis-
sen [4], thrombo-embolische complicaties en de noodzaak tot re-operatie van zowel de intra-
atriale laterale tunnel als van de extracardiale conduit [5]. Daarnaast is het van belang om te kijken 
naar de hydrodynamische efficiëntie van beide modificaties in vivo [6]. Dit zal waarschijnlijk ook 
meer inzicht geven in de invloed van beide modificaties op het functioneren van de longcirculatie.
Functie van het pulmonale vaatbed
Verminderde inspanningscapaciteit bij Fontan patiënten wordt voornamelijk veroorzaakt door een 
beperking van de preload bij stress. De contractiele reserve, zoals in dit proefschrift is beschreven, 
is normaal in de meerderheid van de onderzochte patiënten op de kinderleeftijd en op jong vol-
wassen leeftijd. Het onvermogen van het longvaatbed om de bloedstroom tijdens inspanning te 
vergroten verhindert een toename van het slagvolume. In combinatie met mogelijk diastolische 
dysfunctie en de hoge incidentie van chronotrope incompetentie is toename van het hartminuut-
volume tijdens inspanning beperkt. Om de pathofysiologie van de Fontancirculatie beter te be-
grijpen moet duidelijk worden wat er in de longcirculatie gebeurt tijdens inspannning [7]. Deze 
kennis zal belangrijk zijn bij het vaststellen van toekomstige interventies en/of medicatie, zoals 
behandeling met fosfodiesterase remmers [8, 9]. Cardiale MRI kan een belangrijke rol spelen op dit 
onderzoeksgebied. Het is al aangetoond dat met cardiale MRI op een niet invasieve manier infor-
matie kan worden verkregen over bloedstroom dynamiek in de totale cavopulmonale connectie 
[10, 11]. Om deze data te verifiëren zullen echter invasieve metingen met hartcatheterisatie nodig 
zijn, vanzelfsprekend in een zo klein mogelijke patiëntengroep [12].
Vroege tekenen van Fontan falen
Om de zorg voor patienten met een functioneel univentriculair hart te verbeteren is het belangrijk 
om patiënten met een hoog risico op (acute) achteruitgang van klinische conditie in een vroeg 
stadium te herkennen. Idealiter kan dit worden bepaald met een marker die al in een pre-sympto-
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matisch stadium wordt verkregen. In dit proefschrift hebben we gekeken naar de uitvoerbaarheid, 
veiligheid en meetvariabiliteit van cardiale MRI (zowel in rust als tijdens lage dosering dobutamine 
stress) uitgevoerd bij patiënten met verschillende soorten aangeboren hartafwijkingen. Een abnor-
male reactie op lage dosering dobutamine stress bij cardiale MRI en de mogelijke veranderingen in 
deze reactie bij seriële metingen zou zo’n marker kunnen zijn die patiënten identificeert met een 
verhoogde kans op Fontan falen. Hierbij kan gekeken worden naar het volume van de hartkamer 
– een afgeleide van preload, contractiliteit en afterload van de hartkamer – en bijvoorbeeld naar 
metingen van de functie van het longvaatbed. In de toekomst zal bepaald moeten worden wat de 
optimale dosering van dobutamine is om deze parameters te bepalen. Alhoewel fysieke stress de 
beste stressor is voor het testen van het gehele samenwerkende systeem van respiratie en circula-
tie, is het niet goed mogelijk om dit in combinatie met cardiale MRI uit te voeren. 
Bij verschillende soorten aandoeningen zijn biomarkers nuttig om klinische relevante 
problemen (in een vroeg stadium) aan te tonen [13, 14]. In onze studie is gekeken naar de mogelijk 
waarde van het bepalen van de biomarker NT-pro BNP. In onze kleine en diverse studiepopulatie 
gaf NT-pro-BNP echter geen toegevoegde waarde. Grotere studies met inbegrip van meerdere 
markers moeten uitmaken wat de mogelijkheden zijn voor het gebruik van biomarkers bij patiën-
ten na Fontan operatie. 
Verbetering van de zorg voor Fontan patiënten
De lange termijn resultaten van de Fontan operatie voor patiënten met een functioneel univen-
triculair hart zijn nog relatief onbekend. Studies waarin is gekeken naar lange termijn resulta-
ten zijn veelal uitgevoerd bij patiënten die geopereerd zijn volgens inmiddels verouderde Fontan 
modificaties. Sinds de introductie van de Fontan operatie zijn er veel aanpassingen geweest in 
bijvoorbeeld de indicatiestelling, het gestageerd uitvoeren van de operatie en de leeftijd waarop 
operatie plaatsvindt. Daarnaast zijn er veranderingen in medicamenteuze therapie, alhoewel deze 
niet gestoeld zijn op evidence based medicine. Een belangrijke uitkomstmaat is kwaliteit van leven, 
een parameter die vaak ofwel niet is bepaald, ofwel niet goed is gedefinieerd. Veel studies die zijn 
gedaan bij patiënten na Fontan operatie zijn uitgevoerd in kleine patiëntengroepen. Voor de toe-
komst is het belangrijk om gedetailleerd, gestandaardiseerd en goed gemonitorde follow-up uit te 
voeren om de lange termijn resultaten en hun implicaties te verduidelijken. Multicenter onderzoek 
is hierbij van cruciaal belang teneinde de patiëntenaantallen in toekomstige studies te vergroten. 
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Wat in het vat zit, verzuurt niet. De laatste loodjes wegen het zwaarst.
De afronding van dit proefschrift heeft enige tijd in beslag genomen. Maar hier is het dan en hopelijk 
hebt u eerst de voorgaande inhoud gelezen alvorens aan dit dankwoord te beginnen. Bij de tot-
standkoming van dit proefschrift zijn vele mensen en afdelingen betrokken geweest: 
Zonder de deelnemende patiënten en hun ouders geen onderzoek. Mijn dank aan hen allen is 
groot. Het was een intensieve onderzoeksdag, zowel voor ouders als patiënten. Nieuwe onderzoe-
ken, soms in een voor hun nieuw ziekenhuis. Confronterend qua uitslag of bij het terugdenken aan 
de moeilijke periode die allen in de eerste levensjaren hebben meegemaakt. Het was dapper om 
deel te nemen. Zestig gezonde kinderen kwamen belangeloos voor MRI onderzoek, zodat normaal-
waarden gemaakt konden worden. Bedankt voor jullie deelname, de gegevens zijn zeer waardevol, 
ook voor andere onderzoeken.
Zonder de deelnemende afdelingen geen onderzoek. Dus ook veel dank aan de afdelingen kinder- 
en congenitale cardiologie en de afdelingen thoraxchirurgie van het Erasmus MC, UMC Utrecht en 
UMC St Radboud. Dank aan de kinder- en congenitaal cardiologen voor hulp en vragen over patiën-
tselectie, over uitkomsten van de onderzoeken en bij beoordeling van de artikelen. Natuurlijk ook 
dank aan al het ondersteunend personeel – secretaresses, hartfunctie-assistenten, echo-laboran-
tes – van deze afdelingen voor hun hulp bij dit onderzoek. Veel dank aan de thoraxchirurgen voor 
hun prachtige patientenbestanden en medebeoordeling van de artikelen.
Zonder cardiale MRI geen onderzoek. Dank aan de afdeling radiologie voor gebruikmaking van de 
MRI scanner in het Sophia kinderziekenhuis. Piotr, dank voor de tijd die je hebt vrijgemaakt om na 
te denken over opnames. Adriaan, dank voor je beoordelingen van de artikelen, als radioloog heb 
je een andere kijk op zaken, dat maakt het geheel beter. Prof.dr. G.P. Krestin, promotor, dank voor 
de ondersteuning bij dit project.
Een drietal afdelingen heeft een bijdrage gehad in delen van onderzoeken. 
-  De afdeling klinische chemie, onder supervisie van Yolande de Rijke en Frans Boomsma: 
dank voor het bepalen van biomarkers en jullie beoordeling van het bijbehorende artikel. 
-  De afdeling klinische genetica, onder supervisie van Dennis Dooijes: dank voor je gezel-
ligheid op de 24e verdieping. Ondanks dat mooie uitzicht moet het wel heerlijk zijn om 
dichter bij huis te werken. Marja Wessels bedank ik voor de inbreng in het artikel.
-  De afdeling experimentele cardiologie, met medewerking van Prof.dr. R. Krams en Frank 
Helderman, onderzoeker: het was een uitdaging om de shear stress te berekenen bij de 
Fontan patiënten, dank voor jullie hulp en inzicht bij de analyses.
Zonder leescommissie geen proefschrift. Graag bedank ik Prof.dr. D. Tibboel, Prof.dr. A.J.J.C. Bogers 
en Prof.dr. J.W. Roos-Hesselink voor de beoordeling van mijn proefschrift en de commentaren die 
ik kreeg. 
Zonder grote commissie geen verdediging. Een woord van dank aan Prof.dr. M. Gewillig, Prof.dr. 
N.A. Blom, Prof.dr. A.J. v/d Heijden en Prof.dr. F. Haas voor aanvulling van de grote commissie en 
voor deelname aan deze dag.
Een speciaal woord van dank voor:
Mijn promotor, Prof.dr. W.A. Helbing, beste Wim, ik heb ongetwijfeld een paar grijze haren bij je 
veroorzaakt. Je hebt ooit een mooi project op papier gezet. Je had op het oog om bij deze patiën-
tengroep in één keer zoveel mogelijk parameters te bepalen. Dat is kenmerkend voor je, je bekijkt 
de dingen breed, soms misschien wel te breed. Dank voor je geduld.
Mijn co-promotor, Mw. Dr. L. Kapusta, lieve Livia, dank voor alles! Wat fijn om je te leren kennen. 
Ik heb bewondering voor je gedrevenheid en enthousiasme. 
Dr. J.L.M. Strengers, beste Jan, dank voor je deelname aan dit onderzoek met je afdeling. Wat een 
zoektocht in het WKZ om de patiënten “boven water te krijgen”!
Prof.dr. A.J.J.C. Bogers wil ik bedanken voor de leermomenten bij medebeoordeling van een aantal ar-
tikelen in een vroeg stadium. Altijd de snelste reactie, kritisch en een heldere manier van beoordelen. 
Prof.dr. H. Boersma, beste Eric, onmisbaar en altijd snel bereikbaar voor vragen over statistiek. De 
aantallen waren vaak laag, maar met jouw deskundigheid en eerlijkheid in de analyses is het een 
mooi geheel geworden. Ik heb er veel waardering voor.
Jochem, Matthijs, Wilfred, Saskia: bedankt voor de gezelligheid, de lach en de traan en ik ga er van 
uit dat er nog met regelmaat etentjes volgen.
Jochem: al zolang onderzoeker af, het is nog steeds knap hoe jij destijds in jouw project bent 
doorgegaan. 
Matthijs en Wilfred: 2012 is een prachtig jaar om te promoveren.
Saskia: je gaat dit jaar ook ongetwijfeld halen, wat hebben we samen veel contouren getekend!
198 199
Kees en Vivian, broer en straks officieel schoonzus, ook voor jullie wordt 2012 een jaar om niet te 
vergeten. Dat er nog maar vele feestjes mogen volgen!
Mijn ouders, belangrijke “hulp” in ons gezin, samen met jullie houden we de boel draaiend. Wat 
heerlijk dat we zo’n fijne band hebben. Dank voor jullie steun bij alles wat we doen, ookal hadden 
jullie vaak geen idee wat ik eigenlijk aan het doen was.
Lieve Matthijs, David en Amanda, met jullie heerlijke lach en gedrag is het iedere dag feest. Ik 
geniet intens van jullie!
Lieve Maarten, we hebben al veel mooie dingen samen meegemaakt, dit is er één van. Weet wat 
voor moois er in het verschiet ligt. Ik hoop het allemaal met jou mee te maken. 
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Daniëlle Robbers-Visser is geboren op 8 april in 1977 in Huizen. Zij ging naar de middelbare school 
van 1989 t/m 1995; het christelijk college Stad en Lande dat in het eindexamen jaar werd omge-
doopt naar het Erfgooierscollege. In oktober 1995 werd zij nageplaatst voor de studie geneeskunde 
aan de Universiteit Utrecht. In het 4e jaar deed zij haar wetenschappelijke stage bij de afdeling 
kindercardiologie (begeleider Prof.dr. E.J. Meijboom) naar de waarde van CK-MB na de arteriële 
switch operatie. Voor zij met haar co-schappen begon, ging zij voor 3 maanden naar the Children’s 
Hospital of Philadelphia, afdeling kindercardiologie, voor onderzoek naar de groei van de neo-
aorta na palliatie van het hypoplastisch linker hart syndroom (begeleider Prof.dr. G. Wernovsky). 
De co-schappen werden afgerond met een keuze co-schap bij de afdeling kindercardiologie van 
the Royal Children’s Hospital in Melbourne, Australië (begeleider Prof.dr. D.J. Penny). Na het beha-
len van het artsendiploma eind 2002 werkte zij kort als poortarts in het IJsselmeerziekenhuis in 
Lelystad en daarna als ANIOS kindergeneeskunde in het Gelre ziekenhuis in Apeldoorn (opleider 
Dr. G.T. Heikens). In 2004 startte zij met onderzoek bij de afdeling kindercardiologie/radiologie 
van het Erasmus Medisch Centrum (promotoren Prof.dr. W.A. Helbing en Prof.dr.  G.P. Krestin), de 
basis voor dit proefschrift. In 2009 werkte zij enkele maanden als ANIOS cardiologie in het UMC 
St Radboud te Nijmegen (opleider Prof.dr. J.L.R.M. Smeets) alvorens in augustus vanuit dit centrum 
met de opleiding tot cardioloog te beginnen. Inmiddels is de vooropleiding interne geneeskunde 
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Daniëlle is getrouwd met Maarten Robbers. Zij hebben drie prachtige kinderen: Matthijs (2004), 
David (2007) en Amanda (2010).
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